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Abstract 
The purpose of this investigation was to determine if 8 exercise endurance training 
(ET) sessions over 2 weeks significantly alters cardiac autonomic modulation, as measured by 
heart rate variability (HRV).  Twenty-four college-aged males were recruited for this study 
and were randomized into either an exercise group (EX; n=12) or a control group (CT; n=12).  
EX underwent 2 weeks of ET on a cycle-ergometer (frequency: four times/week; duration: 40 
minutes; intensity 80-85% HRreserve), whereas CT was instructed not to alter their previous 
level of physical activity.  Five-minute ECG tracings were collected for HRV under the 
following conditions:  5 minutes of paced breathing at a frequency of 12 breaths/minute (PB), 
5 minutes of spontaneous breathing (SB1), 5 minutes of 70-degree head-up tilt on a tilt table 
(TILT), and a second 5-minute period of spontaneous breathing (SB2).  The data were 
collected on 5 occasions (Test 1-Test 5) during a 2-week period.  HRV was reported as the 
standard deviation of RR intervals, and as normalized units (NU) of the natural logarithm of 
high- and low-frequency power (lnHF and lnLF).  A mixed-model analysis of variance 
(ANOVA) with repeated measures was used to evaluate any Group X Time interaction, or 
main effects of Group or Time on HRV.  Alpha was set at 0.05.  EX exhibited a significant 
increase in peak oxygen consumption (8%), whereas this parameter was unchanged in CT.  
During PB, ANOVA revealed a Group X Time interaction such that EX exhibited decreases 
in lnLFNU (2.89 vs. 3.45 ln%) and lnLF/lnHF (0.82 vs. 0.90) during Test 5 compared to Test 
1, while there were no such differences across time in CT.  Additionally, there was a Group X 
Time interaction during TILT such that EX exhibited lower lnLFNU (4.12 vs. 4.42 ln%) and 
lnLF/lnHF (1.12 vs. 1.46), and greater lnHFNU (3.52 vs. 2.53 ln%) during Test 5 compared to 
Test 1, while these indices were unchanged across time in CT.  These data suggest that 8 ET 
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sessions over 2 weeks increases vagal modulation of the heart.  Furthermore, these data 
suggest that it takes at least 8 ET sessions to induce such changes.  
 1 
Introduction 
Heart rate variability (HRV) has gained recent popularity as a noninvasive index of 
cardiac autonomic modulation and can provide a reliable measure of cardiac sympathovagal 
balance (Berntson et al. 1997).  More specifically, power spectral analysis of HRV provides a 
marker of cardiac autonomic balance by separating the beat-to-beat fluctuations in heart rate 
into those occurring at lower frequencies (LF: 0.04 – 0.15 Hz) and those occurring at higher 
frequencies (HF: 0.15 – 0.40 Hz).  Those fluctuations in the HF range appear to mainly reflect 
parasympathetic, or vagal, modulation of the heart, whereas those in the LF range are believed 
to reflect both sympathetic and parasympathetic influences (Akselrod et al. 1981; Pagani et al. 
1986).  A list of acronyms regarding HRV indices and arterial pressure variables used in this 
manuscript can be seen in Table 1. 
Previous research further suggests that endurance exercise training may alter HRV to 
reflect a more favorable cardiac autonomic balance (i.e. greater vagal modulation) in young, 
healthy individuals (Al-Ani, Munir, White, Townend, & Coote, 1996; De Meersman, 1992; 
Levy et al. 1998).  For example, Al-Ani et al. reported that 6 weeks of cycling exercise at an 
intensity of 85% HRmax significantly elevated both HF and LF power.  Furthermore, De 
Meersman reported that 8 weeks of running at an intensity of 75-90% HRmax significantly 
elevated the respiratory sinus arrhythmia, and Levy et al. reported significant elevations in the 
standard deviation of normal RR intervals following 6 months of training at 50-85% HRreserve.  
Although the exact mechanism of this shift in sympathovagal balance has not yet been 
determined, there exists evidence of a reduction in right atrial beta-adrenergic receptor density 
(Hammond, White, Brunton, & Longhurst, 1987) and elevated acetylcholine concentration at 
the heart (De Schryver & Mertens-Strythagen, 1975).  Furthermore, De Souza, Michelini, and 
Table 1 
 
Acronyms for HRV and Arterial Pressure Variables 
 
Variable 
 
Definition 
Mean RR Interval (ms) 
 
Average of all RR intervals over entire 5-min ECG recording 
SDNN (ms) 
 
Standard deviation of all RR intervals over entire 5-min ECG recording 
TP (ms2) 
 
Total power; Power between 0.00 and 0.40 Hz of the heart rate power spectrum 
LF (ms2) 
 
Low-frequency power; Power between 0.04 and 0.15 Hz of the heart rate power spectrum 
HF (ms2) 
 
High-frequency power; Power between 0.15 and 0.40 Hz of the heart rate power spectrum 
LFNU (%) 
 
Low-frequency normalized units; LF/(LF+HF) * 100 
HFNU (%) 
 
High-frequency normalized units; HF/(LF+HF) * 100 
ln 
 
Natural logarithm 
SBP (mmHg) 
 
Systolic blood pressure 
DBP (mmHg) 
 
Diastolic blood pressure 
MAP (mmHg) 
 
Mean arterial pressure 
 
 
 
2
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Fior-Chadi (2001) recently reported a reduction in α2-adrenoreceptor density and affinity in 
the rat medulla oblongata following exercise training. 
Although it appears that endurance exercise training results in favorable alterations in 
autonomic control of the heart, the time course of these changes are not well understood.  
Most studies that have approached this issue have examined plasma catecholamine and/or 
heart rate at rest and during physical activity (Meredith et al. 1990; Mier, Turner, Ehsani, & 
Spina, 1997; Winder, Hagberg, Hickson, Ehsani, & McLane, 1978).  For example, Winder et 
al. examined the time course of changes in plasma catecholamines in response to 40 minutes 
of interval training at 95% VO2max, in a group of healthy males (age: 30±1 yr).  They 
subsequently reported that heart rate, along with plasma norepinephrine (NE) and epinephrine 
(E) were reduced during submaximal exercise at the same absolute workload following six 
exercise sessions.  Meredith et al. reported a significant reduction in resting heart rate and 
resting plasma NE following six 30-minute sessions of cycling at 60-70% VO2max, with a 
further reduction following the ninth session.  Additionally, Mier et al. reported a reduction in 
resting heart rate in healthy individuals (age: 26±2 yr) in response to 10 sessions of interval 
training on a cycle ergometer at 65-95% VO2peak.  However, the inferences that can be drawn 
from these studies are somewhat limited, mainly due to the inability of these techniques to 
clearly differentiate between the sympathetic and parasympathetic branches of the autonomic 
nervous system.  Thus, it would be of interest to evaluate the time course of training-induced 
autonomic changes using HRV, which appears to be more sensitive to changes in 
sympathovagal balance (Pagani et al. 1986).  Additionally, since altered indices of HRV have 
been associated with an increased risk of cardiac events (Tsuji at al. 1994), elucidation of a 
possible time course of any endurance training-induced alterations in HRV would be 
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clinically relevant in that it may provide clinicians with additional information regarding 
exercise programming in both healthy and at-risk populations.   
Of concern when applying such a model is the observation that HRV appears to be 
influenced by acute laboratory conditions.  For example, Hayano et al. (1994) reported that 
paced breathing results in a shift in the HRV power spectrum towards the HF range, a 
phenomenon thought to be a result of the respiratory sinus arrhythmia.  Moreover, autonomic 
reactivity as observed under stressors such as head-up tilt may provide insight beyond that 
which is gleaned from resting measures alone.  Furlan et al. (1993) reported that head-up tilt, 
which elicits a sympathetic outflow, results in a shift towards the LF range.  At present it is 
not clear as to how HRV measured under different laboratory conditions might influence the 
sensitivity of HRV to detect training induced alterations in autonomic modulation of the heart. 
Purposes 
Therefore, the objectives of this investigation are to: 1) examine adaptations in cardiac 
autonomic modulation as measured by HRV under different conditions, including paced 
breathing and head-up tilt, in response to 8 endurance exercise training sessions performed 
over 2 weeks, and 2) to evaluate a possible time course of any training-induced alterations in 
autonomic modulation of the heart. 
Hypotheses 
 It is hypothesized that participants undergoing 2 weeks of high-intensity exercise 
training will exhibit a greater relative vagal modulation of the heart, as identified by an 
increase in HF power, and a concurrent decrease in LF power, expressed as normalized units.  
Furthermore, in accordance with previous studies evaluating endurance training on markers of 
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autonomic activity, it is hypothesized that these training-induced alterations will be evident at 
least by the sixth training session.    
 6 
Materials and Methods 
 
Participants 
Twenty-four participants (mean age = 23.1 years) were recruited from classes at 
Louisiana State University in Baton Rouge, and voluntarily completed all of the study 
requirements. Criteria for eligibility were: 1) male sex, 2) 18-30 years of age, 3) an energy 
expenditure of less than 2000 kcal•week-1 for the previous 3 months, and 4) a VO2peak 
between 30-45 ml•kg-1•min-1. Exclusion criteria were: 1) presence of any documented 
cardiovascular, metabolic, or neurological disease, 2) regular consumption of any medication 
that influences the cardiovascular system, 3) participation in regular physical activity (an 
energy expenditure of greater than 2000 kcal•week-1), and 4) a VO2peak lower than 30    
ml•kg-1•min-1 or greater than 45 ml•kg-1•min-1.  
Materials 
 The Health Status Questionnaire (Howley & Franks, 1997) was used to obtain details 
of each participant’s health history and the Aerobics Center Longitudinal Study Physical 
Activity Questionnaire (Pereira et al. 1997) was used to evaluate the participants’ level of 
habitual physical activity.  A Biopac MP100 (Santa Barbara, CA) data acquisition system and 
AcqKnowledge ACK100 (Santa Barbara, CA) software program were used to capture, 
process, and analyze an electrocardiogram (ECG) signal.  A SensorMedics Vmax 29c (Yorba 
Linda, CA) pulmonary gas exchange system was used for evaluation of each participant’s 
peak oxygen consumption (VO2peak) during a symptom-limited graded exercise test (SL-GXT) 
and a Monark 818E (Stockholm, Sweden) cycle ergometer was used for all exercise testing 
and training.  Measures of arterial blood pressure during the SL-GXT and ECG collection 
were collected using a standard sphygmomanometer and stethoscope.  Body composition was 
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evaluated using Lange skinfold calipers (Cambridge, MD).  A standard physician’s scale was 
used to evaluate participants’ height and weight.  All other information was obtained through 
a personal interview with each participant. 
Procedure 
Sequence of tests.  On the initial visit to the laboratory, each participant gave written informed 
consent, completed the Health Status Questionnaire and physical activity questionnaire, was 
assessed for body composition, and completed a SL-GXT for determination of VO2peak.  
Participants were then randomly assigned to either an exercise training group (EX) or to a 
control group (CT) via stratified random selection in an attempt to experimentally control for 
the possible influence of VO2peak and physical activity on the dependent measures and 
treatment effects.   
Following the initial assessment, the EX group underwent two-weeks of endurance 
exercise training, whereas the CT group was asked to maintain their previous level of physical 
activity.  Training was performed four days per week (Monday, Tuesday, Thursday, and 
Friday).  In order to evaluate the time course of any changes in HRV that occurred during the 
course of the training protocol, ECGs were collected and HRV was evaluated in both groups 2 
times per week (Monday and Thursday) and at the same time of day as their previous ECG 
collection, with the EX group being evaluated prior to their exercise session.  On the Monday 
immediately following the training period, all participants underwent a post-testing session, 
during which HRV, VO2peak, and skinfold measures were reassessed, and the physical activity 
questionnaire was completed.  The 5 days in which HRV was assessed were identified as 
Tests 1 through 5, respectively. 
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Assessment of peak oxygen consumption.  A SensorMedics Vmax 29c pulmonary gas 
exchange system (Yorba Linda, CA) was used to evaluate the participant’s VO2peak during a 
SL-GXT on an 818E Monark cycle ergometer (Stockholm, Sweden).  The SensorMedics 
system was calibrated prior to each participant reporting to the laboratory.  Upon reporting to 
the laboratory, participants were given detailed instructions regarding the SL-GXT and the 
participant was prepared as follows: 1) a Polar (Woodbury, NY) heart rate monitor was 
secured around the participant’s thoracic region, 2) a mouthpiece with a flow sensor was 
attached to the Vmax system and inserted into the participant’s mouth to sample expired air, 
and 3) a sphygmomanometer was secured around the participant’s upper left arm for 
evaluation of blood pressure. The participant was then asked to sit upright on the cycle 
ergometer while resting heart rate, blood pressure, and cardiorespiratory measures were 
recorded. Following a brief resting period on the cycle ergometer, the participant was asked to 
begin cycling at 70 rpm at a workload of 0.5 Kp.  The workload on the ergometer was 
progressively increased by 0.5 Kp every 2 minutes.  Heart rate and ratings of perceived 
exertion (RPE) using the Borg’s scale (American College of Sports Medicine, 2000) were 
recorded every minute.  Additionally, arterial blood pressure was recorded during every stage 
of the test.  The participant was encouraged to continue cycling until he could no longer 
maintain a pace of 70 rpm, at which time the workload was reduced to 0.5 Kp while the 
participant continued to pedal slowly for 2-4 minutes.  Other cardiorespiratory variables 
measured during the SL-GXT included oxygen consumption (VO2) in both relative      
(ml•kg-1•min-1) and absolute (l•min-1) units, minute ventilation (VE), respiratory frequency 
(RF), tidal volume (VT), volume of expired carbon dioxide (VCO2), and the respiratory 
quotient (RQ).  Three of the following criteria had to be met to ensure that the participant put 
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forth a maximal effort: 1) failure of heart rate to increase with further increases in intensity, 2) 
plateau of oxygen uptake with increased workload, 3) RQ of > 1.15, and 4) an RPE >17.          
Assessment of body composition.  Body composition was assessed using Lange skinfold 
calipers (Cambridge, MD).  Skinfold measures were taken at the following sites on each 
participant and reported in millimeters: 1) chest, 2) tricep, 3) abdominal, 4) suprailliac, 5) 
subscapular, 6) mid-axillary, and 7) thigh.  The sum of the 7 skinfold sites were used to 
estimate percent body fat using previously established equations (American College of Sports 
Medicine, 2000). 
Physical activity questionnaire.  In order to evaluate the participants’ level of habitual 
physical activity, all participants completed the Aerobics Center Longitudinal Study Physical 
Activity Questionnaire (Pereira et al. 1997) prior to, and following participation in the study.  
This questionnaire asked the participants questions about their physical activity patterns for 
the previous 3 months.  Metabolic equivalent (MET) values were assigned to the various 
activities reported using established guidelines (American College of Sports Medicine, 2000), 
and energy expenditure was initially recorded in units of MET•min•week-1.  Energy 
expenditure was then converted to units of kilocalories•week-1. 
Exercise training.  The 2 weeks of endurance exercise training consisted of 40 minutes of 
cycling on an 818E Monark cycle ergometer (Stockholm, Sweden).  Each exercise bout 
consisted of a 5-minute “warm-up” period (cycling with no added resistance), followed by 30 
minutes of cycling at a resistance that elicited a heart rate of 80-85% HRreserve, and ended with 
a 5-minute “cool-down” period (cycling with no added resistance).  Exercise intensity was 
closely monitored using a Polar heart rate monitor (Woodbury, NY). 
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Data Acquisition 
All procedures were performed in a controlled laboratory setting (23-24 °C; ~760 
torr).  Upon reporting to the laboratory, the participant was asked to lie supine on a tilt table.  
Ag/AgCl electrodes were then arranged on the participant’s anterior side in a standard 3-lead 
configuration and the electrodes were connected to the Biopac MP100 data acquisition system 
(Santa Barbara, CA).  The AcqKnowledge ACK100 software program (Santa Barbara, CA) 
was used to collect a continuous ECG signal at 500 Hz.  Following a 15-minute resting 
period, ECG data was collected during a 5-minute period of paced breathing at a frequency of 
12 cycles per minute (PB), during a 5-minute period in which the participant breathed 
spontaneously (SB1), during a 5-minute period of 70-degree head-up tilt (TILT), and during a 
subsequent 5-minute period of supine rest (SB2). Arterial pressure was assessed at the 
midpoint of each 5-minute period.  
Data Analysis 
HRV was evaluated in accordance with guidelines previously set forth (Task Force of 
the European Society of Cardiology and the North American Society of Pacing and 
Electrophysiology, 1996).  ECGs were visually inspected for non-sinus beats and, if no ectopy 
was found, were subsequently plotted as a tachogram of heart period.  The tachograms were 
then evaluated for the mean and standard deviation of all normal RR intervals (SDNN).  
Spectral analysis of HRV was derived via a 1024-point linear fast Fourier Transformation 
using a Hamming window. The resultant power density spectrum was then analyzed for total 
power (TP; 0.00-0.40 Hz), LF (0.04-0.15 Hz), and HF (0.15-0.40 Hz). LF and HF were 
further normalized (LFNU and HFNU) to better quantify sympathovagal balance. Systolic 
(SBP) and diastolic (DBP) arterial blood pressures were initially recorded and were used to 
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calculate mean arterial pressure (MAP) using the equation: MAP = DBP + 1/3 (SBP-DBP).     
Statistical Analysis 
All statistical analyses were performed with the SAS statistical package (Cary, NC).  
The Shapiro-Wilk test of normality was performed on all variables and those that violated 
assumptions of normality were transformed using the natural log (ln) algorithm.  All tests 
were considered significant at the 0.05 level. 
Descriptive and cardiorespiratory measures.  Independent T-Tests were used to examine any 
initial group differences in age and height. A mixed-model, two-way analysis of variance 
(ANOVA) with repeated measures was used to examine main effects of group or training 
period, and group X training period interactions on body weight, body composition, or 
physical activity between groups.  Similarly, a mixed-model, two-way ANOVA with repeated 
measures was used to examine cardiorespiratory measures at rest and at peak exercise during 
the SL-GXT.  When a significant Group X Time interaction was found, a one-way repeated 
measures ANOVA was used to test for simple effects and identify any pre-post differences 
within each group.   
Heart rate variability and arterial pressures during each testing session.  HRV indices and 
arterial pressures collected each testing session (Test 1 through Test 5) were analyzed with a 
mixed model, two-way ANOVA with repeated measures to examine differences between 
groups and conditions.  When a significant Group X Condition interaction was found, a one-
way repeated measures ANOVA was used to test for simple effects, and thus identify any 
differences between conditions for each group.  When the test for simple effects was 
significant, post-hoc contrasts were used to identify which conditions differed from each 
other.  Similarly, when a significant main effect of Condition was found in the absence of a 
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Group X Condition interaction, contrasts were used to identify differences between 
conditions.      
Heart rate variability and arterial pressures across time.  HRV and arterial pressures collected 
during each condition (PB, SB1, TILT and SB2) were analyzed with a mixed model, two-way 
ANOVA with repeated measures to examine differences between groups and testing sessions.  
When a significant Group X Time interaction was found, a one-way repeated measures 
ANOVA was used to test for simple effects, and thus identify any differences between testing 
sessions for each group.  When the test for simple effects was significant, post-hoc contrasts 
were used to identify which tests significantly differed from Test 1.  Similarly, when a 
significant main effect of Time was found in the absence of a Group X Time interaction, 
contrasts were used to identify which tests significantly differed from Test 1.      
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Results 
Descriptive Statistics 
 Descriptive statistics for the participants can be seen in Table 2.  There were no 
between group differences in height or weight.  Two-way ANOVA with repeated measures 
revealed a main effect of Time on percent body fat (F[1,22] = 8.21, p<0.01), indicating lower 
body fat for the entire group at post-test.  Furthermore, analysis of the PAQ revealed a Group 
X Time interaction (F[1,22] = 5474.37, p<0.01) such that EX reported an increase in physical 
activity at the post-test.   
Table 2 
 
Descriptive Statistics for the Participants (Mean, sd) 
 
Group Age 
(yr) 
 
Height 
(inches) 
Weight 
(kg) 
Body Fat 
(%) 
PAQ 
(kcal•week-1) 
 
 
  Pre Post Pre Post Pre Post 
EX 
 
 
23.1 
3 
69.6 
2 
82.6 
16 
82.2 
16 
18.1 
6 
17.2 
6† 
1685.8 
387 
3795.0 
406† 
CT 
 
 
23.1 
4 
69.1 
4 
79.1 
13 
79.1 
13 
 
15.3 
5 
15.0 
5† 
1704.9 
428 
1721.0 
419.6 
PAQ = physical activity questionnaire 
† = p<0.05 vs. pre 
 
 
Cardiorespiratory Measures 
 Cardiorespiratory measures at rest and at peak exercise can be seen in Table 3.  
ANOVA revealed a main effect of Group on resting RQ (F[1,22] = 4.42, p<0.05), reflecting 
that CT had lower values of RQ.  There was also a main effect of Time on resting VO2 
(F[1,22] = 5.24, p<0.05),  VE (F[1,22] = 6.58, p<0.05), RF (F[1,22] = 4.37, p<0.05), and VT 
(F[1,22] = 8.81, p<0.01).  These were such that VO2, VE, and VT were greater and RF was 
lower during the post-test for both groups.  ANOVA revealed Group X Time interactions on  
Table 3 
 
Cardiorespiratory Measures at Rest and at Peak Exercise (Mean, sd) 
 
Group VO2  
(ml•kg-1•min-1) 
 
VE 
(l•min-1) 
RF 
(breaths•min-1) 
VT 
(l•breath-1) 
RQ 
 
HR 
(beats•min-1) 
 
 
Pre Post Pre Post Pre Post Pre Post Pre Post Pre Post 
EX 
(Rest) 
 
4.62 
1.1 
5.36 
1.4† 
15.7 
4.1 
17.0 
4.6† 
20.6 
4.9 
17.9 
3.4† 
0.88 
0.3 
1.03 
0.3†† 
1.04 
0.1 
1.07 
0.1 
83.1 
12 
83.3 
14 
CT 
(Rest) 
 
5.60 
1.8 
6.44 
2.1† 
15.0 
2.5 
16.9 
4.4† 
18.8 
3.9 
18.2 
5.1† 
0.88 
0.3 
1.05 
0.3†† 
0.98 
0.1‡ 
0.99 
0.1‡ 
73.5 
15 
75.7 
14 
EX 
(Peak) 
 
33.48 
3.7 
36.07 
3.2†† 
113.3 
21 
126.6 
24† 
41.2 
8 
43.7 
8 
2.83 
0.7 
2.98 
0.7 
1.33 
0.1 
1.35 
0.1 
184.4 
10 
185.3 
10 
CT 
(Peak) 
 
33.88 
3.0 
32.65 
2.6 
113.6 
24 
108.5 
17 
41.4 
8 
39.8 
8 
2.82 
0.6 
2.66 
0.6 
1.34 
0.1 
1.31 
0.1 
181.2 
10 
178.9 
8 
VO2 = oxygen consumption   VT = tidal volume 
VE = minute ventilation    RQ = respiratory quotient 
RF = respiratory frequency   HR = heart rate 
† = p<0.05 vs. pre 
†† = p<0.01 vs. pre 
‡ = p<0.05 vs. EX  
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VO2peak (F[1,22] = 15.46, p<0.01), VEpeak (F[1,22] = 11.66, p<0.01), and VTpeak (F[1,22] = 
4.68, p<0.05).  These interactions were such that EX experienced increases in VO2peak 
(F[1,11] = 12.7, p<0.01) and VEpeak (F[1,11] = 6.01, p<0.05) across time, whereas these 
variables were unaltered in CT.   
Heart Rate Variability and Arterial Blood Pressure Within the Testing Sessions 
 HRV values observed within each testing session are reported in Tables 4 through 8.  
ANOVA revealed a Group X Condition interaction on the mean RR interval only during Test 
1 (F[3,66] = 3.0, p<0.05).  Tests for simple effects revealed that there were changes in the 
mean RR interval over each condition in both CT (F[3,33] = 102.2, p<0.01) and EX (F[3,33] 
= 25.08, p<0.01).  Contrasts found that in EX, the mean RR interval during TILT was less 
than that during the other three conditions (p<0.01), while in CT, the mean RR interval during 
each condition were all different from each other (p<0.01).  During Tests 2 through 5 there 
were main effects of Condition on the mean RR interval (p<0.01).  Contrasts revealed during 
these tests, the mean RR interval during TILT was lower than that during the other three 
conditions (p<0.05), and also that the mean RR interval during SB2 was greater than that 
during PB and SB1 (p<0.05).  Additionally, during Test 2, the mean RR interval during SB1 
was greater than that during PB (p<0.05).   
ANOVA also revealed a main effect of Condition on SDNN that was consistent across 
all testing sessions.  Post-hoc contrasts revealed that SDNN during TILT was significantly 
lower than that during the other three conditions during Tests 1 through 4 (p<0.01).  
Additionally within Test 2, SDNN during SB2 was higher than that during PB (p<0.05).  
Furthermore within Test 5, SDNN during TILT was significantly lower than that during PB 
and SB2 (p<0.05), and SDNN during SB2 was greater than that during SB1 (p<0.05). 
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Table 4 
HRV During Test 1 (Mean, sd) 
 
 Group 
 
 
EX CT 
 
 
PB SB1 Tilt SB2 
 
PB SB1 Tilt SB2 
 
Mean RR 
(ms)  
 
925.88 
137.3 
948.3 
140 
759.7 
108* 
987.2 
160 
956.56 
105.5†‡ 
1028.8 
124‡ 
776.2 
104* 
1092.9 
142 
SDNN 
(ms)  
 
74.3 
32 
72.5 
33 
64.4 
31* 
80.1 
21 
81.7 
29 
85.4 
29 
62.1 
26* 
90.3 
19 
lnLFNU 
(ln%)  
 
3.45 
0.5†‡ 
4.07 
0.2‡ 
4.42 
0.2* 
3.79 
0.3 
3.43 
0.4†‡ 
3.88 
0.4‡ 
4.39 
0.2* 
3.68 
0.5 
lnHFNU 
(ln%)  
 
4.17 
0.2†‡ 
3.61 
0.5‡ 
2.53 
0.7* 
3.93 
0.4 
4.16 
0.3†‡ 
3.77 
0.5‡ 
2.69 
0.7* 
3.96 
0.4 
lnLF/ 
lnHF  
 
0.90 
0.1†‡ 
1.08 
0.1‡ 
1.46 
0.3* 
0.99 
0.1 
0.90 
0.1†‡ 
1.03 
0.1‡ 
1.40 
0.2* 
0.96 
0.1 
Mean RR = mean RR interval    TP = total power 
SDNN = standard deviation of normal RR intervals  LF = low-frequency power 
HF = high-frequency power    NU = normalized units 
ln = natural logarithm     ms = milliseconds 
* = p<0.05 vs. other 3 conditions for specified group 
† = p<0.05 vs. SB1 for specified group 
‡ = p<0.05 vs. SB2 for specified group 
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Table 5 
 
HRV During Test 2 (Mean, sd) 
 
 Group 
 
 
EX CT 
 
 
PB SB1 Tilt SB2 
 
PB SB1 Tilt SB2 
 
Mean RR 
(ms)  
 
923.64 
112.6†‡ 
951.8 
115‡ 
736.0 
83* 
1009.0 
107 
969.42 
102.5†‡ 
1051.3 
138‡ 
787.0 
131* 
1090.2 
142 
SDNN 
(ms)  
 
77.0 
38‡ 
77.5 
36 
63.5 
28* 
95.4 
32 
84.3 
29‡ 
89.3 
28 
60.7 
25* 
88.9 
14 
lnLFNU 
(ln%)  
 
3.29 
0.7†‡ 
4.06 
0.2 
4.40 
0.1* 
3.94 
0.4 
3.19 
0.5†‡ 
3.92 
0.4 
4.39 
0.2* 
3.75 
0.4 
lnHFNU 
(ln%)  
 
4.17 
0.3†‡ 
3.66 
0.3 
2.78 
0.5* 
3.73 
0.4 
4.28 
0.2†‡ 
3.75 
0.5 
2.71 
0.6* 
3.94 
0.4 
lnLF/ 
lnHF  
 
0.89 
0.1†‡ 
1.07 
0.1 
1.40 
0.2* 
1.05 
0.1 
0.85 
0.1†‡ 
1.03 
0.1 
1.44 
0.3* 
0.98 
0.1 
Mean RR = mean RR interval    TP = total power 
SDNN = standard deviation of normal RR intervals  LF = low-frequency power 
HF = high-frequency power    NU = normalized units 
ln = natural logarithm     ms = milliseconds 
* = p<0.05 vs. other 3 conditions for specified group 
† = p<0.05 vs. SB1 for specified group 
‡ = p<0.05 vs. SB2 for specified group 
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Table 6 
 
HRV During Test 3 (Mean, sd) 
  
 Group 
 
 
EX CT 
 
 
PB SB1 Tilt SB2 
 
PB SB1 Tilt SB2 
 
Mean RR 
(ms)  
 
958.3 
101‡ 
971.8 
145‡ 
768.2 
137* 
1036.2 
165 
998.23 
97.2‡ 
1053.5 
100‡ 
797.7 
130* 
1123.5 
98 
SDNN 
(ms)  
 
91.0 
50 
78.4 
30 
69.4 
21* 
94.4 
31 
82.9 
32 
83.4 
35 
63.8 
26* 
84.7 
31 
lnLFNU 
(ln%)  
 
3.36 
0.7†‡ 
3.99 
0.3 
4.39 
0.2* 
3.83 
0.3 
3.26 
0.5†‡ 
3.83 
0.4 
4.46 
0.1* 
3.73 
0.4 
lnHFNU 
(ln%)  
 
4.14 
0.3†‡ 
3.70 
0.5 
2.75 
0.6* 
3.89 
0.4 
4.25 
0.2†‡ 
3.84 
0.5 
2.36 
0.8* 
3.95 
0.6 
lnLF/ 
lnHF  
 
0.91 
0.1† 
1.07 
0.2 
1.38 
0.2* 
1.00 
0.1 
0.86 
0.1 
0.99 
0.1 
1.54 
0.3* 
0.97 
0.1 
Mean RR = mean RR interval    TP = total power 
SDNN = standard deviation of normal RR intervals  LF = low-frequency power 
HF = high-frequency power    NU = normalized units 
ln = natural logarithm     ms = milliseconds 
* = p<0.05 vs. other 3 conditions for specified group 
† = p<0.05 vs. SB1 for specified group 
‡ = p<0.05 vs. SB2 for specified group 
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Table 7 
 
HRV During Test 4 (Mean, sd) 
 
 Group 
 
 
EX CT 
 
 
PB SB1 Tilt SB2 
 
PB SB1 Tilt SB2 
 
Mean RR 
(ms)  
 
958.33 
123‡ 
982.9 
155‡ 
775.4 
126* 
1039.5 
166 
965.22 
161‡ 
1004.7 
156‡ 
773.6 
131* 
1091.5 
145 
SDNN 
(ms)  
 
91.8 
52 
85.9 
30 
71.6 
30* 
89.8 
25 
79.4 
32 
87.5 
33 
61.3 
26* 
90.6 
25 
lnLFNU 
(ln%)  
 
3.31 
0.8†‡ 
4.07 
0.3 
4.41 
0.2* 
3.89 
0.4 
3.19 
0.6†‡ 
3.88 
0.5 
4.40 
0.1* 
3.82 
0.4 
lnHFNU 
(ln%)  
 
4.09 
0.4†‡ 
3.56 
0.5 
2.62 
0.7* 
3.75 
0.5 
4.24 
0.2†‡ 
3.79 
0.4 
2.72 
0.6* 
3.81 
0.6 
lnLF/ 
lnHF  
 
0.91 
0.2†‡ 
1.11 
0.2 
1.48 
0.4* 
1.04 
0.2 
0.85 
0.1†‡ 
1.02 
0.1 
1.42 
0.3* 
1.01 
0.2 
Mean RR = mean RR interval    TP = total power 
SDNN = standard deviation of normal RR intervals  LF = low-frequency power 
HF = high-frequency power    NU = normalized units 
ln = natural logarithm     ms = milliseconds 
* = p<0.05 vs. other 3 conditions for specified group 
† = p<0.05 vs. SB1 for specified group 
‡ = p<0.05 vs. SB2 for specified group 
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Table 8 
 
HRV During Test 5 (Mean, sd) 
 
 Group 
 
 
EX CT 
 
 
PB SB1 Tilt SB2 
 
PB SB1 Tilt SB2 
 
Mean RR 
(ms)  
 
985.34 
149‡ 
983.2 
167‡ 
773.2 
142* 
1025.0 
185 
987.06 
100‡ 
1042.2 
140‡ 
801.7 
108* 
1116.0 
159 
 
SDNN 
(ms)  
 
99.3 
56 
79.8 
32‡ 
79.7 
50‡φ 
101.2 
30 
91.1 
29 
87.8 
23‡ 
68.0 
29‡φ 
93.5 
27 
lnLFNU 
(ln%)  
 
2.89 
0.8* 
4.06 
0.3 
4.12 
0.2 
3.63 
0.4 
3.36 
0.5† 
3.84 
0.5 
4.41 
0.1* 
3.67 
0.3 
lnHFNU 
(ln%)  
 
4.32 
0.2 
3.59 
0.44φ 
3.52 
0.5φ 
4.01 
0.4 
4.19 
0.2 
3.78 
0.5 
2.65 
0.6* 
4.03 
0.3 
lnLF/ 
lnHF  
 
0.82 
0.1 
1.10 
0.1‡φ 
1.12 
0.1‡φ 
0.96 
0.1φ 
0.89 
0.1 
1.01 
0.1 
1.41 
0.2* 
0.95 
0.1 
Mean RR = mean RR interval    TP = total power 
SDNN = standard deviation of normal RR intervals  LF = low-frequency power 
HF = high-frequency power    NU = normalized units 
ln = natural logarithm 
* = p<0.05 vs. other 3 conditions for specified group 
† = p<0.05 vs. SB1 for specified group 
‡ = p<0.05 vs. SB2 for specified group 
φ = p<0.05 vs. PB 
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 Regarding the spectral indices, there were main effects of Condition on lnLFNU and 
lnHFNU during Tests 1 through 4.  Contrasts then revealed that lnLFNU was greater (and 
lnHFNU was lower) during TILT compared to the other three conditions (p<0.05), and that 
lnLFNU was lower (and lnHFNU was greater) during PB compared to SB1 and SB2 
(p<0.05).  Likewise, there was also a main effect of Condition on lnLF/lnHF during Tests 1, 
2, and 4 (p<0.01).  Contrasts revealed that during these tests, lnLF/lnHF during TILT was 
greater than that during the other three conditions (p<0.05), and that lnLF/lnHF during PB 
was less than that during SB1 and SB2 (p<0.05).  Exclusively during Test 5, there were 
Group X Condition interactions on lnLFNU (F[3,66] = 3.33, p<0.01), lnHFNU (F[3,66] = 
8.81, p<0.01), and lnLF/lnHF (F[3,66] = 10.39, p<0.01).  Tests for simple effects found that 
both EX and CT displayed differences in lnLFNU, lnHFNU, and lnLF/lnHF between the 
conditions (p<0.01).  Contrasts revealed that lnLFNU during PB was significantly lower than 
the other three conditions in EX (p<0.05), whereas in CT, lnLFNU during TILT was greater 
than that during the other three conditions (p<0.05) and lnLFNU during PB was less than that 
during SB1 and TILT (p<0.05).  Additionally, contrasts found that lnHFNU during PB was 
greater than that during SB1 and TILT in EX (p<0.05), whereas in CT, lnHFNU during TILT 
was lower than that during the other three conditions (p<0.05).  Contrasts also revealed that 
while lnLF/lnHF during TILT was greater than that during the other three conditions in CT 
(p<0.05), in EX lnLF/lnHF during PB was lower than the other three conditions (p<0.05), and 
lnLF/lnHF during SB2 was lower than SB1 and TILT (p<0.05).  Lastly, during Test 3 there 
was a Group X Condition interaction on lnLF/lnHF (p<0.05).  Tests for simple effects found 
that both CT (p<0.01) and EX (p<0.01) exhibited changes in lnLF/lnHF across time.  
Contrasts revealed that lnLF/lnHF during TILT was greater than that of the other three 
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conditions in CT (p<0.05), while in EX, lnLF/lnHF was lower during PB compared to SB1 
(p<0.05) in addition to lnLF/lnHF during TILT being greater than the other three conditions 
(p<0.05).   
 Arterial blood pressures within Tests 1 through 5 can be seen in Tables 9 though 13, 
respectively.  ANOVA revealed a main effect of Condition on DBP and MAP within all Tests 
(p<0.01).  Post-hoc contrasts revealed that DBP and MAP were higher during TILT compared 
to the other three conditions (p<0.01).  Additionally, DBP and MAP were greater during PB 
compared to SB2 during Test 3 (p<0.05), and greater during PB compared to SB1 during Test 
4 (p<0.05).  There was also a main effect of Condition on SBP within Tests 2 and 5 (p<0.05).  
Contrasts revealed that during Test 2, SBP was lower during TILT compared to the other 
three conditions (p<0.01), and further that during Test 5, SBP was lower during TILT 
compared to SB2 (p<0.05).    
Table 9 
Blood Pressure Responses During Test 1 (Mean, sd) 
 
 Group 
 
 
EX CT 
 
 
PB SB1 Tilt SB2 
 
PB SB1 Tilt SB2 
 
SBP 
(mmHg) 
 
118.2 
11 
117.3 
11 
116.8 
11 
118.3 
10 
117.3 
12 
115.3 
12 
113.5 
12 
115.0 
14 
DBP  
(mmHg) 
 
76.5 
6 
76.8 
8 
87.8 
6* 
76.7 
6.9 
74.0 
6 
73.0 
7.6 
84.8 
8* 
74.2 
7 
MAP  
(mmHg) 
 
90.4 
6 
90.3 
8 
97.5 
7* 
90.5 
6 
 
88.4 
6 
87.1 
5 
94.4 
8* 
87.8 
6 
SBP = systolic blood pressure * = p<0.05 vs. other 3 conditions for specified group 
DBP = diastolic blood pressure 
MAP = mean arterial pressure 
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Table 10 
 
Blood Pressure Responses During Test 2 (Mean, sd) 
 
 Group 
 
 
EX CT 
 
 
PB SB1 Tilt SB2 
 
PB SB1 Tilt SB2 
 
SBP  
(mmHg) 
 
116.6 
8 
117.7 
5 
112.2 
6* 
116.8 
10 
115.7 
13 
113.8 
10 
108.7 
12* 
113.0 
13 
DBP  
(mmHg) 
 
76.2 
7 
77.0 
6 
88.3 
8* 
74.5 
7 
73.7 
8 
71.8 
6 
85.8 
8* 
72.7 
8 
MAP  
(mmHg) 
 
89.7 
7 
90.5 
5 
96.3 
7* 
88.6 
8 
 
87.7 
8 
85.8 
6 
93.4 
9* 
86.1 
8 
SBP = systolic blood pressure * = p<0.05 vs. other 3 conditions for specified group  
DBP = diastolic blood pressure 
MAP = mean arterial pressure 
 
 
 
Table 11 
 
Blood Pressure Responses During Test 3 (Mean, sd) 
 
 Group 
 
 
EX CT 
 
 
PB SB1 Tilt SB2 
 
PB SB1 Tilt SB2 
 
SBP 
(mmHg) 
 
116.3 
10 
116.8 
11 
116.2 
11 
114.7 
11 
112.8 
11 
112.0 
12 
110.3 
12 
112.2 
12 
DBP  
(mmHg) 
 
75.3 
9‡ 
72.8 
8 
87.5 
7* 
71.8 
6 
73.2 
7‡ 
73.2 
6 
84.0 
7* 
71.8 
5 
MAP  
(mmHg) 
 
89.0 
8‡ 
87.5 
9 
97.0 
7* 
86.1 
7 
 
86.4 
7‡ 
86.1 
8 
92.8 
8* 
85.3 
7 
SBP = systolic blood pressure * = p<0.05 vs. other 3 conditions for specified group 
DBP = diastolic blood pressure ‡ = p<0.05 vs. SB2 for specified group 
MAP = mean arterial pressure 
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Table 12 
 
Blood Pressure Responses During Test 4 (Mean, sd) 
 
 Group 
 
 
EX CT 
 
 
PB SB1 Tilt SB2 
 
PB SB1 Tilt SB2 
 
SBP  
(mmHg) 
 
115.8 
13 
112.7 
13 
114.0 
10 
113.8 
11 
111.5 
9 
111.3 
13 
111.0 
12 
115.0 
13 
DBP  
(mmHg) 
 
75.3 
9† 
74.2 
8 
86.8 
10* 
74.5 
8 
75.2 
6† 
72.8 
6 
85.8 
6* 
72.7 
7 
MAP  
(mmHg) 
 
88.8 
10† 
87.0 
9 
95.9 
9* 
87.6 
8 
 
87.3 
6† 
85.7 
7 
94.2 
6* 
86.8 
6 
SBP = systolic blood pressure * = p<0.05 vs. other 3 conditions for specified group 
DBP = diastolic blood pressure † = p<0.05 vs. SB1 for specified group 
MAP = mean arterial pressure 
 
 
 
Table 13 
 
Blood Pressure Responses During Test 5 (Mean, sd) 
 
 Group 
 
 
EX CT 
 
 
PB SB1 Tilt SB2 
 
PB SB1 Tilt SB2 
 
SBP  
(mmHg) 
 
120.8 
10 
120.8 
12 
116.3 
13‡ 
119.5 
10 
112.3 
10 
111.8 
12 
110.0 
11‡ 
113.8 
12 
DBP  
(mmHg) 
 
74.8 
7 
75.3 
8 
87.3 
8* 
75.7 
5 
73.3 
6 
72.5 
6 
85.7 
7* 
72.5 
5 
MAP  
(mmHg) 
 
90.2 
7 
90.5 
8 
97.0 
9* 
90.3 
6 
 
86.3 
6 
85.6 
6 
93.8 
8* 
86.2 
6 
SBP = systolic blood pressure * = p<0.05 vs. other 3 conditions for specified group 
DBP = diastolic blood pressure ‡ = p<0.05 vs. SB2 for specified group 
MAP = mean arterial pressure 
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Heart Rate Variability and Arterial Blood Pressure Across Time 
Paced breathing.  ANOVA revealed a main effect of Time (p<0.01) on SDNN.  Contrasts 
revealed that SDNN during Test 5 was greater than during Test 1 (p<0.01).  Regarding the 
spectral indices, there were Group X Time interactions on lnLFNU (p<0.05) (Figure 1) and 
lnLF/lnHF (p<0.05) (Figure 2).  Tests for simple effects found that these variables were not 
altered across time in CT, whereas lnLFNU and lnLF/lnHF were lower during Test 5 
compared to Test 1 (p<0.01) in EX.  The Group X Time interaction for lnHFNU, however, 
fell short of statistical significance (F[4,88] = 2.36, p=0.06), as did the main effects of Group 
and Time.  Furthermore, there were no main effects of Group or Time, nor were there any 
Group X Time interactions on arterial blood pressure.      
Spontaneous breathing.  There were no main effects of Group or Time, nor Group X Time 
interactions on the mean RR interval, HRV parameters, or arterial blood pressure during SB1.  
During SB2, ANOVA revealed a main effect of Time on lnLF/lnHF (p<0.05).  However, 
contrasts revealed that there were no differences in lnLF/lnHF between Test 1 and any of the 
other tests.  Additionally, there were no main effects of Group or Time, nor Group X Time 
interactions on arterial blood pressure during SB2.   
Head-up tilt.  ANOVA revealed Group X Time interactions on lnLFNU (p<0.01) (Figure 1), 
lnHFNU (p<0.01), and lnLF/lnHF (p<0.05) (Figure 2).  Tests for simple effects revealed no 
change in spectral parameters for CT, but that EX displayed greater lnHFNU (p<0.01), and 
lower lnLFNU (p<0.01) and lnLF/lnHF (p<0.01) during Test 5 compared to Test 1.  
Additionally, there were no main effects of Group or Time, nor Group X Time interactions on 
arterial blood pressure.   
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Figure 1 LnLFNU During the 4 Conditions Across Time in A) EX and B) CT 
  
* = p<0.05 vs. T1 for specified group 
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* 
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Figure 2 LnLF/lnHF During the 4 Conditions Across Time in A) EX and B) CT 
  
* = p<0.05 vs. T1 for specified group 
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Discussion 
This investigation examined the influence of 2 weeks of exercise training, 4 days per 
week, 40 minutes per session, at 80-85% HRreserve, on cardiorespiratory fitness and vagal 
modulation of the heart.  The initial values obtained for the cardiorespiratory variables and 
HRV are consistent with other studies using participants of similar fitness levels (Furlan et al. 
1993; Mier et al. 1997).  For example, the initial range of VO2peak of our participants (30 to 41 
ml•kg-1•min-1) is nearly identical to that of Mier et al., and the mean values of RR intervals 
(940 ms), SDNN (77.5 ms), and normalized power (lnLFNU: 3.4 & lnHFNU: 4.2) are in line 
with Furlan et al.  With respect to the influence of training, participants in the treatment group 
improved their cardiorespiratory fitness, as indicated by an 8% increase in VO2peak from 33.5 
to 36.1 ml•kg-1•min-1, whereas the control group exhibited no such changes in this parameter.  
A training effect of this magnitude appears to be consistent with the 10% improvement in 
VO2peak reported by Mier et al. in response to 10 days of training. 
 HRV was examined under a variety of conditions, both to examine  its construct 
validity, as well as to examine the extent to which these conditions expose alterations in 
autonomic behavior following periods of exercise training.  Of particular interest was the 
influence that breathing pattern might have on autonomic modulation of the heart.  Therefore, 
paced and spontaneous breathing conditions were included.  In addition, the autonomic 
adjustment to head-up tilt was of interest inasmuch as autonomic reactivity may provide 
information that is unique from resting autonomic modulation alone.  To this end, there were 
some general observations regarding the influences of the different conditions on HRV.   
With respect to the influence of breathing pattern, the present data revealed that 
lnLFNU and lnLF/lnHF were lower and lnHFNU was greater during PB compared to the 
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other conditions, including SB.  These findings are consistent with previous reports that PB 
results in an elevation of power in the HF range of the power spectrum (Hayano et al. 1994).  
This phenomenon is thought to be a result of an augmented respiratory sinus arrhythmia due 
to input from pulmonary stretch receptors and/or modulation of cardiomotor neurons in the 
central respiratory center (Hayano et al.).    
With respect to the orthostatic challenge, TILT resulted in a significant reduction of 
the mean RR interval (i.e. increase in heart rate).  Moreover, this was typically accompanied 
by increases in lnLFNU and lnLF/lnHF and decreases in SDNN and lnHFNU with the 
exception of Test 5.  These findings are consistent with previous reports that TILT results in a 
greater sympathetic outflow and/or a vagal withdrawal (Furlan et al. 1993).  Furthermore, 5 
minutes of TILT resulted in a consistent elevation of DBP and MAP.  This response, which 
was observed on each test day, is further evidence of an increased sympathetic outflow 
following 5 minutes of TILT.  Such a response appears to be mediated by the baroreflex 
mechanism.     
The behavior of HRV and hemodynamics described above are consistent with our 
understanding of cardiovascular regulation during such laboratory conditions, and therefore 
the results suggest some degree of construct validity.  The primary purpose of this 
investigation, however, was to examine the response of these parameters to 8 exercise training 
sessions performed over 2 weeks.  Previous studies have demonstrated that endurance 
exercise training in young, healthy participants results in significant alterations in HRV that 
reflect an increased vagal modulation of the heart.  For example, Al-Ani et al. (1996) reported 
that 6 weeks of cycling significantly elevates HF power.  Furthermore, De Meersman (1992) 
and Levy et al. (1998) reported improvements in time domain indices of HRV following 8 
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weeks and 6 months of training, respectively.  However, there is limited information 
regarding the time course of these training-induced changes.  Thus, it was our intention to 
examine if 2 weeks of training could elicit such changes, and if so, to examine the time course 
of these alterations.  The data from this investigation demonstrate that 8 sessions of high-
intensity exercise training performed over 2 weeks is sufficient to alter HRV, but only as 
detected during the PB and head-up TILT conditions.  Training effects were not observed 
during SB.  During PB we found significant Group X Time interactions on lnLFNU and 
lnLF/lnHF.  Further analysis revealed that both of these variables were lower (16 and 9%, 
respectively) during Test 5 compared to Test 1 in EX, while there were no differences across 
time in CT.  These findings suggest that our training protocol resulted in a shift in 
sympathovagal balance favoring a greater relative vagal modulation of the heart.  Although 
the Group X Time interaction did not reach statistical significance for SDNN and lnHFNU 
during PB, there was a trend towards an interaction for each of these indices (p=0.08 and 
p=0.06, respectively).  Therefore, measures of HRV during the paced breathing condition are 
generally in agreement with previous work indicating a shift in sympathovagal balance 
following exercise training, and moreover suggest that this effect may not be observed until 8 
training sessions into the training period.   
During TILT, there were significant Group X Time interactions on lnLFNU, lnHFNU, 
and lnLF/lnHF.  Specifically, the group undergoing exercise training displayed lower lnLFNU 
and lnLF/lnHF, and greater lnHFNU during Test 5 compared to Test 1, while CT exhibited no 
differences in these indices across time.  Thus, an additional finding of this investigation is 
that 2 weeks of endurance exercise training may elevate the parasympathetic and/or lessen the 
sympathetic response to TILT.  In further support of this hypothesis, during Test 5 there were 
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significant Group X Condition interactions on lnLFNU, lnHFNU, and lnLF/lnHF.  These 
interactions were such that EX did not demonstrate the elevation of lnLFNU and lnLF/lnHF, 
or the reduction in lnHFNU during TILT that were present during the first 4 tests.   
An unexpected finding of this investigation was that the mean RR interval, and thus 
heart rate, was not altered during any of the conditions following the training protocol.  This 
was somewhat perplexing in that we detected alterations in HRV that indicate a reduction in 
sympathovagal balance, and also that a reduced resting heart rate is an established adaptation 
to exercise training (Wilmore et al. 2001).  Possible explanations for this discrepancy include: 
1) our assessment of the mean RR interval during conditions which the participants were not 
truly at rest, and 2) the possibility that the exercise training protocol used was insufficient to 
alter resting heart rate.  However, it should be noted that although non-significant, the mean 
RR interval of the training group increased from 925 to 985 ms from Test 1 to Test 5, 
reflecting a reduction in heart rate from 65 to 61 beats per minute, during PB.   
Our ability to detect a training effect on HRV only during PB and TILT suggests that 
HRV may be a more sensitive measure of training-induced changes in autonomic modulation 
when collected under such conditions.  In fact, a few studies that have reported training-
induced changes in HRV used a paced breathing protocol and/or head-up tilt (De Meersman, 
1992; Hedelin, Bjerle, & Henriksson-Larson, 2001; Yamamoto, Miyachi, Saitoh, Yoshioka, & 
Onodera, 2001).  The absence of any significant findings during SB further emphasizes the 
need for careful standardization procedures during collection of HRV data.  Thus, the addition 
of either of these two conditions would be useful to any longitudinal investigation examining 
cardiac autonomic modulation.   
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The findings of the present investigation are somewhat consistent with Hedelin et al. 
(2001) who recently reported alterations in HRV following a 7-month training period in a 
group of canoeists and cross-country skiers.  Following training, they reported a reduction in 
LF power during head-up tilt, and further that this reduction was significantly correlated with 
the change in VO2peak.  Although the participants in this study appear to have had higher 
fitness levels than our participants, the present findings are very similar.  In contrast to the 
present study, however, Yamamoto et al. (2001) recently evaluated HRV following one week, 
4 weeks, and 6 weeks of exercise training.  They subsequently reported a significant increase 
in HF power after one-week of training, followed by no further increases over the rest of the 
training period.  Whereas, we did not report any changes in autonomic modulation until the 
second week of training.  This finding is perplexing, in that the training protocol of 
Yamamoto et al. was very similar to the present study (frequency: 4 days per week; duration: 
40 minutes; intensity: 80% VO2peak).  However, Yamamoto gave no information regarding the 
participant’s habitual level of physical activity and their participants had an initial fitness level 
that surpassed those of our participants (VO2peak = 48.2 ml•kg-1•min-1).  Loimaala, Huikuri, 
Oja, Pasanen, and Vuori (2000) reported no significant changes in HRV following a 5-month 
jogging protocol (frequency: 4-6 times/week; duration: 30 minutes; intensity: 75% of 
VO2max).  Possible reasons for the discrepancy between these results and our findings include: 
1) the lower exercise intensity used compared to our study, 2) the lack of a paced breathing 
protocol during collection of HRV, and 3) the lack of daily supervision by Loimaala et al.  
This group only provided supervision during one exercise session a week, thus the researchers 
cannot be certain that the participants fully adhered to the training protocol.   
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Lastly, there are studies that have found changes suggesting heightened sympathetic 
activity following exercise training.  Pichot et al. (2000) reported that during a 3-week high-
intensity training protocol, there was a shift towards cardiac sympathetic dominance, marked 
by a loss of global HRV.  At first glance, such findings might seem directly opposed to those 
of the present investigation.  However, the participants in Pichot’s study engaged in 6-10 
exercise sessions a week, and therefore there may have been insufficient recovery between 
sessions, at least in terms of identifying a training adaptation on autonomic activity.  This is 
somewhat supported by their data indicating that following a fourth “recovery” week, there 
was a shift back towards parasympathetic dominance, leading the authors to indicate that 
indeed there is an important aspect of a sufficient recovery period on autonomic modulation.  
Similarly, Furlan et al. (1993) reported an increase in cardiac sympathetic outflow, as 
identified by elevated LF power, following an acute bout of exercise that persists up to 24 
hours following cessation of exercise.  They further reported that this sympathetic elevation 
was absent 48 hours after the exercise bout.  Inasmuch as the present investigation allowed at 
least 48 hours following the participant’s last exercise session prior to collection of HRV data, 
thereby optimizing the recovery period, the findings of the present study stand in agreement 
with Pichot et al. and Furlan et al.      
 Thus, our finding of a training-induced reduction in sympathovagal balance is in 
general agreement with other research.  While the present investigation cannot offer an 
explanation as to where training adaptations may occur, the appearance of training effects 
under some conditions, but not all, seems to suggest that the training adaptations extend 
beyond changes at the end-organ, alone.  Otherwise it could be argued that pre vs. post 
training differences should have existed under any of the laboratory conditions (including 
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spontaneous breathing).  One possible mechanism for our findings is an increased blood 
volume, which has been documented as an early adaptation to exercise training (Yang, Mack, 
Wolfe & Nadel, 1998).  Spinelli et al. (1999) recently reported that acute plasma volume 
expansion via saline infusion resulted in an increase in the HF range of the HRV power 
spectrum.  They subsequently suggested that increases in plasma volume activate arterial and 
cardiopulmonary baroreceptors, which inhibit sympathetic, and increase parasympathetic 
outflow from the cardiorespiratory center in the medulla.  This could further explain how our 
participants were able to maintain arterial pressure during TILT with a lower sympathetic 
outflow following training.  Other possible mechanisms include changes in receptor 
sensitivity at the cardiorespiratory center (De Souza et al. 2001) or adaptations in sensory 
organelles (e.g. baroreceptors) and afferent nerve traffic (Hedelin et al. 2001), or both.  
In conclusion, our data suggest that 8 endurance exercise training sessions performed 
over 2 weeks significantly alters cardiac vagal modulation.  We reported changes in HRV 
during PB and TILT that are consistent with a shift towards greater parasympathetic and/or 
lesser sympathetic modulation of the heart following training.  Furthermore, these data 
suggest that it takes at least eight exercise training sessions to alter HRV.  Our ability to only 
detect changes in autonomic modulation during PB and TILT suggests that either or both of 
these conditions should be included in any longitudinal investigation examining autonomic 
modulation of the heart.  Lastly, in light of the fact that HRV provides a good indication of 
the likelihood of developing dangerous cardiac arrhythmias, these findings may have 
important implications regarding exercise prescription in both healthy and at-risk populations. 
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Summary 
 The results of this investigation suggest that 8 endurance exercise training sessions 
performed over 2 weeks significantly alters cardiac autonomic modulation.  We reported a 
shift in sympathovagal balance favoring a vagal modulation of the heart following training.  
These changes were reflected by alterations in the HRV power spectrum such that there were 
increases in lnHFNU and decreases in lnLFNU.  These alterations were only present during 
periods of paced breathing and head-up tilt.  The changes in autonomic modulation during 
head-up tilt further suggest that 2 weeks of exercise training may attenuate the sympathetic 
outflow and/or the vagal withdrawal associated with an orthostatic challenge.  An additional 
finding of this study was that these training-induced alterations in cardiac autonomic 
modulation are not evident until the eighth training session.  Our ability to detect these 
changes in cardiac autonomic modulation only during periods of paced breathing and head-up 
tilt suggests that these conditions should be included in any longitudinal investigation 
examining autonomic modulation of the heart.  Lastly, given the close association between 
HRV indices and risk of unfavorable cardiac events, these findings may have implications 
regarding exercise programming in both healthy and at-risk populations.  
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Influence of Peak Aerobic Power and Exercise Endurance Training on Autonomic Regulation 
of the Cardiovascular System 
 
Introduction 
The heart and blood vessels are constantly challenged by a wide variety of stimuli (i.e. 
temperature, bodily movement, etc.).  In order to respond to these challenges, the 
cardiovascular (CV) system is tightly regulated by the autonomic nervous system (ANS).  The 
ANS helps regulate systemic arterial blood pressure (BP), cardiac function, body temperature, 
gastrointestinal motility, bladder emptying and other physiologic functions.  It is an integral 
part of the properly functioning human body due to the rapidity and intensity with which it 
can alter physiologic processes.  The ANS may be activated by control centers in the brain 
stem, spinal cord, hypothalamus, portions of the cerebral cortex, and by various reflex 
mechanisms that direct afferent signals to these control centers.  Efferent signals are then 
transmitted throughout the body via either sympathetic or parasympathetic pathways. 
Of primary importance to the human body is the proper functioning of the CV system.  
The CV system, consisting of the heart, blood, and vasculature, acts to provide the body with 
a continuous stream of nutrients and oxygen for energy and also allows for the removal of 
metabolic by-products.  In 1870, Fick expressed CV function as an interplay between oxygen 
consumption (VO2), cardiac output (CO), and arteriovenous oxygen difference (a-vO2diff).  
The “Fick equation” that describes the relationship between these factors is still used to 
grossly describe CV functionality and is a useful index of work: VO2 = CO * a-vO2diff.  CO 
is regulated by multiple mechanisms, including factors affecting both heart rate (HR) and 
stroke volume (SV) (i.e. preload, afterload, etc.).  Lakatta and Maughan (1990) described 
multiple factors that help determine cardiovascular performance (Table 1.1) and provide a 
detailed review of CV function.  Thus, the accurate quantitative description of CV function 
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would require a polynomial equation with at least as many terms as the number of factors 
listed in Table A.1.  Each of these factors is subject to autonomic modulation, which forms 
the basis of many CV reflexes. 
Table A.1   
______________________________________________________________________ 
Some Determinants of Cardiovascular Performance. 
______________________________________________________________________ 
 
Cardiovascular system properties   Cardiac muscle properties 
         
Ventricular performance    Myocyte properties  
Pericardial properties     Nonmyocyte properties  
Arterial properties     Nutrient supply and waste removal 
Venous properties     Cell-length  
Blood properties (i.e. volume, viscosity)  Collagen strain  
Body properties       
Intrathoracic pressure     Cardiac myocyte properties  
Heart rate         
       Myofilament properties  
Cardiac ventricular properties   Excitation properties   
       Myofilament activation  
Myocardial properties     Sarcomere length   
Activation sequence     Cross-bridge number   
Coronary vascular properties    Cross-bridge activation 
Afterload system properties    Intracellular skeleton  
Preload system properties    Organelle phosphorylation  
Valves       Oxygen and substrate supply 
Intrachamber communication    Adenosine triphosphate production 
______________________________________________________________________ 
   
The cardiovascular control center (CVC) is found in the reticular formation of the 
brain stem, primarily located in the pons and medulla oblongata.  The CVC receives afferent 
signals from various receptors throughout the body (feedback) or from higher nervous centers 
such as the motor cortex (feedforward) and respond by sending efferent impulses to various 
systems of the body.  Within the CVC, there are both cardiac and vasomotor centers 
controlling cardiac and peripheral blood vessels, respectively.  Within the cardiac center, a 
cardioinhibitory center is found in nucleus ambiguus and dorsal nulceus of the vagus nerve.  
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As its name implies, vagal efferents from these sites act to decrease both heart rate and 
contractility.  Conversely, a cardiostimulatory center is believed to be located in the lateral 
medulla and function to increase heart rate and contractility via sympathetic activity.  Within 
the vasomotor center, a vasoconstrictor area of the medulla is believed to be involved in 
sympathetic vasoconstriction of blood vessels.  The presence of an opposing vasodilator area 
is questionable and vasodilation may be simply the result of inhibition of the vasoconstrictor 
area (Smith & Kampine, 1990).  
Preganglionic nerves of the sympathetic nervous system (SNS) originate in the gray 
matter of spinal segments T-1 through L-2 and pass through the anterior root of the spinal 
cord into the corresponding spinal nerve.  The preganglionic fibers then enter one  
of two paravertebral chains of ganglia.  From there, fibers can synapse with postganglionic 
neurons in the paravertebral ganglia, follow ascending or descending pathways in the chain to 
synapse in other ganglia of the paravertebral chain, or pass out of the paravertebral chain and 
terminate in one of the prevertebral ganglia.  The postganglionic nerves therefore originate in 
either the paravertebral or prevertebral ganglia and travel to destinations throughout the body.  
There are also preganglionic fibers that traverse, without synapsing, all the way to the adrenal 
medulla and cause the release of catecholamines (epinephrine and norepinephrine) into the 
blood.   
Preganglionic nerves of the parasympathetic nervous system (PNS) leave the central 
nervous system via cranial nerves III, VII, IX, and X and sacral spinal nerves 1-4.  
Approximately 75% of PNS fibers are in the vagus nerves (cranial nerve X) supplying the 
heart, lungs, esophagus, stomach, small intestine, colon, liver, gall bladder, pancreas, and 
ureters.  Most preganglionic nerves of the PNS pass uninterrupted to the target organ.  In the 
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wall of the target organ, preganglionic fibers synapse with short postganglionic fibers that 
spread throughout the organ.               
Preganglionic fibers of both the SNS and PNS stimulate postganglionic neurons by 
secreting the neurotransmitter acetylcholine (ACh) and therefore are classified as cholinergic.  
Furthermore, all postganglionic fibers of the PNS are cholinergic.  In contrast, most 
postganglionic neurons of the SNS secrete the neurotransmitter norepinephrine (NE) and are 
classified as adrenergic.  Exceptions include the sympathetic postganglionic fibers of the 
sweat glands, piloerector muscles, and some blood vessels that are cholinergic.  As previously 
mentioned, the adrenal medulla acts as a postganglionic neuron in that some preganglionic 
neurons of the SNS innervate the adrenal medulla and cause the release of epinephrine (E) 
and NE into the circulation.   
Autonomic neurotransmitters bind with specific receptors on the cell membrane of the 
effector organ.  When the transmitter binds, the receptor changes its conformation and 
generally acts by either altering cell membrane permeability to ions, or by activating or 
inactivating intracellular enzymes.  There are two types of cholinergic receptors found within 
the ANS.  Nicotinic ACh receptors are located on the dendrites and cell bodies of all 
postganglionic neurons of both the SNS and PNS, while muscarinic ACh receptors are found 
on all effector organs of the PNS and those of the SNS that are stimulated by cholinergic 
neurons.  There are also two major types of adrenergic receptors within the ANS, alpha and 
beta.  Alpha and beta receptors are further subdivided into alpha1, alpha2, beta1, beta2, and 
beta3 receptors.  Catecholamines have somewhat different effects on alpha and beta receptors.  
E stimulates both alpha and beta equally, while NE excites predominantly alpha, and to a 
lesser extent beta receptors.  Thus, the effect of catecholamines on various organs depends on 
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the receptor distribution.  The location and responses to stimulation of the adrenergic 
receptors are described in Table A.2.  
As described in Table A.2, complete understanding of SNS and PNS function on 
effector organs requires one to inspect the effect of each branch of the ANS on each organ 
individually.  With regard to the CV system, SNS stimulation generally increases the activity 
of the heart by increasing both HR and contractility, while the PNS acts oppositely.  
Therefore, the SNS acts to increase the efficiency of the heart during periods of stress, 
whereas the PNS is more predominant during resting conditions.  Sympathetic stimulation 
results in the constriction of most blood vessels via alpha receptors while PNS activation has 
little or no effect, although in some instances SNS activation results in a beta receptor-
mediated vasodilation.  Since BP is a product of CO and total peripheral resistance (TPR), 
SNS stimulation elevates BP by increasing both CO and TPR.  Activation of the PNS usually 
results in a slight decrease in BP as a result of diminished cardiac performance, and extreme 
levels of parasympathetic activity may result in the cessation of cardiac activity causing a 
drastic loss of BP. 
The design of the ANS provides the human body with the means to maintain a state of 
homeostasis in the face of various physiological challenges.  Modulation of the ANS is 
largely attributed to the presence of various autonomic reflexes.  Receptors that respond to 
stretch, chemical stimuli, temperature, and pain are located throughout the body and activate 
these reflexes.  However, due to limited influence on the CV system, pain-sensitive free-nerve 
endings will not be discussed further in this review.  Arterial baroreceptors are located in the 
walls of the aortic arch and internal carotid arteries.  These stretch-sensitive receptors are 
innervated by afferent fibers that connect with vagus and glossopharyngeal nerves and relay  
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Table A.2 
____________________________________________________________________________ 
Locations and Responses of Adrenergic Receptors. 
______________________________________________________________________ 
 
Receptor Locations    Effects of stimulation 
 
Alpha1 Smooth muscle fibers of blood   Excitation → contraction, leading to  
vessels; radial muscle of iris;   vasoconstriction, dilation of pupil, 
sphincter muscles of stomach and  and closing of sphincters 
urinary bladder     
       
Salivary gland cells   Secretion of potassium and water 
       
Sweat glands on palms    Increased sweating 
and soles     
        
Alpha2 Smooth muscle fibers in   Inhibition → relaxation →  
blood vessels    vasodilation 
       
Beta cells of pancreatic islets  Decreased insulin secretion 
       
Blood platelets    Platelet aggregation 
        
Beta1  Cardiac muscle fibers   Excitation → increased force and rate  
       of contraction 
 
Juxtaglomerular cells of kidney  Renin secretion 
        
Posterior pituitary gland   Secretion of antidiuretic hormone 
        
  Adipose cells    Breakdown of triglycerides → release  
       of fatty acids into the blood 
 
Beta2 Blood vessels supplying skeletal  Inhibition → relaxation, leading to 
muscle, adipose tissue, liver, and  dilation of airways, vasodilation, 
heart; smooth muscle in walls of  relaxation of organ walls 
airways; walls of visceral organs  
        
Liver hepatocytes   Glycogenolysis 
        
Beta3  Brown adipose tissue   Thermogenesis 
____________________________________________________________________________________
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impulses to the CVC.  In response to stretch (due to changes in arterial pressure), these 
receptors initiate action potentials of a frequency proportional to the magnitude of the stretch.  
Upon reaching the CVC, the action potential elicits an appropriate response.  For example, a 
decrease in BP detected by the baroreceptors results in an activation of the cardiostimulatory 
and vasoconstrictor areas, along with an inactivation of the cardioinhibitory areas of the CVC.  
This in turn increases heart rate, contractility, and vasoconstriction, which result in increased 
BP. Conversely, this negative feedback mechanism acts oppositely for an increase in blood 
pressure.   
In general, the aortic and carotid baroreceptors function synergistically.  However, the 
aortic baroreceptors operate over a higher range of arterial pressures than the carotid 
baroreceptors and account for the majority (approxiamtely two-thirds) of the arterial 
baroreflex response.  Interestingly, Donald and Edis (1971) demonstrated that both carotid 
and aortic baroreceptors are more sensitive to changes in blood pressure at physiological 
ranges (80-150 mmHg).  In addition, baroreceptors respond more readily to decreases than to 
increases in blood pressure.  In cases of chronic or acute alterations in baseline blood 
pressure, baroreceptors have the capability to “reset”, or alter their own baseline to higher 
levels.     
Other low-pressure baroreceptors are located in the walls of the heart and pulmonary 
vessels and are collectively referred to as cardiopulmonary baroreceptors.  Cardiopulmonary 
baroreceptors are located within the venoatrial junctions, atria, ventricles, and pulmonary 
vessels (Edis, Donald, & Shepher, 1970; Paintal, 1973).  These baroreceptors are primarily 
subserved by the afferent vagus limb (Oberg & White, 1970; Paintal, 1973) that constantly 
exerts a tonic restraint on the CVC.  Stimulation of the cardiopulmonary baroreceptors by 
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hypervolemia or increased central venous pressure results in an enhancement of this tonic 
restraint and a subsequent peripheral vasodilation (Echt, Duweling, Gauer, & Lange, 1974).  
This vasodilation appears to be mediated via an inhibition of sympathetic efferent nerve 
activity and helps maintain arterial pressure and prevent the disturbance of the arterial 
baroreceptors.  Under conditions in which the cardiopulmonary baroreceptor-mediated 
vasodilation is unable to accommodate increases in central volume and cannot maintain 
arterial pressure, the arterial baroreflex will take over and allow for the vasodilatory effect.  
Additionally, cardiopulmonary baroreceptors have the capability to elicit a peripheral 
vasoconstriction, via elevated sympathetic outflow, in response to periods of central 
hypovolemia. 
Other receptors in the body regulating CV activities are sensitive to chemical stimuli.  
Central chemoreceptors located just beneath the ventral surface of the medulla are sensitive to 
changes in cerbrospinal fluid composition and blood chemistry.  These receptors respond 
primarily to the partial pressure of carbon dioxide (PCO2) and hydrogen ion  (H+) 
concentration.  Stimulation of central chemoreceptors results in increased strength of both the 
inspiratory and expiratory signals to respiratory muscles and does not have a pronounced 
effect on the cardiovascular system.  Peripheral chemoreceptors located in the carotid and 
aortic bodies respond not only to changes in PCO2 and H+, but are also sensitive to decreases 
in the partial pressure of oxygen (PO2) and increases in arterial potassium (K+) concentration.  
In humans, greater emphasis is placed on the chemoreceptors of the carotid bodies, as the 
aortic bodies are believed to be inactive (Nye, 1994).  Carotid body chemoreceptors are 
located at the bifurcation of the carotid artery where they can sample blood composition prior 
to the perfusion of the brain.  These chemoreceptors are composed of both type-I and type-II 
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cells.  Type-I cells appear to be the sensors of arterial blood and make synaptic contact with 
sensory nerves leading to the carotid sinus nerve.  The neurotransmitter activating the sensory 
nerves is not known, but is thought to be either a catecholamine (Fidone & Gonzales, 1986) or 
substance P (Prabhakar et al. 1989).  The type-II cells envelope the type-I cells and sensory 
nerve endings and are believed to control the ionic environment of the synapse between the 
type-I cells and the sensory nerves.  Sympathetic nerves innervate blood vessels of the carotid 
body and are thought to decrease blood flow and therefore excite the chemoreceptors by 
increasing the concentration of metabolic byproducts.  Sympathetic nerves also appear to 
innervate the type-I cells, leading researchers to believe that the chemoreceptors can be 
activated independent of changes in blood flow or composition.   
Carotid chemoreceptor stimulation, via experimentally-induced hypoxia or 
hypercapnia, has been shown to evoke bradycardia in several species, including humans (Jain, 
Subramanian, Julka, & Guz, 1972; Marshall, 1994).  Furthermore, removal of the carotid 
bodies in humans has been shown to elicit a tachycardic effect (Gross, Whipp, Davidson, 
Koyal, & Wasserman, 1976; Honda, Hashizume, Kimura, & Severinghaus, 1988).  The 
chemoreceptor-induced bradycardia is most probably mediated via the vagus nerve (Daly & 
Kirkman, 1989; Daly & Scott, 1958; Daly & Scott, 1962;), while a decreased sympathetic 
component may also play a minor role (Schmidt, Ledderhas, & Honig, 1985).  Chemoreceptor 
stimulation has also been reported to have a negative inotropic effect on the heart mediated by 
either a sympathetic withdrawal (Hainsworth, Karim, & Sofola, 1979) or vagal activation (De 
Geest, Levy, & Zieske, 1965).  Cardiac output also is reduced by chemoreceptor activation, 
most probably a result of the bradycardic effect (Daly & Scott, 1963). Carotid chemoreceptor 
stimulation also results in a vasoconstriction in the coronary arteries (Vatner & McRitchie, 
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1975), skeletal muscle arterioles (Oberg, 1964), and the small vessels of the cutaneous 
circulation (Calvelo, Abboud, Ballard, & Abdel-Sayed, 1970), likely via increases in 
sympathetic noradrenergic activity. 
Mechanical and chemical receptors are also located in skeletal muscle tissue.  Four 
groups of sensory afferent neurons arise from skeletal muscle.  Groups I, II, and III are 
ensheathed within myelin, while group IV afferents are unmyelinated.  Groups I and II are 
relatively large in diameter (6-20 um) and have conduction velocities >30 meters•second-1.  
Group I and II afferents do not play a role in chemoreception or CV control and so will not be 
dealt with in this review (Waldrop, Rybicki, & Kaufman, 1984).  Conversely, group III and 
IV are smaller in diameter (1-6um) and have slower conduction velocities (<15 
meters•second-1).  Group III nerve endings seem to be associated with collagen structures 
within the skeletal muscle, while group IV endings are associated with blood and lymphatic 
vessels (von During, Andres, & Schmidt, 1984).  The types of stimuli to which these muscle 
afferents primarily respond are reflected in the terminology by which they are described.  
Group III nerve endings are primarily activated by deformation changes and are termed 
mechanoreceptors, whereas group IV afferents primarily respond to changes in metabolic by-
products (i.e. lactic acid, arachidonic acid, potassium, bradykinin) and are termed metabo- or 
chemoreceptors (Mitchell & Schmidt, 1983).  However, the separation between the two is not 
perfect as a portion of mechanoreceptors respond to metabolites and a portion of 
metaboreceptors respond to mechanical stimuli.  Group III and IV afferents synapse in the 
dorsal horn of the spinal cord, ultimately activating the cells of ascending tracts that project to 
the medulla.  These receptors play a major role in the exercise pressor reflex, a feedback 
mechanism to the CVC originating in skeletal muscle that results in a reduced 
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parasympathetic and increased sympathetic outflow to the cardiovascular system during 
exercise. 
 There are also temperature-sensitive receptors located either peripherally in the skin or 
deep in the abdominal viscera and spinal cord.  Interestingly, there are far more cold-sensitive 
than heat-sensitive receptors, likely reflecting an effort to prevent hypothermic conditions in 
the body.  In response a hot environment, the body exhibits a vasodilation of cutaneous blood 
vessels mediated by a sympathetic inhibition in an attempt to transfer heat to the skin.  On the 
other hand, a cold stimulus results in a sympathetic-mediated cutaneous vasoconstrition in an 
attempt to reduce heat loss through the skin (Guyton & Hall, 1994). 
As previously stated, the CVC is also under the influence of higher nervous centers.  
Central command consists of centrally generated nerve activity that activates, either in parallel 
or separate neural pathways, the CV and skeletal muscle motor systems (Rowell, 1986).  
Signals may originate in the motor cortex, basal ganglia, cerebellum, or spinal cord.  The 
traditional view of central command as proposed by Krogh and Lindhard (1913) consists of 
motor signals arising from the cerebral cortex acting directly on the CVC and autonomic 
preganglionic cells controlling the heart and vasculature.  More recent researchers have 
provided evidence that the subthalamic area and cerebellum may also play a role in generating 
CV and respiratory responses (Eldridge, Millhorn, Kiley, & Waldrop, 1985; Rowell, 1993; 
Smith, Rushmer, & Lasher, 1960).  
The hypothalamus also plays a role in the regulation of body activities.  As a key 
regulator of homeostasis, sensory impulses arrive at the hypothalamus via afferent pathways 
along with impulses from hearing, taste, and olfactory receptors.  Other receptors within the 
hypothalamus monitor osmotic pressure, hormone concentration, and temperature.  
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Specifically regarding CV regulation, neuronal axons extend from the hypothalamus to 
sympathetic and parasympathetic nuclei in the brain stem and spinal cord and can exert 
influence on CV activity.  The hypothalamus also influences the release of several hormones 
from the pituitary gland that may influence the CV system.  
 There exists evidence, both for and against, an influence of CV fitness, as defined by 
VO2peak, and exercise endurance training on the ANS.  When investigating these issues, 
however, it is imperative to control for possible mitigating factors such as age, gender, race, 
environmental conditions, that may also impact autonomic regulation of the CV system.  
Therefore, the objectives of this review are as follows: 1) to briefly describe some of the 
current techniques of quantifying autonomic activity, 2) to review evidence for autonomic 
control of the CV system during an acute bout of rhythmic exercise involving large muscle 
groups, 3) to discuss several mitigating factors that may influence autonomic regulation of the 
CV system, 4) to review literature that has examined the influence of aerobic fitness, as 
estimated by peak oxygen consumption, on autonomic regulation of the CV system estimated 
by the previously mentioned techniques, and 5) review literature that has examined the 
influence of exercise endurance training on autonomic regulation of the CV system estimated 
by these techniques.  
Evaluating Autonomic Control 
Cardiovascular responses to laboratory stressors.  The assessment of HR and BP reactivity to 
stressful stimuli in a controlled environment are commonly used to investigate autonomic 
control of the circulation (Grassi et al.1996).  Stressful stimuli can be physical, as in the cold-
pressor test or isometric exercise, or psychological, as in the Stroop color-word conflict task 
(CWCT) or other mental tasks.  Methods using hemodynamic reactivity to assess autonomic 
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control are based on the assumption that whenever the HR or BP effects are greater than 
normal, the SNS is hyperactive and/or there is some degree of vagal withdrawal (Mancia, & 
Grassi, 1991).  However, these techniques are not without their limitations.  For example, 
there is evidence that vascular hypertrophy amplifies the effects of smooth muscle 
constriction.  Therefore, an elevated pressor response may be secondary to structural factors 
rather than autonomic abnormalities (Folkow, 1982).  Other limitations relate to the 
generalizability and reliability of these responses.  For example, it has been demonstrated that 
CV hyperresponsiveness to laboratory stress may not reflect a hyperreactivity to normal “real-
life” stressors (Parati et al. 1988).  Moreover, CV responsiveness is not always consistent 
across various laboratory stressors (Parati, Pomidossi, Ramirez, Cesana, & Mancia, 1985).  
Lastly, HR and BP reactivity to laboratory stimuli exhibit considerable within-subject 
variability (Mancia & Grassi, 1991; Parati et al. 1985; Swain & Suls, 1996).  Swain and Suls 
published an excellent meta-analytic review regarding the reproducibility of HR and BP 
reactivity to laboratory stressors.  By reviewing 24 studies, they report overall correlation 
coefficients of 0.555 for HR, 0.407 for systolic BP (SBP), and 0.348 for diastolic BP (DBP).  
Furthermore, the reproducibility of HR and SBP were much better for studies with shorter 
test-retest periods (<1 week) than for those with longer periods (>1 month), whereas DBP 
varied in a non-uniform manner.  Other findings of this review are that older subjects exhibit 
better BP reproducibility than younger subjects and that BP reproducibility is greater in those 
tasks that do not involve vocal effort.  In general, these findings suggests that results obtained 
from hemodynamic reactivity to laboratory stressors need to be interpreted cautiously, with 
regards to test-retest length, subject age, and stressor type. 
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Assessment of catecholamine concentration.  Plasma NE is frequently used as an indicator of 
SNS activity under various conditions, as it is the major neurotransmitter of the SNS.  A 
percentage of NE spills over from terminal nerve endings into the circulation, making its 
concentration 3-4 times higher than that of E at rest (Esler et al. 1990).  The chromaffin cells 
of the adrenal medullas are the primary source of plasma E and are under direct sympathetic 
control, although they may be activated by acute conditions such as hypoglycemia (Esler et al. 
1990).  Therefore, the assessment of catecholamines has been an important tool in 
investigating the sympathetic branch of the autonomic nervous system. 
Several different techniques have been developed to assess plasma catecholamines.  
These include plasma and tissue concentrations of catecholamines, release, clearance, 
spillover into plasma, intrasynaptic NE concentration, neuronal NE uptake, and urinary 
excretion.  See Esler et al. (1988) for a review.  However, some of the more commonly used 
methods, (plasma NE concentration, NE clearance, and NE spillover), deserve a brief review 
here.  
Plasma NE is the most commonly used index of sympathetic tone in man (Mancia & 
Grassi, 1991).  Physiological conditions or perturbations that alter sympathetic drive are 
reflected by changes in NE concentration.  However, plasma NE concentration reflects two 
concurrent processes, its appearance (or spillover) into the plasma after release from 
sympathetic nerve endings, and its clearance from the circulation.  Therefore, examination of 
plasma NE kinetics provides a more sensitive index of SNS activity than measuring plasma 
concentrations alone.  This has led to the development of techniques using radiolabelled NE 
to assess NE clearance and the “spillover rate” of NE into the plasma, assuming steady-state 
conditions hold. (Esler, 1982; Poehlman, McAuliffe, & Danforth, 1990).  The same 
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techniques can also be used for examination of the kinetics of E released from the adrenal 
medulla (Kjaer, Christensen, Sonne, Richter, & Galbo, 1985).   
NE plasma clearance rate (l•min-1) =  
[3H] NE infusion rate / plasma [3H] NE concentration 
NE spillover rate (ug•min-1) =     
[3H] NE infusion rate / specific radioactivity of plasma NE 
or NE clearance rate * plasma NE concentration 
 Although the measurement of the NE spillover rate is a valid method to assess the 
activity of sympathetic effector-junctions, it is not without its limitations.  For example, the 
exact source of the NE release is not identified, although in humans there is good agreement 
that the sympathetic nerves of the kidneys, skeletal muscles, and lungs all contribute 
substantially (Esler et al. 1988).  Moreover, some vascular beds may contribute significantly 
more NE than others and may exhibit differential adrenergic receptor densities making it an 
unbalanced and/or insensitive index (Mancia & Grassi, 1991).  Lastly, Hjemdahl (1984) 
reported that plasma NE measurements suffer from poor inter- and intralaboratory 
reproducibility, possibly a result of the wide variety of assay techniques available, and would 
benefit from better standardization and continuous quality control.     
Muscle sympathetic nerve activity.  The use of microneurography to directly measure 
sympathetic nerve activity to muscle (MSNA) in humans was first developed by Hagbarth and 
Valbo (1968).  This method detects raw action potentials via tungsten microelectrodes 
inserted under the skin at one of several possible sites.  The action potentials are then 
amplified, filtered, and integrated, yielding a mean voltage neurogram (Rothman, Easty, 
Frecker, & Floras, 1991).  Sympathetic bursts on the neurogram are abolished by 
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pharmacologic blockade of sympathetic ganglia and local anesthesia applied to the nerve 
proximal, but not distal to the recording site.  Furthermore, the conduction velocity of the 
bursts are ~ 1 meter • second-1, the same velocity of unmyelinated nerve fibers in animals 
(Mitchell & Schmidt, 1983).  Finally, studies have demonstrated a close positive relationship 
between MSNA (expressed as burst • min-1) and plasma NE levels (Leimbach et al. 1986; 
Wallin et al. 1981; Yamada, Miyajima, Tochikubo, Hatsukawa, & Ishii, 1989).  Therefore, the 
neurogram is believed to reflect sympathetic nerve activity to the skeletal muscle bed.  The 
use of microneurography to detect MSNA has been useful to many researchers by providing 
insight into the neural regulation of the circulation at rest and during perturbations that alter 
sympathetic outflow (Ray & Hume, 1998). 
MSNA has traditionally been quantified by visual inspection of the mean voltage 
neurogram.  Using visual inspection, the observer spots the bursts of activity by searching for 
triangular peaks with a “smooth envelope” rising from a noisy baseline.  Average inter- and 
intra-observer variabilities of 4% and 9%, respectively, have been reported by Mark and 
Victor (1985) for this technique. However, the subjective and labor-intensive process of 
visually inspecting peaks may be inferior to more recently developed automated techniques 
that are faster and objective.   
 Several automated techniques have been used to evaluate MSNA in humans.  Rea, 
Birckett, Hamdam, and Mark (1989) developed a burst averaging technique to quantify 
MSNA.  Several researchers have also developed peak detection algorithms to quantify 
sympathetic bursts (Ebert, 1988; Rothman, Easty, Frecker, & Floras, 1991; Wallin & 
Eckberg, 1982).  By comparing burst averaging to visual inspection, Rothman et al. (1991) 
reported that manual interpretation of MSNA overestimated sympathetic activity by an 
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average of 112 units/min, or 19%.  This group further reported that visual inspection 
overestimated  MSNA by 183 units/min, or 31% compared to the use of a peak detection 
algorithm.  However, there was only a 70.6 unit/min difference between burst averaging and 
the peak detection technique.      
 The use of MSNA to quantify sympathetic outflow to the muscle has shown high 
intra-individual reproducibility (Fagius & Wallin, 1993; Fagius & Wallin, 1983; Sundlof & 
Wallin, 1977; Yamada, Miyajima, Tochikubo, Matsukawa, & Ishii, 1989).  For example, 
Fagius and Wallin (1993) reported high long-term reproducibility (10-14 yr) of MSNA in 
adults.  This group reported correlation coefficients of 0.81 and 0.90 for MSNA expressed as 
bursts•min-1 and bursts•100 heart beats-1, respectively, between recordings.  Yamada et al. 
(1989) demonstrated good short-term (3-20 days) reproducibility of MSNA expressed as 
bursts•min-1 (r=0.88), bursts•100 heart beats-1 (r=0.84), and spike frequency (r=0.84).  Fagius 
and Wallin (1983) also demonstrated exceptional reproducibility over a test-retest period of 2 
days to 4 years (r=0.94), while Sundlof and Wallin (1977) reported little differences in MSNA 
measures repeated over 3 weeks to 21 months (range of differences = 0.5-11.2 bursts•100 
heart beats-1).      
However, MSNA measures have been reported to vary considerably between healthy 
individuals making it difficult to establish normality criteria at rest (Fagius & Wallin, 1993; 
Sundlof & Wallin, 1978; Sundlof & Wallin, 1977).  For example, resting MSNA in healthy 
individuals is commonly found within the range of 1-60 bursts•min-1 (Fagius & Wallin, 
1993).  This wide range makes it difficult to determine differences among groups and could 
possibly give rise to false observations.  Therefore, data obtained from MSNA may be most 
appropriate for repeated measures designs.      
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Heart rate variability.  Homeostasis does not imply rigidity, but rather that physiologic 
systems operate within specific limits that allow oscillations around mean optimal values.  
Such behavior is observed even under steady state conditions, as exemplified by beat-to-beat 
fluctuations in heart period.  Heart rate variability (HRV) has recently become a popular 
noninvasive tool to estimate cardiac autonomic modulation (Malik, 1998), because it is easily 
measured and is a fairly straightforward index of autonomic control.  Analysis of these 
fluctuations has been useful in providing information regarding the physiology of the active 
autonomic control branches (Akselrod et al. 1981; Pomeranz et al. 1985).  Advantages to 
analyzing these fluctuations include obtaining physiologic information noninvasively and 
without interfering with neural functions of the control mechanisms. 
In the most basic form, HRV may be expressed as a time domain measure.  This often 
includes the computation of the variance of a series of RR intervals around the mean heart 
period.  The most commonly used time domain measure is the standard deviation of normal-
to-normal RR intervals (SDNN), which reflects all of the cyclic components accountable for 
the variability of the HR during the recording period.  Other common time domain variables 
include the following: the standard deviation of the average RR intervals calculated over 5-
minute segments (SDANN), the mean of the 5-minute standard deviations of normal RR 
intervals calculated over 24-hours (SDNN index), the square root of the mean squared 
differences of successive RR intervals (rMSSD), the number of pairs of adjacent RR intervals 
differing by more than 50 ms (NN50), and the percentage of NN50 relative to all RR intervals 
(pNN50).  Although these measures are able to provide an estimate of the overall variability 
in the HR, such measures neglect important information, namely the frequency content of the 
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variations (Task Force of the European Society of Cardiology and the North American 
Society for Pacing and Electrophysiology, 1996).   
As a result, frequency domain methods (spectral analysis) have been adopted, usually 
consisting of algorithms for the computations of power spectra of heart rate.  This method has 
yielded he most promise regarding the amount and specificity of the information obtained 
from HRV.  Spectral analysis of HRV may be performed by two different methods: a 
technique focusing on “fast” HR oscillations (<30 seconds), and  a “broad band” technique 
which  considers all components of variability within a given recording time (minutes to 
hours).  Since most research has centered on the fast fluctuations of HR, broad band spectral 
analysis will not be further dealt with in this review.  The two most commonly used 
algorithms used for spectral analysis of fast HR fluctuations are the fast Fourier 
transformation (FFT) and autoregressive (AR) modeling.  The spectrum derived from the FFT 
includes the entire signal variance, regardless of whether the power appears as peaks or as 
broadband (non-peaked) powers.  Conversely, the AR algorithm identifies a best-fitting model 
for the raw data from which the final spectrum, consisting of a variable number of peaks, is 
derived (Parati, Saul, Di Rienzo, & Mancia, 1995).   
Spectral analysis techniques used to quantify HRV focus on the frequency components 
between 0.025 and 0.5 Hz, as this range of power has been reported to reflect neural 
autonomic influences (Akselrod et al. 1981; Malliani, Pagani, Lombardi, & Ceruti, 1991).  
Rosenblueth and Simeone (1936) demonstrated long ago that whereas slow heart rate 
fluctuations are mediated by both sympathetic and parasympathetic control, sympathetic 
activity is unable to mediate faster heart rate changes.  Therefore spectral analysis, by 
separating components by their frequency, should be able to discriminate between frequency 
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ranges to which slow and faster mechanisms contribute (vagal activity should be expressed at 
a higher frequency).  It was in fact later determined that vagal cardiac control can modulate 
the HR up to 1.0 Hz, while sympathetic outflows to the heart can only modulate the HR at 
frequencies below 0.15 Hz.  The power spectra bands have been further divided into the 
following ranges: high-frequency (HF) (0.15 – 0.4 Hz), low-frequency (LF) (0.04 – 0.15 Hz), 
very low-frequency (VLF) (0.003 – 0.04 Hz), and ultra low-frequency (ULF) (0.0 – 0.003 Hz) 
(Task Force of the European Society of Cardiology and the North American Society for 
Pacing and Electrophysiology, 1996).   
 The HF peak is thought to be an indicator of vagal modulation and is commonly 
referred to as the respiratory peak as it corresponds to the heart rate variations related to the 
respiratory cycle (Parati et al. 1995).  Studies using the vagal blocker atropine have 
demonstrated a dose-dependent reduction in the HF peak, leaving power below 0.15 Hz partly 
unaffected (Eckberg, 1983; Katona & Jih, 1975; Saul et al. 1991). Therefore, the HF 
component of the power spectrum is often used as a measure of the integrity of vagal control.  
Conversely, the control mechanisms reflected by power in the LF range are not as well 
understood.  Studies have shown that power between 0.04 and 0.15 Hz are reduced by both 
parasympathetic and sympathetic blockade.  Furthermore, power of these lower frequencies 
has been associated with a wide variety of stimuli including thermoregulation, periodic 
breathing, and hemodynamic instability.  Therefore, it appears that power in the LF range 
reflects sympathetic and parasympathetic control of the heart along with other mechanisms.  
Although there is usually a large amount of power in the VLF and ULF ranges, their 
physiological correlates still remain unknown. 
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HRV during resting conditions has generally been reproducible (Table 2.1).  For 
example, Huikuri et al. (1990) analyzed the SDNN index over 2 consecutive 24-hour periods 
and 1 week apart in healthy adults.  The authors grouped all data together and reported an 
interindividual coefficient of variation (COV) of 24% and an intraindividual COV of 7±6%.  
However, recalculation of the intraindividual COV for separate time periods results in the 
day-to-day variation being lower (COV: 4.2±3%) than that of the 1-week period (COV: 
7.3±7%).  Hohnloser, Klingenheben, Zabel, Schroder, and Just (1992) showed good 
reproducibility of time and frequency domain parameters on days 7 and 28 in healthy subjects 
with intraclass correlation coefficients (ICC) between 0.63 and 0.93.  Kleiger et al. (1991) 
also reported good reproducibility of time and frequency measures of HRV between 3 and 60 
days apart, with all of the ICC’s above 0.84 with the exception of SDNN (ICC=0.7).  
Regarding clinical populations, Van Hoogenhuyze et al. (1991) and Piepoli et al. (1996) both 
demonstrated good reproducibility in patients with heart failure.  Bigger, Fleiss, Rolnitzky, 
and Steinman (1992) found remarkable stability of HRV measures in post-myocardial 
infarction patients on day 7 with ICCs >0.79.  In diabetic populations, Nolan et al. (1996) 
reported an ICC of 0.91 for pNN50, while Burger, Charlamb, Weinrauch, and D’Elia (1997) 
showed good short and long-term reproducibility of HRV measures. 
Blood pressure variability.  Similar to heart rate, blood pressure exhibits beat-to-beat 
fluctuations.  Blood pressure variability (BPV) has been widely assessed by calculating the 
standard deviation of the mean of SBP, DBP, and mean arterial pressure (MAP) from a 24-
hour tracing.  However, this technique is associated with several limitations. For example, the 
24-hour signal has non-stationary components more suitable to nonparametric than to 
parametric methods of signal analysis such as the standard deviation (SD). Also, 24-hour  
Table A.3 
 
Test-Retest Reliabilities of Commonly Measured Indices of Heart Rate Variability 
 
Author/Date  Population Acquisition Test-retest  Variable CV  r 
   (age)    length  period 
 
Bigger et al.  Post-MI  24-hr  7-days  TP  ---  0.90 
(1992)   (59±11 yr)     HF  ---  0.92 
LF  ---  0.96 
 
Burger et al.   IDDM  24-hr  3, 6, 9, & SDNN  ---  0.81 (3-mo), 0.84 (6-mo),  
(1997)   (37±10 yr)   12-months   ---  0.47 (9-mo), 0.85 (12-mo) 
         SDANN ---  0.74 (3-mo), 0.78 (6-mo), 
           ---  0.35 (9-mo), 0.83 (12-mo)  
         pNN50  ---  0.98 (3-mo), 0.99 (6-mo), 
           ---  0.81 (9-mo), 0.81 (12-mo) 
         rMSSD  ---  0.94 (3-mo), 0.92 (6-mo), 
           ---  0.72 (9-mo), 0.82 (12-mo) 
         TP  ---  0.78 (3-mo), 0.77 (6-mo), 
           ---  0.63 (9-mo), 0.47 (12-mo) 
         HF    ---  0.84 (3-mo), 0.79 (6-mo),  
           ---  0.65 (9-mo), 0.78 (12-mo) 
         LF  ---  0.93 (3-mo), 0.79 (6-mo), 
           ---  0.71 (9-mo), 0.82 (12-mo) 
 
SDNN, SDANN,  pNN50, rMSSD, SDNN index = see text HF=high-frequency power  MI=myocardial infarction 
r=intraclass correlation coefficient    LF=low-frequency power 
CV=coefficient of variation     TP=total power 
nu=normalized units      IDDM=insulin-dependent diabetes mellitus 
 
Table Con’d. 
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Table A.3  
 
Author/Date  Population Acquisition Test-retest  Variable CV  r 
   (age)    length  period 
 
Freed et al.  Healthy  10-min  10-hr  TP  9%  0.75 
(1994)   (44-83 yr)     HF  11%  0.92 
         LF  15%  0.74 
 
Hohnloser et al.  Healthy  24-hr  1-week  & SDNN  ---  0.78 (1-wk), 0.63 (1-mo) 
(1992)   (24±2.5 yr)   1-month rMSSD  ---  0.89 (1-wk), 0.83 (1-mo) 
pNN50  ---  0.93 (1-wk), 0.78 (1-mo) 
TP  ---  0.87 (1-wk), 0.83 (1-mo) 
HF  ---  0.85 (1-wk), 0.80 (1-mo) 
         LF  ---  0.86 (1-wk), 0.81 (1-mo) 
 
Huikuri et al.  Healthy  24-hr  1 & 7 days SDNN  7±6%  --- 
(1990)   (20-40 yr)  
   
Kleiger et al.  Healthy  24-hr  3-65 days SDNN  ---  0.70 
(1991)   (20-55 yr)     pNN50  ---  0.90 
         rMSSD  ---  0.90 
SDNN index ---  0.90 
TP  ---  0.89 
         HF  ---  0.84 
         LF  ---  0.91 
 
Table Con’d. 
62
 
Table A.3  
 
Author/Date  Population Acquisition Test-retest  Variable CV  r 
   (age)    length  period 
 
Marks et al.   Healthy  5-min   1-week  SDNN  ---  0.90 
(1999)   (27.5±6.3 yr)     HF  ---  0.67 
         LF  ---  0.82 
         LF:HF  ---  0.86 
 
Nolan et al.  Healthy  24-hr  2-weeks pNN50  ---  0.97  
(1993)   (44±13 yr)       
    
   Heart disease 24-hr  2-weeks pNN50  ---  0.94 
   (58±7 yr) 
 
   IDDM  24-hr  29, 63, 92, pNN50  ---  0.91 (29-d), 0.93 (63-d) 
   (52±12 yr)   &115 days     0.80 (92-d), 0.86 (115-d) 
 
Piepoli et al.   Heart failure 5-min  3-weeks SDNN  16%  0.78 
(1996)   (64.3±5.4 yr)     HF  14.5%  0.75 
         HFnu  ---  0.83 
         LF  10%  0.79 
         LFnu  ---  0.83 
         LF:HF  ---  0.74 
 
Table Con’d. 
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Table A.3  
 
Author/Date  Population Acquisition Test-retest  Variable CV  r 
   (age)    length  period 
 
Pitzalis et al.  Healthy  24-hr  2-weeks & SDNN  ---  0.57 
(1996)   (28±2 yr)   30-weeks pNN50  ---  0.78 
         rMSSD  ---  0.79 
     10-min  2-weeks & SDNN  ---  0.56 
       30-weeks pNN50  ---  0.40 
         rMSSD  ---  0.23 
         TP  ---  0.75 
         HF  ---  0.48 
         LF  ---  0.77 
 
Sinnreich et al.  Healthy  6-min  2-months SDNN  6.0%  0.77 
(1998)   (31-67 yr)     rMSSD  8.0%  0.75 
         TP  7.0%  0.77 
         HF  12.1%  0.76 
         LF  11.5%  0.68 
 
VanHoogenhuyze Heart failure  24-hr  1-day  SDNN  8.5%  0.97 
et al. (1991)  (59±7 yr)     SDANN 13.8%  0.87 
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blood pressure values commonly are characterized by a non-normal distribution limiting the 
standard deviation to correctly reflect the shape of dispersion around the mean.  Furthermore, the 
standard deviation lumps together different variability phenomenon, making it more difficult 
to single out different mechanisms of origination.  Therefore, other techniques of assessing 
BPV have become popular. 
 Other techniques include the range of BP values measured over 24-hours, the 
difference between average day and night pressures, the difference between hourly BP means 
averaged for 24-hours, and power spectral analysis of BPV.  Of these, power spectral analysis 
of BPV has shown the most promise.  Similar to HRV, spectral analysis of BPV allows the 
splitting of variability phenomenon into various components of different frequencies of BP 
oscillations.  Techniques that focus on fast oscillations in BP generally focus on frequencies 
between 0.025 and 0.5 Hz.  Fluctuations in this range are thought to reflect the features of 
some cardiovascular control mechanisms.  A clear peak is usually located at the respiratory 
frequency (~0.25-0.3 Hz), while other peaks are commonly found at ~0.1 and ~0.04 Hz.  As 
with HRV, these peaks may be analyzed via a FFT or through AR techniques. 
The HF (0.15-0.4 Hz) blood pressure component has been reported to reflect the 
mechanical effects of respiration on the pressure gradients, size, and functions of the heart and 
large thoracic vessels (Parati et al. 1995).  It has also been reported that the vagally mediated 
changes in HR and CO contribute to the HF component of BPV (Parati et al.).  Although the 
LF component (0.07-0.15 Hz) of BPV is not greatly affected by dual autonomic blockade 
with atropine and propranolol, it has been reported to increase with laboratory stimuli that 
increase sympathetic CV influences and decrease with those that decrease sympathetic 
influences.  Therefore, it is believed that LF power represents a marker of sympathetic 
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vasomotor tone and systemic vascular resistance (Parati et al.).  Frequencies between 0.025 
and 0.07 Hz  have been reported to reflect the renin-angiotensin system, endothelial factors, 
and local influences related to thermoregulation (Parati et al.).  
 There exist few studies that have specifically addressed the reproducibility of BPV 
measures.  In general, studies that have assessed BPV by the SD have not been reliable.  For 
example, Van Egeren and Sparrow (1989) reported ICCs of 0.11/0.00 (SBP/DBP) measured 1 
month apart, while James et al. (1988) found ICCs of 0.18/0.22 measured 2 weeks apart.  
Furthermore, Gerin, Rosofsky, Pieper, and Pickering (1993) reported ICCs of 0.52/0.63 and 
0.60/0.49 for SD and rMSSD, respectively, measured on 2 consecutive days.  With regards to 
spectral indices of systolic BP, Taverner, Nunan, and Tonkin (1996) found poor 
reproducibility over days 1, 2, 3, 4, and 5 with CV’s of 41 and 25% for LF/HF and LF power, 
respectively.  Additionally, Dimier-David, Billon, Costagliola, Jaillon, and Funck-Brentano 
(1994) used Bland-Altman plots (Bland, & Altman, 1986) to assess the reproducibility of the 
HF and LF spectral components of systolic BP and reported good reproducibility between 
days 1 and 2 and between days 2 and 30.   
Baroreflex sensitivity.  Investigation of the cardiac baroreflex, which is concerned with the 
short-term regulation of arterial BP, has been used to gain insight into vagal and sympathetic 
control of the heart (Dawson et al. 1997).  Baroreceptor sensitivity (BRS) was originally 
estimated in humans by assessing alterations in the pulse interval to pharmacologically-
induced BP changes (Smyth, Sleight, & Pickering, 1969). Other methods of inducing cardiac 
baroreceptor activation that have been used include neck suction/pressure (Eckberg, 
Convertino, Fritsch, & Doerr, 1992), lower body negative pressure (LBNP) (Raven, Potts, & 
Shi, 1997), the Valsalva maneuver (Smith, Stallard, Salih, & Littler, 1987), and/or various 
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combinations of these.  In all of these methods, the successive SBP values (measured intra-
arterially) are correlated with the length of the next RR interval and the regression coefficient 
of the correlation gives the BRS in ms of RR interval per mmHg (Dawson et al., 1997; Robbe 
et al. 1987).   
 With the recent technology of beat-to-beat BP monitors and high-powered computers, 
BRS may now be assessed noninvasely.  In sequence analysis, BP and RR intervals are 
measured over time and are evaluated for a sequence of > 3 beats in which SBP and RR 
interval increase or decrease simultaneously.  The threshold for a change in BP and RR 
interval is usually set at 1 mmHg and 4 ms, respectively.  When there is a linear relationship 
between RR interval and SBP changes (r>0.85), the slope of the regression line may be taken 
as an index of BRS (Dawson et al. 1997; Iida et al. 1999).  Thus, the sequence method is 
analogous to invasive methods previously employed.   
An even more recent method, the cross-spectral technique, uses power spectral 
analysis of HR and BP to quantify BRS (Iida et al., 1999; Pagani et al. 1988; Robbe et al., 
1987).  In this method, the square root of the ratio between the spectral powers of RR interval 
and SBP variabilities is termed the α-index and has been used as an index of BRS (Pagani et 
al.). The coherence function of the two spectra describes their linear dependence and only 
frequencies with a squared coherence greater than 0.5 are used to calculate the α-index 
(Pagani et al.). The α-indices may be computed for any frequency, but are usually computed 
for the LF and HF ranges as previously described (Dawson et al., 1997; Iida et al.).  
  Dawson et al. (1997) demonstrated good reproducibility of such noninvasive 
techniques to assess BRS.  This group reported intra-individual CV’s of 18.9% and 23.9% for 
BRS derived via α indices and the sequence technique, respectively, measured after 1 week 
 68
and 6 months.  Furthermore, Iellamo et al. (1996) reported an intra-individual CV of 15% for 
the sequence technique assessed on two consecutive days.  
Sympathetic skin response.  It has been well documented that sympathetic skin activity 
stimulates the eccrine sweat glands of the body (Bini, Hagbarth, Hynninen, & Wallin, 1980; 
Hallin, & Torebjork, 1974; Torebjork, 1974).  This physiological phenomenon has been used 
to quantify sympathetic nervous system activity to the skin.  The sympathetic skin response 
(SSR), a change in voltage across the surface of the skin, and the classical Galvanic skin 
response, the change in skin resistance across the skin, have both been used as tools to 
investigate sympathetic skin activity (Shahani, Halperin, Boulu, & Cohen, 1984).  These 
measures are usually assessed during electrical, physiological, or psychological stimuli.  The 
nervous system pathway to the sweat glands is believed to begin in the posterior 
hypothalamus, traverse down the lateral columns of the spinal cord to preganglionic 
sudomotor neurons, and then to the postganglionic neurons that innervate the sweat glands 
(Gutrecht, 1994).  Since most current research assessing electrodermal activity is performed 
by measuring SSR, the remainder of this section will focus on the techniques concerned with 
obtaining this measure. 
 Recordings of SSR are usually obtained from electrodes placed on the palm and 
dorsum of the hand and/or the sole and dorsum of the foot (Gutrecht, 1994).  The type of 
stimulus used varies, although an electric shock (~10-30 mA) of approximately 0.1-0.2 ms 
duration is commonly used (Gutrecht).  Skin temperature is also of concern as low 
temperatures may inhibit conduction of nervous impulses (Franz & Iggo, 1968).  Thus, skin 
temperature is commonly maintained ≥ 32 degrees Celsius (Gutrecht).   
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 The waveform obtained from the SSR may be biphasic or triphasic (Baba, Watahiki, 
Matsunaga, & Takebe, 1988) and is usually greater in the hand compared to the foot (Shahani 
et al. 1984).  The magnitude of the waveform varies considerably between subjects and has 
been reported to habituate rapidly following repeated stimuli causing some researchers to use 
progressively increasing stimuli (Hoeldtke, Davis, Hshich, Gaspar, & Dworkin, 1992).  
However, the latency of the SSR (measured by stimulating the opposite side of the body) is 
not effected by repeated stimuli and is usually ~1.3-1.5 m/s at the hand and ~1.9-2.1 m/s at 
the foot (Shahani et al.).   
 Current data suggest that only an absent SSR should be considered abnormal due to 
the habituation and variability of responses (Hoeldtke et al. 1992).  Additionally, caution must 
be used when attempting to use this methodology in the elderly as the SSR may not be 
elicitable in subjects > 60 years of age (Gutrecht, 1994).  The clinical importance of SSR has 
been somewhat controversial.  Although several studies have reported abnormal SSRs in 
various disease states including diabetic neuropathy (Soliven et al. 1987), familial amyloid 
polyneuropathy (Montagna, Salvi, & Liguori, 1988), chronic renal disease (D’Alpa, 
Scandurra, Lanaia, Scrofani, & Grasso, 1988), scleroderma (Raszewa, Hausmanowa-
Petrusewicz, Blaszczyk, & Jablonska, 1991), Parkinson’s disease (Johns, Gress,  Shahani, & 
Young, 1986), and multiple sclerosis (Yokota, Matsunaga, Okiyama, et al., 1991), most of 
these findings are anecdotal and are not consistent.  Therefore, more detailed studies 
comparing SSR to other clinical autonomic function tests are needed. 
Autonomic Control During Rhythmic Exercise Involving Large Muscle Groups 
At the onset of rhythmic exercise, several CV adjustments take place to meet the 
demands placed on the CV system.  Heart rate and SV both increase resulting in an increased 
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CO and BP.  Blood flow is directed towards active muscle and away from inactive tissues and 
the (a-v)O2diff increases, reflecting an increase in oxygen transfer to the working muscles.  In 
general, rhythmic exercise results in a parasympathetic withdrawal followed by a sympathetic 
activation.  Many of these alterations are under the control of various autonomic regulatory 
mechanisms.  Under the stress of rhythmic exercise, both central and peripheral autonomic 
reflex mechanisms initiate autonomic-mediated CV adjustments.  This section will address 
autonomic behavior during acute submaximal rhythmic exercise involving large muscle 
groups. 
Several studies have used HRV to examine the autonomic response to an acute bout of 
exercise (Table 3.1).  Studies using spectral indices of HRV as an indicator of cardiac 
autonomic modulation have suggested a withdrawal of parasympathetic activity, as HF power 
is reduced with increasing exercise intensity (Arai et al. 1989; Brenner, Thomas, & Shepard, 
1993; Casadei, Cochrane, Johnston, Conway, & Sleight, 1995; Kamath, Fallen, & McElvie, 
1991; Perini, Milesi, Biancardi, Pendergast, & Veicsteinas, 1998; Perini, Orizio, Baselli, 
Cerutti, & Veicsteinas, 1990; Perini et al. 1993; Sekiguchi et al. 1979; Sun, Elken, & 
Mekjavic, 1993; Warren, Jaffe, Wraa, & Stebbins, 1997; Yamamoto, Hughson, & Peterson, 
1991). It further appears that this decrease in HF power occurs at very light exercise 
intensities.  For example, Yamamoto, Hughson, and Nakamura (1992) demonstrated a 
reduction in the HF component at <60% of the ventilatory threshold.  Additionally, Perini et 
al. (1990) reported that HF power decreases during 5 minutes of upright cycling at 21% of 
aerobic power, while Perini et al. (1993) reported 6 minutes of supine cycling at 28% of 
maximal oxygen consumption was sufficient to significantly reduce HF power.  
 
Table A.4 
 
The Effects of Acute Dynamic Exercise on HRV Indices 
       Exercise 
Author/Date  Frequencies analyzed  (mode; duration; intensity)  Results  
 
Casadei et al.   HF (0.14-0.60Hz)  cycle; 23 min; max incremental HF ↓ (with ↑ int); HFnu ↓ (with ↑ int); 
(1995)   LF (0.04-0.14Hz)       LFnu ↓ (with ↑ int) until disappeared 
 
Nakamura et al. HF (0.15-0.80Hz)  cycle; NA; max incremental  HF:TP ↓ at >50%VO2max; 
(1993)   LF (0.00-0.15Hz)       LF:HF ↑ up to 80% VO2max 
   TP (0.00-0.80Hz) 
    
Arai et al.  HF (0.15-0.80Hz)  cycle; NA; max incremental  HF ↓ (with ↑ int); LF ↓ (with ↑ int); 
(1989)   LF (0.03-0.15Hz)       LF:HF ↔ (with ↑ int) 
 
Bernardi et al.  HF (0.15-0.80Hz)  cycle; NA; max incremental  HF:TP ↓ (with ↑ int); HF:TP ↑ at max;  
(1990) LF (0.05-0.12Hz)       LF:TP ↑ (with ↑ int); LF:TP ↓ at max  
TP (0.00-0.80Hz) 
____________________________________________________________________________________________________________ 
HF = high-frequency power  LF = low-frequency power  NA = not applicable   
TP = total power   int = intensity    max = maximal 
↑ = increase    ↓ = decrease    ↔ = no change 
bpm = beats per minute  Tvent = ventilatory threshold  VO2max = maximal oxygen consumption 
rpm = revolutions per minute  min = minute    nu = normalized units 
____________________________________________________________________________________________________________ 
Table Con’d. 
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Table A.4  
 
       Exercise 
Author/Date  Frequencies analyzed  (mode; duration; intensity)  Results  
 
Brenner et al.  HF (0.15-0.80Hz)  supine cycle; 8 min;    HF ↓ at 100 & 150 bpm; 
(1993)   LF (0.06-0.15Hz)  100 & 150 bpm   LF ↓ at 100 & 150 bpm  
 
Hayashi et al.  HF (0.15-0.50Hz)  cycle; NA; 20% & 100% Tvent HF ↔ at 20%; HF ↓ at 100%;   
(1992)   LF (0.00-0.15Hz)       LF:HF ↔ at 20%; LF:HF ↑ at 100% 
 
Kamath et al.  HF (0.18-0.40Hz)  cycle; 10 min; 50% VO2max  HF ↓ vs. supine rest; HF ↔ vs. stand rest;  
(1991)   LF (0.08-0.11Hz)       LF ↑ vs. supine rest; LF ↔ vs. stand rest 
 
Perini et al.  HF (0.15-1.0Hz)  cycle; 5 min; 21%, 49%,   HF ↓ at 21%, 49%, & 70%; 
(1990) LF (0.05-0.15Hz)  & 70% VO2max   HF:TP ↔ at 21%, 49%, & 70%; 
TP (0.0-1.0Hz)       LF:TP ↔ at 21%, ↓ at 49% & 70%; 
         LF:HF ↓ at 21%, 49%, & 70% 
 
Perini et al.  HF (0.15-1.0Hz)  cycle; 6 min; 14%, 28%,  HF:TP ↑ at 14% & 28%;  
(1993) LF (0.05-0.15Hz)  45%, & 67% VO2max   HF:TP ↓ at 45% & 67%;  
TP (0.0-1.0Hz)       LF:TP ↔ at 14% & 28%; 
         LF:TP ↓ at 45% & 67% 
____________________________________________________________________________________________________________ 
Table Con’d. 
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Table A.4  
 
       Exercise 
Author/Date  Frequencies analyzed  (mode; duration; intensity)  Results  
 
Perini et al.   HF (0.15-1.0Hz)  cycle; 6 min; 0, 50, 125,  HFnu ↓ with ↑ intensity 
(1998)   LF (0.04-0.15Hz)  & 175 W at 60rpm   LFnu ↑ with ↑ intensity 
 
Sekiguchi et al. HF (0.25-0.30Hz)  Treadmill; 10 min;    HF ↓ at moderate & max 
(1979)    LF (0.10Hz)   moderate & max   LF ↓ at moderate & max 
 
Sun et al.  HF (0.15-1.0Hz)  supine cycle; 14 min;   HF ↓; HF:TP ↔; 
(1993)   LF (0.05-0.15Hz)  30% peak work rate   LF ↓; LF:TP ↔ 
   TP (0.0-1.0Hz) 
 
Yamamoto et al. HF (0.15-1.0Hz)  cycle; 17 min; 20 watts,  HF progressively ↓ at all workloads;  
(1991) LF (0.05-0.15Hz)  30%, 60%, 90%, 100%,   LF:HF ↔ at 20 watts, 30%, 60%, 90%,   
  & 110% Tvent    & 100% Tvent; LF:HF ↑ at 110% Tvent 
 
Warren et al.   HF (0.15-0.1Hz)  cycle; 6 min; 0, 50, 100,   HF ↓ with ↑ intensity 
(1997)   LF (0.05-0.15Hz)  150 W     LF:HF ↔ with ↑ intensity 
____________________________________________________________________________________________________________ 
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Research further suggests that power in the LF range of the HR spectrum is also 
reduced during rhythmic exercise (Arai et al. 1989; Perini et al. 1993; Sekiguchi et al. 1979; 
Sun et al. 1993).  Although both HF and LF power are decreased with acute exercise, one 
would expect the balance of sympathetic to parasympathetic activity, expressed as either 
LF:HF or as normalized units, to be altered to reflect an increased sympathovagal balance.  
Indeed, several studies have supported this hypothesis.  For example, Nakamura, Yamamoto, 
and Murakoa (1993), Yamamoto et al. (1991), and Hayashi, Nakamura, and Murakoa (1992) 
reported increases in the LF:HF ratio at submaximal workloads, while Perini et al. (1998) 
reported increases and decreases in LF and HF normalized units, respectively, with increasing 
exercise intensity. In contrast, Arai et al. (1989) and Warren et al. (1997) reported no change 
in LF:HF with increasing exercise intensity, while Perini et al. (1990) reported decreases in 
LF:HF at an intensity of 70% VO2max.                  
Rowell and O’Leary (1990) reported that vagal withdrawal appears to be nearly 
complete at exercise heart rates of approximately 100 beats • minute –1 in humans.  At 
intensities greater than this, sympathetic nervous activity begins to rise as indicated by 
increases in MSNA, plasma NE and plasma rennin, and decreases in renal and splanchnic 
blood flow (Christensen & Brandsborg, 1973; Rowell & O’Leary, 1990).  Pharmacological 
studies have further supported these findings and have similarly reported an early decrease in 
parasympathetic activity during moderate exercise, and a gradual increase in sympathetic 
activity at intensities that elicit heart rates greater than 100 beats • minute –1 (Ekblom, 
Goldbarg, Kilbom, & Astrand, 1972; Fagraeus & Linnarsson, 1976; Maciel, Gallo, Marin 
Neto, Lima Filho, & Martins, 1986; Robinson, Epstein, Beiser, & Braunwald, 1966).  
Hohimer, Hales, Rowell, and Smith (1983) reported an increased blood flow to the heart and 
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exercising skeletal muscle, while blood flow was reduced to the skin, splanchnic organs, 
kidneys, nonexercising skeletal muscle, and subcutaneous adipose tissue during mild cycling 
exercise, suggesting a significant sympathetic response.    
The withdrawal of vagal efferent activity at the onset on exercise is believed to be 
primarily mediated by central command (Williamson, Nobrega, Winchester, Zim, & Mitchell, 
1995).  Signals arising from a central area of the brain activate the motor cortex and the CVC 
in the medulla, which, in turn, alters autonomic outflow via a feedforward mechanism 
(Mitchell, 1990).  Although some researchers have also hypothesized a role of muscle 
mechanoreceptors in mediating this autonomic alteration (Hollander, & Bouman, 1975), it 
appears that central command plays a predominant role at exercise onset.  For example, 
Williamson et al. (1995) recently demonstrated that the RR interval can be shortened within 
300 ms of voluntary cycling, which is quicker than the time-course needed for muscle 
mechanoreceptors (~550 ms), providing evidence for a predominant role of central command 
at the onset of exercise.  However, as exercise time increases, various autonomic reflex play a 
role in regulating CV function.  
Contracting skeletal muscle during rhythmic exercise activates both mechanically and 
chemically sensitive muscle afferents that reflexly activate the CVC in the medulla. This 
reflex, commonly referred to as the “exercise pressor reflex,” therefore results in autonomic 
alterations and plays a major role in the CV response to rhythmic exercise.  As previously 
mentioned, Hollander and Bouman (1975) provided evidence supporting the muscle-heart 
reflex in which the activation of mechanically sensitive muscle afferents can initiate a vagal 
withdrawal (independent of central command) within 550 ms.   
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O’Leary (1993) provided evidence for a significant role of muscle metaboreceptors in 
regulating the CV response to exercise.  By using post-exercise muscle ischemia with or 
without atropine or propranolol, he demonstrated that both the HR and BP responses to 
exercise are mediated, at least in part, by sympathetic outflow to the heart via activation of the 
muscle chemoreflex.  He further reported that during parasympathetic blockade, the reduction 
in HR following exercise was attenuated, suggesting that increases in vagal activity can 
obscure the influence of the muscle metaboreflex on the heart. 
As described previously, the baroreceptors act as a negative feedback controller and 
are important to the beat-to-beat regulation of BP at rest.  However, the transition from rest to 
exercise is marked by an increase in both HR and BP.  Obviously this could only occur if the 
baroreflex is somehow altered by the exercise.  There is a general consensus that the arterial 
baroreflex is reset to a higher operating pressure at the onset of rhythmic exercise, without a 
concurrent change in sensitivity (Bevegard, & Shepard, 1966; Melcher, & Donald, 1981; 
Potts, Shi, & Raven, 1993).  Using bilateral carotid occlusion, Melcher and Donald (1981) 
demonstrated that the HR and BP stimulus-response curves were the same at rest and during 
exercise indicating no difference in BRS between conditions.  Their study also demonstrated 
that the removal of extracarotid baroreceptor input by vagotomy yielded no difference in 
carotid baroreceptor sensitivity during exercise.  Using varying amounts of neck 
pressure/suction, Potts et al. (1993) constructed stimulus-response curves of the baroreflex 
during rest and exercise at 25% and 50% VO2max.  They demonstrated that the open-loop 
stimulus-response relationship of the carotid baroreflex is reset during dynamic exercise by 
shifting the baroreflex response curve to new systemic pressures.  They also reported that the 
operating-point of the baroreflex curve was shifted away from the centering point towards the 
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threshold region.  Therefore, at rest the carotid baroreflex can alter cardiac and vascular 
responses to both increases and decreases in BP, whereas during exercise it responds more 
readily to a hypertensive stimulus.  This likely enables the receptors to respond better to the 
hypertensive response of exercise resulting from the exercise pressor reflex.  Ludbrook and 
Graham (1985) further reported that the resetting of the baroreflex operating point occurs 
faster than the change in BP, resulting in a baroreflex error signal.  Such an error signal may 
cause an overshoot in HR at the onset of exercise, but as exercise time progresses, the BP 
increases closer to the operating point and HR is reduced slightly to a lower steady-state 
value.  For the most part, the aortic baroreceptors function in concert with the carotid 
baroreceptors.  The primary differences between the two are that baroreceptors of the aortic 
arch work at higher operating pressures (Raven, Potts, & Shi, 1997) and account for one-third 
more of the entire arterial baroreflex than the carotid baroreceptors (Sanders, Ferguson, & 
Mark, 1988).  
The cardiopulmonary baroreceptors also play an important role in the regulation of BP 
during rhythmic exercise.  These receptors, which are sensitive to cardiac filling volume and 
central venous pressure, regulate BP by peripheral vasoconstriction or vasodilation (Raven et 
al. 1997).  As previously mentioned, Melcher and Donald (1981) provided evidence for a 
significant role of the cardiopulmonary baroreceptors during exercise by assisting the carotid 
baroreflex in establishing the operating range.  Furthermore, Mack, Nose, and Nadel (1988) 
concluded that during exercise the cardiopulmonary baroreflex is involved in regulating 
cardiac filling pressure and is reset to higher cardiac filling pressures to regulate the increased 
cardiac filling volumes during exercise.  Potts, Shi, and Raven (1995) also reported that 
exercise combined with –18 torr of lower body negative pressure (unloading of 
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cardiopulmonary baroreceptors) results in an augmented carotid baroreceptor gain suggesting 
that the cadiopulmonary baroreceptors exert a tonic inhibition on the carotid baroreflex during 
exercise.  Although the exact mechanism by which the baroreflex is reset during rhythmic 
exercise has not been elucidated, both central command and activation of muscle afferents are 
believed to play a role.  
In conclusion, at the onset of an acute bout of rhythmic exercise, there is a withdrawal 
of parasympathetic activity to the heart.  This withdrawal is likely mediated via central 
command, although the role of the arterial baroreflex cannot be dismissed.  As exercise 
intensity increases, there is a gradual sympathetic activation, which may be mediated via 
muscle mechanoreceptors, muscle metaboreceptors, and/or the arterial baroreflex (via further 
resetting).  
Mitigating Factors of Autonomic Regulation 
Age.  There are many changes in cardiovascular function that are associated with age that 
implicate age-related changes in ANS activity.  Several of these changes can be attributed to 
alterations in autonomic nervous system activity.  However, while CV regulation differs 
between old and young individuals, the effects of age versus the effects of factors that may 
co-vary or interact with age (e.g. lifestyle, physical fitness, nutritional status, disease, etc.), 
have not been completely elucidated.  Thus, one must exercise caution when describing 
differences between the young and old, as age usually does not account for all of the variance 
in the data.   
 As individuals grow older, maximal HR is reduced, while resting and maximal SBP 
are elevated.  The resting end-diastolic volume index (end-diastolic volume normalized for 
body size) and stroke volume index increase with age, while end-diastolic and end-systolic 
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volume indices are greater in older versus younger individuals during maximal exercise.  
While cardiac ejection fraction and cardiac index at rest appears to be unaffected by age, they 
are dramatically reduced in older individuals during maximal or near-maximal exercise.  
Additionally, peripheral vascular resistance increases with age at rest and during maximal 
exercise. (Fleg et al. 1990). 
 As previously mentioned, cardiac output has been reported to be influenced by age.  
Furthermore, each of the factors that determine cardiac output (heart rate, preload, afterload, 
coronary flow, myocardial cell performance) is subject to autonomic modulation.  An age-
related reduction in the effectiveness of sympathetic modulation of the cardiovascular 
response to exercise could contribute to some of these alterations.  For example, it has been 
reported that the age-related changes in the end-diastolic volume index and end-systolic 
volume index during upright cycle exercise do not occur in the presence of propranolol (Fleg 
et al. 1991).  Conway, Wheeler, & Sannerstedt (1971) further demonstrated that the age-
related decrease in cardiac index during exercise is reduced under β-blockade.   
 It seems unlikely that the age-associated reduction in the effectiveness of β-adrenergic 
modulation of the cardiovascular system during exercise is caused by a reduced secretion of 
catecholamines during exercise.  Numerous reports have demonstrated that resting plasma 
concentrations of NE and E are greater in older subjects, reflecting an increased spillover into 
the plasma (Featherstone et al. 1987; Fleg, Tzankoff, & Lakatta, 1985; Goldstein et al. 1983; 
Pfeifer et al. 1983; Prinz, Halter, Benedetti, & Raskind, 1979; Rowe & Troen, 1980; Rubin, 
Scott, McLean, & Reid, 1982; Sowers, Rubenstein, & Stern, 1983).  A more likely 
explanation for age-associated reductions in adrenergic modulation is that responses to β-
adrenergic stimulation decline with age.  That is, neurotransmitters are not as effective at the 
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level of the target organ (Lakatta, 1993).  For example, it has been demonstrated that 
isoproterenol infusion elicits a greater increase in left ventricular ejection fraction and cardiac 
index in young compared to older subjects (Stratton et al. 1992).  Infusions of β-adrenergic 
agonists (Kuramoto, Matsushita, Mifune, Sakai, & Murakami, 1978; London, Safar, Weiss, & 
Milliez, 1976; Stratton et al., 1992; Vestal, Wood, & Shand, 1979; Yin, Spurgeon, Greene, 
Lakatta, & Weisfeldt, 1979) and isoproterenol (Abrass, Davis, & Scarpace, 1982; Le Blanc & 
Rakusan, 1987; O’Conner, Scarpace, & Abrass, 1981) result in a reduced heart rate response 
with increasing age.  Although these results could be explained by either a reduced response 
to adrenergic stimuli or by increased vagal modulation of the heart with advancing age, Yin et 
al. (1979) demonstrated that the heart rate increase in response to isoproterenol infusion in the 
presence of vagal blockade decreases with age.   
 Although, early evidence for changes in vagal modulation with increasing age were 
not entirely clear, more recent evidence suggests a reduction in parasympathetic activity with 
age.  For example, Chevalier, Mansier, Teiger, Callens-El Amrani, & Swynghedauw (1991) 
reported that the number of cholinergic receptors in the left ventricle, along with the response 
to acetylcholine decreased with age.  Additionally, numerous studies have demonstrated that 
HRV and BRS decrease with age (Laitinen et al. 1998; O'Mahony, Bennett, Green, & 
Sinclair, 2000; Schwartz, Gibb, & Tran, 1991; Shannon, Carley, & Benson, 1987; 
Waddington, MacCulloch, & Sambrooks, 1979).     
 Researchers have also addressed the effects of age on vascular responsiveness to 
adrenergic stimuli.  Pan, Hoffman, Pershe, & Blaschke (1986) demonstrated that the 
redistribution of blood to skeletal muscle and various other organs during isoproterenol 
infusion decreases with age.  Using a dog model, Yin, Weisfeldt, & Milnor (1981) reported a 
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reduced β-adrenergic relaxant effect on aortic smooth muscle.  Additionally, Van Brummelen, 
Buhler, Kiowski, & Amann, (1981) showed a reduced dilation of forearm vasculature in 
response to isoproterenol infusion with age.   
Race.  Several studies have suggested racial differences in autonomic activity.  For example, 
African American children have been shown to exhibit a more pronounced alpha-adrenergic 
increase in peripheral vasoconstriction than Caucasians (Treiber, Musante, Braden, et al., 
1990).  Additionally, borderline hypertensive Caucasian adults have a higher increase in 
cardiac index (Sherwood, Hinderliter, & Light, 1995), while their African American 
counterparts exhibit a higher increase in vascular tone (Sherwood, May, Siegal, & 
Blumenthal, 1995).  Furthermore, Caucasian children reportedly exhibit higher HR and CO at 
rest (Voors, Webber, & Berenson, 1980), while African American children exhibit greater 
peripheral vascular resistance (Soto, Kikuchi, Arcilla, Savage, & Berenson, 1989).   Other 
studies have demonstrated reduced plasma renin levels in African Americans compared to 
Caucasians, suggesting a lower sympathetic tone (Gillum, 1979; He, Klag, Appel, Charleston, 
& Whelton, 1999).  
Regarding studies that have used HRV, Liao, Barnes, Chambless, Simpson, Sorlie, & 
Heiss  (1995) reported that African Americans exhibited favorable HRV parameters (higher 
HF, lower LF, and lower LF/HF) compared to Caucasians in a large population study.  
Furthermore, Urbina, Bao, Pickoff, and Berenson (1998) demonstrated greater pNN50 values 
and lower LF/HF for African Americans compared to Caucasians during supine rest and 
during several CV reactivity tests. In contrast, by controlling for environmental factors (i.e. 
diet, alcohol consumption, physical activity), Horodyski, De Meersman, Vandenburgh, and 
Gallagher (1995) reported that there were no racial differences in HRV and BRS.  However, 
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the subjects of this study were cadets at a military academy and the high volume of physical 
training in which they were involved may have overshadowed any racial differences that were 
present.   
 The findings of He et al. (1999), Voors et al. (1980), Liao et al. (1995), and Urbina et 
al. (1998) suggest increased sympathetic activity in Caucasians and increased parasympathetic 
modulation in African Americans.  This has puzzled investigators since previous studies have 
reported a sympathetic predominance in early hypertension (Pieper, & Hammill, 1995; 
Takalo, Korhonen, Turjanmaa, Majahalme, Tuomisto, & Uusitalo, 1994) and there is a higher 
prevalence of hypertension in the African American population (Hypertension Detection and 
Follow-up Program Cooperative Group, 1979).  Although there is no clear explanation for 
these findings, it may be that the lower sympathetic activity in African Americans is a 
consequence of an elevated plasma volume of renal origin (Gillum, 1979; Schachter, & 
Kuller, 1984). 
Gender.  There are several studies that suggest a significant effect of gender on autonomic 
balance in young adults.  For example, Hirsch and Bishop (1981) reported a trend towards 
higher RSA in a group of 7 females compared to that of 10 age-matched males.  Ryan, 
Goldberger, Pincus, Mietus, and Lipsitz (1994) reported a greater total and HF spectral power 
of HRV in young women compared to a group of age-matched males.  Additionally, Gregoire 
et al. (1994) reported a greater HF-to-TP ratio and a lower LF-to-HF ratio, which would 
suggest a lower sympathovagal balance, in females (age=21.6±2 yr) compared to males 
(age=21.4±1 yr) of similar fitness levels.  In a recent study in healthy adults (age=20-83 yr), 
Barnett et al. (1999) reported that females exhibited a lower NE response to head-up tilt, and 
an elevated HF power of HRV at rest, compared to age-matched healthy males. Other recent 
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studies have provided similar results (Huikuri et al. 1996; Rossy & Thayer, 1998).  
Furthermore, Matsukawa, Sugiyama, Watanabe, Kobayashi, and Mano (1999) recently 
reported that MSNA was significantly lower in a group of women under 50 years of age 
compared to age-matched males.   
 In contrast, studies seem to suggest that no gender differences in autonomic balance 
exist in older subjects.  For example, in a cohort of 15,800 subjects (age=45-64 yr), Liao et al. 
(1995) reported no differences in HF power between males and females.  Furthermore, they 
reported a higher LF/HF in females, which contradicts the majority of the findings in younger 
subjects.  Ryan et al. (1994) also reported that the gender-related differences in HRV present 
in younger adults, are not present in middle-aged and older adults.  Additionally, in a 
previously mentioned study (Matsukawa et al. 1999), there were no differences in resting 
MSNA in subjects greater than 50 years of age.   
 Thus, research seems to suggest that in young adults, females may exhibit a lower 
sympathovagal balance compared to males of similar health status.  However, in older adults, 
the age-related increase in sympathetic drive appears to negate these gender differences.  A 
possible mechanism for the differences in autonomic control between males and females is 
hormonal levels.  Specifically, estrogen and progesterone, which are significantly higher in 
young females have been reported to alter sympathetic autonomic outflow.  For example, it 
has been reported that infusions of estrogen reduce the NE response to mental stress in 
postmenopausal women (Del Rio et al. 1994), and also that progesterone infusion reduces 
plasma NE in men (Tollan, Oina, Kjelden, Eida, & Maltass, 1993).  This would therefore 
explain why gender differences were no longer present in older adults.  In conclusion, there is 
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evidence that gender is a significant factor that may influence autonomic modulation and 
should be considered in research investigations. 
Environment.   Several environmental factors, including temperature and altitude, influence 
autonomic regulation and, therefore, should be considered when investigating autonomic 
function.  For example, there is ample evidence to suggest that elevated environmental 
temperatures result in an augmented sympathetic outflow.  Several studies that have used 
HRV as an index of autonomic control have reported attenuated HF power, suggesting a 
reduction in vagal outflow to the heart and/or an enhanced sympathetic outflow (Brenner, 
Thomas, & Shepard, 1997; Parsons, Scott, & Macdonald, 1992; Saul, 1990).  In rats, Walsh 
(1969) reported similarly that infusion of either atropine or a beta-antagonist blocked the rise 
in HR associated with an increase in core temperature from 35 to 40 degrees Celsius.  
Likewise, Gorman and Proppe (1984) reported that infusions of atropine or propranolol 
attenuated the HR rise to arterial temperature increases of 2-3 degrees Celsius.  Furthermore, 
they estimated that the autonomic contributions of the sympathetic and parasympathetic 
branches to the temperature-induced HR elevation were 15% and 45%, respectively.  
Additionally, Niimi et al. (1997) reported an elevated MSNA during temperature increases 
from 29 to 40 degrees Celsius.  Together, these studies suggest that increases in 
environmental temperature lead to an elevated sympathetic noradrenergic outflow, likely in 
order to redistribute blood towards the skin to facilitate body cooling via convection.   
 Acute periods of cold stress also elicit elevations in sympathetic activity.  In fact, 
researchers have used the cold pressor test, which involves a subject immersing a limb in cold 
water, as an index of CV reactivity for a number of years.  Some of the CV responses to acute 
periods of cold stress include increases in ventilation, HR, BP and TPR, and a reduced blood 
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flow to the periphery as blood is shunted towards the core of the body (Brooks, Fahey, & 
White, 1995).  Furthermore, Kinugasa and Hirayanagi (1999) recently reported a decreased 
HF component of the power spectrum of HRV along with an increase in LF/HF in response to 
acute cold stress (18 degrees Celsius), reflecting a reduced parasympathetic and/or increased 
sympathetic cardiac outflow.  Thus it appears that acute exposure to a cold environment 
results in alterations in autonomic balance favoring an enhanced sympathetic noradrenergic 
component. 
 Another environmental condition that may substantially influence autonomic nervous 
system activity is altitude-induced hypoxia.  Hypoxic conditions not only effect ventilation 
(via chemoreceptors in the aortic and carotid bodies), but also influence autonomic CV 
regulation by activating the sympathoadrenal system.  For example, several researchers have 
reported that acute exposure to high altitude (>4000 meters) results in the elevation of arterial 
and urinary catecholamines (Mazzeo et al. 1991; Mazzeo, Wolfel, Butterfield, & Reeves, 
1994; Pace, Grinswold, & Grunbaum, 1964; Surks, Beckwitt, & Chidsey, 1967).  These 
sympathoadrenal responses, therefore, can influence CV variables including HR, BP, and 
vascular resistance.  In fact, by using autonomic blockade via propranolol and atropine, 
Koller, Drechsel, Hess, Macherel, & Boutellier (1988) reported that increases in HR, BP and 
CO induced by exposure to simulated altitude (6000 meters) were mediated by both an 
elevated sympathetic and a reduced parasympathetic activity.  Studies that have used HRV to 
assess the autonomic response to hypoxic environments have also provided evidence to 
support these findings.  For example, Hughson, Yamamoto, McCullough, Sutton, and Reeves 
(1994) reported that following 4-5 days at 4300 m, there were alterations in spectral power to 
reflect an increased sympathetic and reduced parasympathetic influence on the heart.  They 
 86
also reported a slight recovery towards pre-hypoxic values for these indices following 11-12 
days at altitude.  Ponchia et al. (1994) further reported a reduction in cardiac vagal 
modulation, noted by attenuated HF power and pNN50, following 1 week of exposure to an 
altitude of 5000 meters.  Lastly, Bernardi et al. (1998) recently reported that acute (1 day) 
exposure to altitude (4970 meters) resulted in reduced HF and elevated LF spectral power, 
also reflecting a reduced vagal modulation of the heart.  In closing, these findings suggest that 
acute hypoxia results in an elevated sympathetic drive with a concomitant reduction of 
parasympathetic outflow, both of which may alter CV variables. 
Influence of Peak Aerobic Power on Autonomic Regulation of the Cardiovascular System 
Aerobic fitness, as defined by peak aerobic power, is related to autonomic regulation 
of the CV system.  Compared to individuals of a low-to moderate fitness level, high-fit 
subjects have been shown to exhibit significant alterations in certain CV variables (i.e. 
reduced resting HR, reduced resting BP, increased CO).  Interestingly, there is evidence that 
several of the alterations in these variables may be the result of fitness-related differences in 
autonomic nervous system activity.  Therefore, the purpose of this section of the review is to 
examine cross-sectional studies that have used various methodologies to look at the 
relationship between aerobic fitness and autonomic regulation of the CV system. 
Studies assessing CV reactivity to laboratory stressors.  Research regarding the influence of 
aerobic fitness on CV reactivity to laboratory stressors has produced equivocal results. 
Several studies have reported improvements in CV reactivity in subjects with enhanced 
fitness (Boutcher, Nugent, McLaren, & Weltman, 1998; Claytor, Cox, Howley, Lawler, & 
Lawler, 1988; Czajkowski et al., 1990; De Geus, Van Doornen, De Visser, & Orlebeke, 1990; 
Holmes & McGilley, 1987; Holmes & Roth, 1985; Hull, Young, & Ziegler, 1984; Lake, 
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Suarez, Schneiderman, & Tocci, 1985; Light, Obrist, James, & Strogatz, 1987; McCubbin, 
Cheung, Montgomery, Bulbulian, & Wilson, 1992; Perkins, Dubbert, Martin, Faulstich, & 
Harris, 1986; Shulhan, Scher, & Furedy, 1986; Sothmann, Horn, Hart, & Gustafson, 1987; 
Spalding, Jeffers, Porges, & Hatfield, 2000; Turner, Carroll, Costello, & Sims, 1988; Van 
Doornen & De Geus, 1989), while others have reported no differences (Dorheim, Ruddel, & 
Eliot, 1984; Plante, & Karpowitz, 1987; Sinyor, Golden, Steinert, & Seraganian, 1986), and 
even exaggerated responses (De Geus, Van Doornen, & Orlebeke, 1993).  A list of studies 
examining this relationship can be seen in Table 5.1.  The majority of studies have reported 
reduced CV reactivity to stress in subjects with a higher aerobic capacity.  For example, in a 
population of young subjects (age=18-26 yr), Van Doornen and De Geus (1989) examined 
CV reactivity to a reaction time task and reported that those with higher fitness (n=8; VO2max 
=67.2 ml•kg-1•min-1) demonstrated lower HR, SV, DBP, TPR, and cardiac pre-ejection 
period (PEP) reactivity than those with lower aerobic fitness (n=7; VO2max =48.9 ml•kg-1•min-
1).  By assessing CV reactivity to video games and mental arithmetic, Perkins et al. reported 
that hypertensives that had undergone 10-weeks of exercise training (n=11; age=44±10 yr) 
exhibited less BP reactivity compared to their untrained counterparts (n=7; age=47.4±11 yr), 
while no differences in HR reactivity were noted.  McCubbin et al. reported less HR reactivity 
to a mental arithmetic task in high- (n=14; age=23±1 yr; VO2max=44.7±1 ml•kg-1•min-1) 
compared to low-fit (n=14; age=20±1 yr; VO2max=36.6±1 ml•kg-1•min-1) individuals, while 
no differences were noted in BP reactivity.  Furthermore, they suggested that differences in 
HR reactivity were mediated via an opioid neuropeptide mechanism, as group differences 
were not significant under the opioid-blocking drug naloxone.  Lake et al. provided evidence 
suggesting that while HR reactivity is not different in subjects with varying fitness levels  
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Table A.5 
______________________________________________________________________ 
Cross-Sectional Studies evaluating the effect of Aerobic Power on Cardiovascular Reactivity 
to Stress. 
______________________________________________________________________ 
Author/Date  Stressor  Dep.Var. Findings 
______________________________________________________________________ 
 
Boutcher et al.  Stroop CWCT  HRV  ↑ decrease in HRV in fit & 
(1998)        unfit w/ low resting HRs 
 
Brooke & Long Rapelling  HR, E, NE, Faster recovery of E 
(1987)      cortiisol 
 
Claytor et al.  Reaction  HR, BP, E, ↓ HR reactivity in  
(1988)   time   NE  high-fit  
 
Czajkowski  M.A.,   HR, BP ↓ HR & BP reactivity in  
(1990)   Video game    high-fit 
 
De Geus et al.  Tone   HR, BP, TPR ↓ DBP, MAP, RSA 
(1990)   avoidance  RSA, PEP,  reactivity in fit 
      CO, SV   
 
De Geus et al.  Reaction  HR, BP, PEP, ↑ BP reactivity in fit   
(1993)   time   CO, TPR subjects 
 
Dorheim et al.  Reaction  HR, BP No differences  
(1984) time 
 
Hollander et al. Word    HR, Skin Faster HR recovery in   
(1984)   recognition  conductance fit subjects 
______________________________________________________________________ 
HR = heart rate   M.A. = mental arithmetic 
HRV = heart rate variability  E = epinephrine  
BP = arterial pressure   NE = norepinephrine 
SBP = systolic blood pressure TPR = total peripheral resistance 
DBP = diastolic blood pressure SV = stroke volume 
CO = cardiac output   PEP = pre-ejection period 
SC = skin conductance  VO2 = oxygen consumption 
RR =  RR interval    RSA = respiratory sinus arrhythmia 
CWCT = color word conflict task ↓ = decrease 
↑ = increase    Dep. Var. = dependent variable 
______________________________________________________________________ 
Table Con’d. 
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Table A.5  
___________________________________________________________________________________ 
Author/Date  Stressor  Dep.Var. Findings 
______________________________________________________________________ 
 
Holmes & McGilley M.A.   HR  ↓ HR reactivity in fit 
(1987)        subjects 
 
Holmes & Roth M.A.   HR, BP ↓ HR reactivity in fit 
(1985)        subjects 
 
Hull et al.  Stroop CWCT  HR, BP, NE ↓ DBP reactivity in fit 
(1984)        subjects 
 
Keller & Seraganian Stroop CWCT  HR, SC Faster HR recovery in 
(1984)        fit subjects 
 
Lake et al.  M.A.   HR, BP ↓ BP reactivity during 
(1985)   Card games    M.A.; ↑ BP reactivity 
        during games in fit 
 
Light et al.  Reaction   HR, BP, ↓ HR, SBP, & PEP 
(1987)   time   PEP  reactivity in active 
 
McCubbin et al. M.A.   HR, BP ↓ HR reactivity in fit 
(1992)          
 
Perkins et al.   M.A.   HR, BP ↓ BP reactivity in  
(1986)   Video games    fit 
 
Plante et al.  I.Q. test  HR  No difference 
(1987) 
 
Shulhan et al.  M.A.    HR, T-wave ↓ T-wave in fit 
(1986)      on EKG 
 
Sinyor et al.   Stroop CWCT  HR, E, NE, Faster HR recovery 
(1983)   M.A.   prolactin, & peak NE 
   EKG quiz  cortisol 
 
Sinyor et al.  M.A., Tone  HR, BP No difference 
(1986)   avoidance      
______________________________________________________________________ 
Table Con’d. 
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Table A.5 
____________________________________________________________________________________ 
Author/Date  Stressor  Dep.Var. Findings 
______________________________________________________________________ 
 
Sothmann et al.  Stroop CWCT  E, NE  ↓ NE reactivity 
(1987)        in fit 
 
Spalding et al.  M.A.   RR, RSA ↑ RR during stress in fit 
(2000)   Stroop CWCT 
 
Steptoe et al.  Problem  HR, BP, RR, ↓ RR & faster HR                                             
(1990)   solving   SC  recovery in fit 
 
Szabo et al.   M.A.   HR, BP Faster HR recovery  
(1994)        in fit 
 
Turner et al.  M.A.   HR, BP,  ↓ HR reactivity in 
(1988)      VO2  fit 
 
Van Doornen &. Reaction   HR, BP, TPR  ↓ HR, SV, PEP, DBP, 
De Geus (1989) time   SV, CO, PEP  & TPR reactivity 
        in fit 
______________________________________________________________________ 
  
(n=40; age=19 yr; VO2max=54.2-67.7 ml•kg-1•min-1 vs. n=21; age=19; VO2max=37.4-47.6 
ml•kg-1•min-1), BP reactivity during mental arithmetic is significantly lower in high-fit 
subjects.  However, they further noted that BP reactivity was actually greater in the high-fit 
individuals during competitive card games.  This seemingly contradictory finding was 
suggested not to be a result of different aerobic capacity, but explained by the fact that the 
high-fit individuals were competitive athletes and were possibly better able to increase 
noradrenergic outflow during competition than the lower fit subjects.  Using both treadmill 
time to exhaustion and self-reported physical activity, Hull et al. reported that DBP reactivity 
to the Stroop CWCT was attenuated in fit (n=9; age=30±2 yr) relative to unfit (n=16; 
age=41±4 yr) subjects.  Although there were no group differences in HR, SBP, NE, or E 
reactivity to the stressor, the investigators failed to take group differences in age into account 
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when performing these analyses, which may have confounded the results.  Additionally, their 
method of assessing physical fitness was not ideal, thus differences in fitness may have 
possibly been exaggerated.  Holmes and Roth (1985) demonstrated a reduced HR response to 
the backwards digit counting test of the Weschler Adult Intelligence Scale in undergraduate 
women with a mean VO2max of 53.5 ml•kg-1•min-1 (n=10) compared to those with a mean 
VO2max of 28.8 ml•kg-1•min-1 (n=10).  However, this group used a submaximal cycle 
ergometer test to estimate VO2max, so it is therefore possible that the subjects’ fitness level 
was not accurately represented.  Sothmann et al. reported group differences in catecholamine 
reactivity to the Stroop CWCT in high- (n=10; age=39±3 yr; VO2max=65.4±6 ml•kg-1•min-1) 
compared to low-fit (n=9; age=42±4; VO2max=44.6±4 ml•kg-1•min-1) individuals.  
Specifically, they found that plasma NE reactivity was significantly attenuated in the high-fit 
group, although there were no group differences in HR and E reactivity.  Holmes and 
McGilley (1987) were able to show fitness-related differences in the HR response to mental 
arithmetic, as subjects classified as highly fit (n=34; age=17-20 yr) exhibited a lower response 
to the stressor compared to a group classified as low-fit (n=34; age=17-20 yr).  However, it is 
possible that true differences in fitness were not present, as functional capacity was evaluated 
via a questionnaires and the 12 minute walk/run test.  De Geus et al. demonstrated a 
significant negative correlation between the BP response to a tone avoidance task and a 
positive correlation between VO2max and vagal withdrawal, measured by the respiratory sinus 
arrhythmia (RSA), in response to a memory task and the tone avoidance task in 24 healthy 
individuals (age=18-28 yr; VO2max=46.4±5 ml•kg-1•min-1).  However, they were unable to 
show any relationship between fitness and CV reactivity to the cold pressor test.  
Additionally, no significant relationships were found between fitness and the reactivity of 
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other CV variables [HR, cardiac PEP, respiratory rate (RR), CO, SV, & TPR].  Boutcher et al. 
used HRV to quantify fitness-related differences in the vagal response to stress.  By assessing 
a group of trained runners (n=10; age=21±1 yr; VO2max=75.4±1 ml•kg-1•min-1), a group of 
untrained subjects with low resting HRs (n=10; age=22±4 yr; VO2max=58.8±1 ml•kg-1•min-1), 
and a group of untrained subjects with high resting HRs (n=10; age=22±1 yr; VO2max=51.4±1 
ml•kg-1•min-1), they reported significantly greater reductions in HRV for the trained and low 
HR groups compared to the high HR group in response to both mental arithmetic and the 
Stroop CWCT. From these results, they suggested that both fitness and genetic influences 
play a role in the CV response to stress.  Steptoe et al. demonstrated lower RR reactivity and a 
tendency towards lower HR reactivity (p=0.06) to a problem-solving task in moderately-fit 
(n=40; age=39±11 yr; VO2max=40.2±8 ml•kg-1•min-1) compared to unfit (n=35; age=39±11 
yr; VO2max=29.1±7 ml•kg-1•min-1) subjects.  However, no fitness-related differences were 
identified for BP or skin conductance reactivity, although HR recovery was quicker in the fit.  
Using age as a covariate, Czajkowski et al. reported reduced HR, SBP, and DBP reactivity to 
a video game task in high-fit (n=32; mean age=41 yr) compared to lesser-fit subjects (n=30; 
mean age=30 yr), with fitness classification based on time to exhaustion during a treadmill 
test.  However, there were no group differences in CV reactivity to mental arithmetic.  
Shulhan et al. examined the effect of aerobic fitness on the T-wave on an ECG in response to 
a mental arithmetic task.  They reported a greater T-wave attenuation in low- (n=12; mean 
age=24.7 yr; mean VO2max=44.0 ml•kg-1•min-1) as compared to high-fit (n=12; mean 
age=25.8 yr; mean VO2max=54 ml•kg-1•min-1) subjects suggesting a fitness-related reduction 
of cardiac sympathetic activity.  However, the use of T-wave amplitude as an index of cardiac 
sympathetic activity remains controversial (Furedy & Heslegrave, 1983) and they found no 
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group differences in HR reactivity.  Moreover, this study used a submaximal step test to 
predict VO2max leading to possible misclassification of some subjects into high- or low-fit 
categories.  Additionally, Brooke and Long (1987) reported no fitness-related differences 
were found regarding CV reactivity to a rapelling task in “fit” (n=9; age=25±2 yr; 
VO2max=58±4 ml•kg-1•min-1) compared to “unfit” subjects (n=9; age=27±4 yr; VO2max=48±4 
ml•kg-1•min-1).  However, the lack of group differences in this study could possibly be a 
result of how fitness was classified, as the “unfit” group exhibited an average VO2max of 48 
ml•kg-1•min-1 which can hardly be considered unfit.    
 There is also some evidence to suggest that enhanced aerobic fitness is associated with 
an improved recovery of CV variables following a stressor (Brooke & Long, 1987; Hollander 
& Seraganian, 1984; Keller & Seraganian, 1984; Sinyor, Schwartz, Peronnet, Brisson, & 
Seraganian, 1983; Szabo et al, 1994; Steptoe, Moses, Mathews, & Edwards, 1990).  For 
example, Brooke and Long reported that their “fit” subjects exhibited a faster recovery of E to 
baseline values following a rapelling task compared to those that were “unfit”.  They 
hypothesized that the enhanced E recovery may be the result of a protective sympatho-
inhibitory effect in the fit subjects.  However, there were no group differences in HR or NE 
recovery.  Similarly, Szabo et al. reported a faster HR recovery following a mental arithmetic 
task in subjects with a higher (n=10; age=16±1 yr; VO2max=64.3±4 ml•kg-1•min-1) compared 
to a lower aerobic capacity (n=10; age=16±1 yr; VO2max=52.7±4 ml•kg-1•min-1), although no 
group differences were reported for CV reactivity.  Again, this group’s failure to find group 
differences in HR or BP reactivity could be a result of their classification of fitness, as the 
lower group exhibited an average VO2max of 52 ml•kg-1•min-1.  Sinyor et al. further 
demonstrated a more rapid HR recovery following the Stroop CWCT in highly trained 
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individuals (n=15; VO2max=69 ml•kg-1•min-1) compared to those who were untrained (n=15; 
VO2max=33 ml•kg-1•min-1).  Furthermore, this group reported a delayed onset of NE to stress 
in untrained subjects.  
 In a recent study, Spalding et al. (2000) reported that individuals with a higher level of 
aerobic fitness (n=10; age=24±1 yr; VO2max=67.0±2 ml•kg-1•min-1) exhibited a greater heart 
period at rest, during psychological stress, and during recovery than lower fit (n=10; 
age=22±1 yr; VO2max=45.4±2 ml•kg-1•min-1) counterparts.  However, they found no group 
differences in cardiac vagal tone, as assessed by RSA, during rest or stress.  Subsequently, 
this group concluded that the group differences in heart period were not vagally-mediated and 
could possibly be a result of differences in sympathetic influences, differences in intrinsic 
heart rate, and/or genetic influences.  This study is unique in that it controlled for the Law of 
Initial Values (Wilder, 1957), which states that group differences in baseline values of a 
variable may influence the magnitude of change of that variable.  By using Myrtek and 
Foerster’s (1986) procedure, they were able to conclude that heart period responses were not 
dependent on baseline values.  Therefore, the use of analysis of covariance (ANCOVA) or 
regression techniques to account for initial group differences would have been inappropriate 
in this study as it may have also been inappropriate in a number of previous studies.  
However, a limitation to this study was their small number of subjects. 
 As one may surmise, research is ambiguous regarding the influence of aerobic fitness 
on the CV response to stress.  Methodological and analytical differences between studies 
make it hard to draw clear-cut conclusions.  Some of the reasons for the discrepancies in the 
data could be a result of statistical modeling, the technique by which aerobic fitness was 
evaluated, the different classifications of fitness level, and/or subject selection.  For example, 
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several earlier studies did not test for the presence of the LIV (Holmes & McGilley, 1987; 
Holmes & Roth, 1985; Lake et al., 1985; Light et al., 1987; Plante et al., 1987; Sothmann et 
al., 1987) and may have used ANCOVA or regression analyses inappropriately.  Furthermore, 
a few studies ignored initial group differences and may have failed to adjust their statistical 
modeling in the presence of the LIV (Boutcher et al., 1998; Brooke & Long, 1987; Hull et al., 
1984).  As previously eluded to, studies have used a variety of techniques to measure aerobic 
fitness.  Obviously, the best estimate of aerobic fitness would be a direct VO2peak obtained 
from a maximal graded exercise test.  However, several of the studies have used other 
methods such as submaximal tests (Holmes & Roth, 1985; Holmes & McGilley, 1987), time 
to exhaustion (Czajkowski et al., 1990), and even self-report techniques (Claytor et al., 1988).  
Additionally, it is difficult to compare the results of studies that have used different 
classifications of high-fit and low-fit individuals (Szabo et al., 1994; Brooke & Long, 1987).  
Furthermore, discrepancies between studies could be a result of subject selection.  For 
example, after Czajkowski et al. (1990) controlled for angry temperament, the group 
differences in DBP reactivity were no longer significant.  Also, studies comparing 
competitive athletes to sedentary subjects could potentially mask fitness-related differences in 
CV reactivity as athletes most likely have a different psychological make-up than sedentary 
individuals (Dorheim et al., 1984).  In conclusion, there is evidence both for and against an 
influence of CV fitness on CV reactivity to laboratory stressors.  Thus, it is of benefit to also 
examine this relationship using other methodologies.             
Studies assessing plasma catecholamines.  Cross-sectional studies that have searched for a 
relationship between resting catecholamine concentrations and aerobic fitness have failed to 
provide evidence to support this hypothesis.  For example, Shi et al. (1992) reported no 
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difference in resting plasma NE (0.25±0.07 vs. 0.36±0.09 ng•ml-1) between high- (n=6; 
age=28±2 yr; VO2max=61.7±2 ml•kg-1•min-1) and low-fit (n=6; age=26±1 yr; VO2max=38.4±2 
ml•kg-1•min-1) young, adult males.  Convertino et al. (1993) also compared high- (n=6; 
age=30±1 yr; VO2max=54.8±1 ml•kg-1•min-1) and low-fit (n=6; age=32±1 yr; VO2max=40.5±1 
ml•kg-1•min-1) groups and found no difference in resting NE (2.3±0.3 vs. 2.2±0.2 pmol•ml-1, 
respectively) or E (0.28±0.06 vs. 0.34±0.1 pmol•ml-1, respectively).  Additionally, Van 
Faassen et al. (1992) and Oleshansky, Zoltick, Herman, Mougey, & Meyerhoff (1990) both 
reported no relationship between aerobic fitness, as estimated by VO2max (n=45; age=22±3 yr; 
VO2max=55±10 ml•kg-1•min-1) and treadmill time to exhaustion, (n=17; age=39.8±10 yr; 
15.2±0.7 min), and resting plasma NE or E.  Poehlman, McAuliffe, & Danforth (1990) further 
examined NE kinetics in active (n=21; age=24±5 yr) and inactive (n=20; age=27±6 yr) young, 
and active (n=11; age=66±4 yr) and inactive (n=15; age=68±5 yr) older men, with VO2max’s 
of 66.0±5, 57.3±5, 51.1±6, and 37.9±4 ml•kg fat-free weight-1•min-1, respectively.  
Interestingly, they reported that the active older subjects exhibited greater levels of resting 
plasma NE relative to the other 3 groups.  Additionally, when adjusted for fat-free mass and 
body surface area, the older active adults displayed greater rates of NE appearance, while 
activity level had little effect on the NE clearance rate.  Although these investigators did not 
run statistical tests to look specifically at plasma NE kinetics between young active and 
inactive subjects, the data appear to suggest that the NE appearance rate was lower in the 
active relative to the inactive young subjects, although there did not appear to be group 
differences in plasma NE concentration nor in the NE clearance rate.  Kjaer et al. (1984) also 
reported no difference in plasma NE between trained (n=8; VO2max=65±4 ml•kg-1•min-1) and 
untrained (n=7; VO2max=49±4 ml•kg-1•min-1) subjects.  However, resting plasma E was 
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elevated in the trained group (0.30±0.06 vs. 0.09±0.03 nmol•l-1).  These findings have also 
been extended to females, as Armstrong (1998) was unable to find any group differences in 
resting plasma NE between trained (n=5; age=28±1 yr; VO2max=56.7±4 ml•kg-1•min-1) and 
untrained (n=5; age=28±6 yr; VO2max=35.0±1 ml•kg-1•min-1) women.  Additionally, several 
other investigations have also reported no effect of physical fitness on resting catecholamines 
(Braun, Potempa, Holm, Fogg, & Szidon, 1994; Hagberg et al. 1988; Kjaer, Christensen, 
Sonne, Richter, & Galbo, 1985; Lehmann, Dickhuth, Schmid, Porzig, & Keul, 1984; 
Lehmann & Keul, 1986; Lehmann, Schmid, & Keul, 1984).   
Although it appears that fitness has little influence on resting plasma catecholamines, 
it may be more appropriate to examine catecholamines under stressful conditions (physical or 
psychological) during which there is less inter-individual variability.  Accordingly, studies 
have also evaluated the relationship between aerobic fitness and the catecholamine response 
to physiological perturbations (i.e. exercise, tilt, psychological challenges, etc.).  However, in 
order to maintain a concise review, only those involving dynamic exercise and psychological 
stress will be reviewed.  Investigations evaluating the relationship between fitness and the 
catecholamine response to dynamic exercise have been somewhat conclusive in that most 
have reported that subjects of lower fitness levels exhibit an exaggerated NE response to a 
given (absolute) level of submaximal exercise.  However, the E response remains debatable 
(Braun et al. 1994; Hagberg et al. 1988; Kjaer et al. 1985; Lehmann, Dickhuth, et al. 1984; 
Lehmann & Keul, 1986; Lehmann, Schmid et al. 1984).  For example, Lehmann, Dickhuth et 
al. found no differences in resting plasma NE (2.64 vs. 2.17 nmol•l-1) or E (1.01 vs. 0.57 
nmol•l-1) between endurance trained (n=6; age=32±5 yr; VO2max=65.7±2 ml•kg-1•min-1) and 
non-endurance trained (n=6; age=27±2 yr; VO2max=54.0±3 ml•kg-1•min-1) individuals.  They 
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also reported a reduced NE response during treadmill running at 12 and 14 km•hr-1 in their 
trained versus untrained subjects, although there were no group differences at maximal 
exercise.  They further reported an increased beta-receptor density in the athletes (2150 vs. 
1300 receptors), estimated by 3H-Dihydroalprenolol binding to leukocytes.  However, close 
examination of these data suggests that the non-trained group was, in fact, physically 
conditioned, suggesting that fitness-related differences in the NE response to exercise may be 
present even at high-fitness levels.  In a subsequent, but poorly described investigation, 
Lehmann, Schmid et al. reported no difference in resting NE or E between a group of trained 
cyclists (n=9; age=26±3 yr) and untrained healthy subjects (n=10; age=28±3 yr).  
Additionally, they reported that the cyclists exhibited lower plasma concentrations of NE and 
E at identical submaximal workloads, although group differences were not present at maximal 
effort.  In yet another investigation, Lehmann and coworkers (Lehmann & Keul) reported no 
differences in resting plasma NE (3.89±1.6 vs. 2.48±0.7 nmol•l-1) or E (0.60±0.2 vs. 0.41±0.2 
nmol•l-1) between trained cyclists (n=10; age=25±3 yr; VO2max= 65.8±5 ml•kg-1•min-1) and 
untrained subjects (n=9; age=27±3 yr; VO2max=46.7±9 ml•kg-1•min-1).  They further reported 
significantly higher NE and E at cycling workloads of 100, 150, 200, and 250 watts in their 
untrained subjects compared to the cyclists, whereas there were no group differences at 
maximal intensity.  Hagberg et al. examined the catecholamine response to 60 minutes of 
treadmill exercise at 70% VO2max in groups of young (n=11; age=25±5 yr; VO2max=64.9±5 
ml•kg-1•min-1) and older (n=11; age=65±4 yr; VO2max=50.0±5 ml•kg-1•min-1) trained and 
young (n=13; age=26±3 yr; VO2max=46.4±4 ml•kg-1•min-1) and older (n=10; age=65±4 yr; 
VO2max=26.8±2 ml•kg-1•min-1) untrained subjects.  There were no notable group differences 
in plasma E at rest or during exercise.  Plasma NE, however, was significantly higher in the 
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older untrained subjects at rest, whereas the older trained men displayed resting NE levels 
similar to younger subjects.  Additionally, plasma NE was significantly higher at 30 and 60 
minutes of exercise in the young trained subjects compared to the other three groups, leading 
to increased lipolysis.  Similarly, the older trained subjects exhibited a greater NE response to 
exercise than the older untrained group.  Kjaer et al. looked specifically at E kinetics during 
exercise in athletes (n=6; age=21-26 yr; ±4 yr; VO2max=59-83 ml•kg-1•min-1) and sedentary 
(n=6; age=20-25 yr; VO2max=39-49 ml•kg-1•min-1) controls.  They assessed plasma E at rest 
and during incremental cycling to exhaustion, and subsequently calculated the clearance and 
appearance rates.  There were no differences in E clearance at rest between groups, although 
resting plasma concentration (1.42±0.27 vs. 0.71±0.16 nmol•l-1) and appearance (2.9±0.7 vs. 
1.5±0.4 nmol•min-1) were significantly greater in the athletes.  Plasma E was not different 
between groups at workloads of 125 and 160 watts, but was substantially greater in the 
athletes at maximal intensity.  The dramatic rise in plasma E in the athletes was more than 
could be accounted for by clearance alone, which was strongly related to relative workload 
and initially increased, and then decreased at intensities greater than 30% VO2max.  With 
regard to NE, there were no group differences at rest, although they reported a greater plasma 
NE response to submaximal exercise in the control group.  Additionally, the athletes 
displayed significantly greater NE concentrations at maximal workloads.  Lastly, Braun et al. 
demonstrated no relationship between VO2max and resting NE or E in a group of hypertensive 
subjects (n=27; age=45±12 yr; VO2max=30.9±10 ml•kg-1•min-1).  Furthermore, they found an 
inverse relationship between VO2max and plasma NE (r= -0.44) during cycle ergometry at 100 
Watts, while reporting positive relationships between VO2max and NE and E (r= 0.73 and 0.6, 
respectively) during maximal exercise. 
 100 
Studies assessing the plasma catecholamine response to a psychological challenge 
have provided equivocal results with some reporting fitness-related differences and others 
reporting no differences.  For example, Brooke and Long (1987) reported no differences 
between subjects with a VO2max ~48 ml•kg-1•min-1 and those with a VO2max of ~58 ml•kg-
1
•min-1 with regards to NE or E reactivity to rapelling.  However, they noted a more efficient 
recovery of plasma E in the subjects with higher aerobic fitness levels.  Similarly, Claytor et 
al. (1988) found differences between high- (VO2max ~71 ml•kg-1•min-1) and low-fit (VO2max 
~45 ml•kg-1•min-1)subjects in NE or E reactivity to a reaction time and the cold pressor test.  
Using groups of similar aerobic fitness levels (VO2max ~71 ml•kg-1•min-1 vs. VO2max ~47 
ml•kg-1•min-1) Hull et al. (1984) further reported no group differences in NE of E reactivity to 
the Stroop color word task or the cold pressor test.  De Geus et al. (1993) also reported no 
relationship between VO2max and NE or E reactivity to the cold pressor and reaction-time 
tasks in a group of untrained subjects.  On the other hand, Sothmann et al. (1987) reported 
that low-fit individuals (VO2max ~32 ml•kg-1•min-1) exhibited an elevated NE response to the 
Stroop test compared to high-fit individuals (VO2max ~51 ml•kg-1•min-1), although no group 
differences in E reactivity were noted.  Additionally, Sinyor et al. (1983) reported  a delayed 
onset of the NE response to a cognitive task in low-fit (VO2max ~33 ml•kg-1•min-1) compared 
to high-fit (VO2max ~69 ml•kg-1•min-1)  subjects, while no group differences in E were 
reported.   
Taken as a whole, research seems to indicate that fitness is not associated with plasma 
catecholamines at rest, although a few studies have reported greater resting E in high-fit 
subjects (Kjaer et al. 1984; Kjaer et al. 1985).  It also appears that there is a reduced plasma 
NE response to exercise at the same absolute intensity in high- compared to low-fit subjects, 
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whereas the E response is more variable.  This could possibly be explained by an increased 
sensitivity or up-regulation of adrenergic receptors leading to a reduced catecholamine 
secretion.  However, at the same relative workload (%VO2max), the data of Hagberg et al. 
(1988) suggest that high-fit subjects may exhibit a greater catecholamine response.  Hagberg 
et al. proposed that this assisted in increasing the rate of lipolysis in trained subjects.  
Furthermore, at maximal intensity exercise, it appears that both NE and E are greater in high- 
compared to low-fit subjects.  This last finding is likely a reflection of the higher workloads 
that high-fit subjects are able to obtain, although Kjaer et al. (1985) proposed a training-
induced increased responsiveness of the adrenal medulla. With regards to the catecholamine 
response to psychological challenges, the studies that found no fitness-related differences in 
NE reactivity compared groups with VO2maxs of ~58-70 ml•kg-1•min-1 and 45-48 ml•kg-1•min-
1
, which is actually comparing “high-fit” subjects to “moderately-fit” subjects.  Conversely, 
the studies that did find fitness-related differences used lower-fit groups with VO2maxs of ~32-
33 ml•kg-1•min-1, which more accurately represents a “low” fitness level.  It is therefore 
possible that the apparent fitness-related differences in these studies are the result of some 
physiological phenomenon associated physical deconditioning (i.e. body composition, blood 
pressure). Another conclusion that can be drawn from this data is that there is no relationship 
between fitness and E reactivity, as none of the studies found any group differences.   
Studies assessing the variability of heart rate and blood pressure.  In healthy adults, several 
studies have evaluated the relationship between aerobic fitness and HRV or the respiratory 
sinus arrhythmia (RSA; the maximum range or the standard deviation of RR interval 
sequence) with most showing a positive relationship (Bonaduce et al. 1998; Boutcher et al. 
1998; De Meersman, 1993; Dixon, Kamath, McCartney, & Fallen, 1992; Gallagher, Terenzi, 
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& De Meersman, 1992; Goldsmith, Bigger, Bloomfield, & Steinman, 1997; Goldsmith, 
Bigger, Steinman, & Fleiss, 1992; Gregoire, Tuck, Yamamoto, & Hughson, 1996; Janssen, de 
Bie, Swenne, & Oudhof, 1993; Kenney, 1985; Shin, Haruyuki, Onishi, Yamazaki, & Lee, 
1997; Sloan et al. 1997).  For example, Kenney reported that aerobic power was significantly 
correlated with the variation in heart period.  In a group of healthy adults (age=29+8; VO2max= 
41-80 ml•min-1•kg-1), Kenney found a correlation coefficient of 0.92 between VO2max and 
HRV, expressed as the difference between the maximal and minimal RR intervals within a 7 
beat cycle.  However, one methodological problem of this study was that the subjects 
synchronized their breathing with HR.  Therefore, these results may have been slightly biased 
as subjects of a greater fitness level exhibited lower resting HRs.  Similarly, De Meersman 
reported a significant augmentation of HRV, expressed as the percent change from the mean 
heart rate, in runners compared to sedentary individuals.  The runners exhibited significantly 
higher values of VO2max compared to their sedentary counterparts of the same age group (15-
25, 26-35, 36-45, 46-55, 56-65, and >65 years) and HRV was higher in runners of all age 
groups, although the difference did not reach significance in the 36-45 yr and the > 65 yr 
groups.  De Meersman concluded that habitual aerobic activity augments HRV and 
counteracts the age-related HRV reduction.  Gallagher et al. reported significantly augmented 
vagal modulation of the heart in a group of high-fit (age= 38+8 yr; VO2max= 70+5 ml•min-
1
•kg-1) compared to sedentary (age= 43+10 yr; VO2max= 29+7 ml•min-1•kg-1) subjects.  The 
high-fit group exhibited a LF/HF of 0.288 compared to that of 0.315 in the sedentary group.  
Dixon et al. compared a group of male long distance runners (age=28.4+4 yr) and a group of 
sedentary males (age=27.4+3 yr) and reported significantly elevated HF and lower LF power 
in the runners supporting the hypothesis that physical fitness is related to sympathovagal 
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balance.  Goldsmith et al. (1992) reported differences in HRV measured over a 24-hour 
between 8 endurance-trained men (age=28+4 yr; VO2max= 67+5 ml•min-1•kg-1) and 8 age-
matched controls (age=29+3 yr; VO2max=35+5 ml•min-1•kg-1).  In this study, SDNN, TP LF, 
and TP were significantly greater in the endurance-trained men.  Janssen et al. found 
differences in autonomic balance as assessed by HRV between a group of professional 
cyclists (age=19-32 yr) and a group of nonathletes (age=23-33 yr).  In this study, the cyclists 
exhibited greater pNN50 and lower LF power, expressed as normalized units, compared to the 
nonathletes in the supine position.  However, they failed to show any group differences in 
pNN50 and LF power in the standing position.  Additionally, the cyclists exhibited higher, 
although not significantly different, values of SDNN in both the supine and standing 
positions.  With this data it was concluded that the athletes exhibited greater parasympathetic 
and/or a lower sympathetic modulation of the heart in the supine, but not the standing 
position. Sloan et al. also reported a significant positive relationship between VO2max and LF 
(r=0.48) and HF (r=0.41) power of the HR power spectrum in a group of subjects aged 19-36 
years.  Shin et al. compared athletes (age=22+2 yr; VO2max >55 ml•min-1•kg-1) and 
nonathletes (age=21+1 yr; VO2max <45 ml•min-1•kg-1) with respect to spectral measures of 
HRV.  They reported significantly higher HF normalized units in the athletes.  Additionally, 
while group differences for LF power did not reach statistical significance, there was a 
tendency for LF power to be reduced in the athletes (p=0.07) suggesting a reduced 
sympathetic cardiac modulation.  However, Shin et al. reported no group differences in 
spectral indices of SBP or DBP variability.  From this data it was concluded that higher 
aerobic fitness is associated with a parasympathetic dominance, which contributes to the 
resting bradycardia seen in athletes.  Furthermore, in a population of young adults (age=20-25 
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yr), Boutcher et al. reported significantly higher spectral indices of HRV in the HF and LF 
ranges in subjects with a VO2max of ~75 ml•min-1•kg-1compared to those with a VO2max of ~51 
ml•min-1•kg-1.  In a group of adults (age=22-44 yr; VO2max=25-70 ml•min-1•kg-1), Goldsmith 
et al. (1997) reported a significant relationship between VO2max and HF power of the HRV 
spectrum.  This study found no relationship between HF power and age and concluded that 
the reported age-associated reduction in vagal modulation may actually be due to an age-
related decline in fitness.  Bonaduce et al. further reported elevated HRV in a group of 
cyclists (age=21±4 yr; VO2max=62±4 ml•min-1•kg-1) compared to sedentary controls 
(age=21±3 yr; VO2max=43±4 ml•min-1•kg-1).  They reported elevated SDNN, pNN50, rMSSD, 
TP, LF, and HF, along with a lower LF/HF in the cyclists.  In an additional study, Gregoire et 
al. compared subjects of different fitness levels, age, and gender.  These investigators reported 
that middle-aged subjects, who had a history of exercising aerobically at least 5 times a week 
for >45 minutes, exhibited lower LF/HF, higher HF/TP (an index of vagal activity), and a 
trend towards higher SDNN (p=0.08). However, they were unable to find differences in HRV 
between trained (age=27±4 yr; VO2max=59±5 ml•min-1•kg-1) and untrained (age=21±2 yr; 
VO2max=49±6 ml•min-1•kg-1) young subjects.   
Conversely, Reilling and Seals (1988) reported no significant relation between HRV 
and physical fitness.  This study compared 12 collegiate cross-country athletes (age=20+1 yr) 
to 12 untrained college students (age=22+1 yr).  Although the athletes exhibited significantly 
lower resting HRs, there were no group differences in SDNN.  From these data, they 
concluded that the resting bradycardia seen in athletes was of non-autonomic origin.  
However, the failure of Reilling and Seals to measure spectral indices of HRV may have 
played a role in their lack of finding group differences.  Additionally, Sacknoff, Gleim, 
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Stachenfeld, and Coplan (1994) reported that a group of athletes (age=26±2 yr) exhibited 
lower spectral indices of HRV (TP, LF, and HF) compared to untrained controls (age=30±1 
yr), although time domain parameters (SDNN and pNN50) were greater in the athletes as 
predicted.  From these data, Sacknoff et al. concluded that spectral indices of HRV may not 
be sensitive to detecting differences in fitness levels.  However, it should be noted that these 
investigators used self-report measures of physical activity and resting HR as indicators of 
fitness.  Therefore, these subjects may have not actually been significantly different with 
regards to fitness level.   
Similar findings have been demonstrated in older adults.  For example, Yataco, 
Fleisher, and Katzel (1997) demonstrated that senior athletes (age=69+7 yr; VO2max=41+6 
ml•min-1•kg-1) exhibited greater HRV indices than sedentary individuals of a similar age 
(age=69+4 yr; VO2max=24+2 ml•min-1•kg-1).  All parameters of HRV measured (SDNN, 
rMSSD, LF, LH, TP, and LF/HF) were significantly greater in the athletes suggesting a 
greater parasympathetic modulation of the heart.  Additionally, Van den Hombergh, Dekker, 
and Schouten (1995) used regression analysis to report a positive association between SDNN 
in the supine position and the scores on a physical activity questionnaire in a group of men 
aged 65-85.  However, this association was not present in older women of the same age, nor 
was it present in the standing position.  These studies suggest that aerobic fitness is positively 
associated with parasympathetic modulation of the heart.  Most studies have reported that HF 
power, which reflects cardiac vagal activity, is significantly elevated in subjects of a high 
fitness level when resting in a supine position.  This enhanced vagal modulation of the heart 
likely contributes to the resting bradycardia seen in high-level athletes.      
 106 
Studies assessing baroreflex sensitivity.  Studies that have assessed the influence of aerobic 
fitness on BRS have provided mixed results.  In young, adult males, there have been several 
reports of an attenuation of baroreflex control of HR in endurance-trained athletes, resulting 
in orthostatic intolerance (Luft, Myrhe, Leoppky, & Venters, 1976; Mack, Shi, Nose, Tripathi, 
& Nadel, 1987; Raven, Rohm-Young, & Blomqvist; 1984; Shi, Andresen, et al., 1993; Shi, 
Crandall, et al., 1993; Smith et al. 2000; Smith, Graitzer, Hudson, & Raven, 1988).  By using 
LBNP to selectively unload the cardiopulmonary baroreceptors, Luft et al. reported a 
decreased tolerance (527 Torr/min vs. 913 Torr/min) and an increased incidence of 
presyncopal reactions in a group of athletes (VO2max= 50 ml•kg-1•min-1) compared to 
nonathletes (VO2max= 34 ml•kg-1•min-1).  They further reported a higher rate of change of leg 
volume per unit Torr and time of exposure for the athletes (0.75% 100 Torr-1•min-1 vs. 0.42% 
100 Torr-1•min-1), suggesting an increased venous compliance or possibly a less effective 
vasoconstrictor response in the athletes.  Raven et al. reported a lower tachycardic response 
and lower peripheral resistance in a group of endurance athletes (age=27±2 yr; VO2max= 
70.2±3 ml•kg-1•min-1) compared to subjects of an average fitness level (age=28±2 yr; 
VO2max= 41.3±3 ml•kg-1•min-1) in response to graded LBNP.  However, there were no group 
differences in leg venous compliance.  Similarly, Mack et al. found differences in BRS 
between fit and unfit subjects using LBNP to unload the baroreceptors.  This group reported a 
diminished gain of the baroreceptors, expressed as the relationship between forearm vascular 
resistance and estimated central venous pressure, in “fit” subjects (age= 31±2 yr; VO2max= 
54±2 ml•kg-1•min-1) compared to “unfit” subjects (age= 30±3 yr; VO2max= 38.5±3 ml•kg-
1
•min-1).  They reported baroreflex gains, expressed as the slope of vascular resistance-
peripheral vascular pressure, of –2.42 units/mmHg and –5.15 units/mmHg for fit and unfit 
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subjects, respectively.  They further reported a significantly higher blood volume in the fit 
group and noted a linear relationship between blood volume and baroreflex gain, suggesting 
that blood volume could possibly play a role in the lower BRS in trained subjects.   
Since LBNF elicits both hypotension and central hypovolemia, this technique likely 
results in an integrated response of the arterial and cardiopulmonary baroreceptors.  
Therefore, researchers have used other techniques in an attempt to distinguish between the 
two.  Smith et al. (1988) used both LBNP and phenylephrine (PE) infusion to examine fitness-
related differences in cardiopulmonary and arterial BRS, using the PE method specifically to 
examine the arterial baroreceptors.  The data of Smith et al. during LBNP supported previous 
findings as they reported an attenuated BRS, calculated by ∆HR/∆SBP (0.91±0.3 vs. 1.62±0.3 
bpm•mmHg-1) and ∆HR/∆MAP (2.05±0.3 vs. 4.08±0.4 bpm•mmHg-1), in the endurance-
trained group (n=10; age=25±2 yr; VO2max= 65.0±1 ml•kg-1•min-1) compared to the untrained 
group (n=10; age=27±1 yr; VO2max= 42.8±1 ml•kg-1•min-1).  Furthermore, they found an 
attenuated BRS, expressed as the slope of HR against SBP during PE infusion in the trained 
subjects (-0.57 vs. –0.91) although the difference was not as great as during LBNP.  The data 
from this investigation further provided evidence that BRS is attenuated in “trained” subjects 
and that this difference is mediated by a combination of arterial and cardiopulmonary 
baroreceptors.   
 Shi, Andresen et al. (1993) proposed that the aortic baroreflex may be more sensitive 
to change than the carotid baroreflex and, with an elegant experimental design, estimated the 
relative influences of the carotid and aortic baroreceptors in average-fit (n=7; age=27.9±2 yr; 
VO2max= 42.9±1 ml•kg-1•min-1) and high-fit subjects (n=7; age=26.4±2 yr; VO2max= 62.3±2 
ml•kg-1•min-1).  This group calculated BRS, expressed as ∆HR/∆MAP, during PE infusion, 
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which is believed to stimulate both the carotid and aortic baroreceptors, and during PE 
infusion combined with neck pressure (NP) and/or LBNP, which is believed to isolate the 
aortic baroreflex.  They then calculated the carotid BRS by subtracting the aortic ratios (PE + 
NP and PE + NP + LBNP) from the total arterial BRS obtained during PE infusion alone.  
They reported that the total arterial BRS was attenuated in the high- compared to the average-
fit subjects (0.33±0.04 vs. 0.94±0.14).  They further reported a reduced aortic BRS in the 
high- compared to the average-fit subjects (0.16±0.02 and 0.14±0.03 bpm/mmHg vs. 
0.52±0.08 and 0.59±0.08 bpm/mmHg, for PE + NP and PE + NP + LBNP respectively).  
Additionally, they reported no difference in carotid BRS, estimated by BRS during PE 
infusion alone minus BRS during PE + NP + LBNP, between the high- (0.19±0.02 
bpm/mmHg) and average-fit groups (0.35±0.09 bpm/mmHg).  Furthermore, they reported 
between group differences in the relative contribution of the carotid BRS to the total arterial 
BRS, with it contributing 35% in the average-fit group compared to 59% in the high-fit group.  
With these data, Shi et al. concluded that the sensitivity of the aortic baroreflex control of HR 
was reduced in the high-fit subjects and that the aortic baroreflex predominantly contributes to 
the HR reflex control in average-fit subjects, while in high-fit subjects the carotid baroreflex 
predominates.  Furthermore, it was concluded that the attenuated arterial BRS in high-fit 
subjects is due mainly to alterations in aortic BRS.  In a follow-up study, Shi, Crandall et al. 
(1993) compared the isolated aortic baroreflex between high (n=7; age=26±1 yr; 
VO2max=64±2 ml•kg-1•min-1) and average fit (n=8; age=28±1 yr; VO2max=45±1 ml•kg-1•min-
1) subjects.  After infusing sodium nitroprusside to induce a drop in BP, they used calculated 
neck and lower body positive pressures in an attempt to remove the influences of the carotid 
and cardiopulmonary baroreceptors, respectively.  They reported that aortic BRS was 
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significantly attenuated in the high-fit group, as they exhibited lower HR responses to the 
induced drop in BP (+7.9±2 bpm) compared to the average-fit subjects (+16.8±3 bpm) and 
had significantly lower baroreceptor gains (1.0±0.3 vs. 1.9±0.3 bpm•mmHg-1).  Similar to the 
previous study, they also reported that the percent contribution of the aortic to the total arterial 
baroreflex was significantly higher in average- compared to high-fit subjects.  Most recently, 
Smith et al. (2000) also reported a reduced arterial BRS in high-fit subjects (n=8; age=24±1 
yr; VO2max= 61.9±2ml•kg-1•min-1) relative to their average-fit counterparts (n=8; age=25±1 
yr; VO2max= 42.2±2 ml•kg-1•min-1).  Using techniques similar to Shi, Crandall et al. (1993), 
they were able to construct stimulus-response curves of the arterial, aortic, and carotid 
baroreflexes in each group.  With this data, they reported an attenuated arterial and aortic BRS 
in the high-fit group, while carotid BRS remained similar between groups.  They further noted 
a vertical downward shift of the arterial and aortic baroreflex curves in the high-fit individuals 
as a result of a smaller HR response range, without a difference in the operating point (resting 
MAP).   
 Other investigators have reported either no effect of fitness (Fiocchi, Fagard, Vanhees, 
Grauwels, & Amery, 1985; Levine et al. 1991; Shin et al. 1997; Williamson & Raven, 1994) 
or an augmented BRS (Barney et al. 1988; Savard & Lundie, 1994) in individuals with a high 
fitness level.  Fiocchi et al. were unable to find a significant relationship between physical 
fitness and carotid BRS, expressed as the slope of the linear relationship between RR interval 
response and various degrees of neck suction.  However, they studied touring cyclists with a 
narrow range of fitness levels, all of whom could be classified as being highly fit (n=47; age= 
33±1 yr; VO2max= 54±1 ml•kg-1•min-1).  Similarly, Levine et al. reported no differences in 
carotid BRS between high- (n=8; age= 25±2 yr; VO2max= 60±1 ml•kg-1•min-1), mid- (n=8; 
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age= 23±1 yr; VO2max= 49±1 ml•kg-1•min-1), and low-fit (n=8; age= 24±1 yr; VO2max= 36±1 
ml•kg-1•min-1) subjects.  Using varying levels of neck suction/pressure, Levine et al. found no 
differences in carotid BRS assessed by either open-loop gain [acute (~10 second) changes in 
RR interval or BP in response to varying neck pressure] or closed-loop gain [steady-state (2-
min) changes in BP in response to varying neck pressure].  Despite similar carotid BRS 
among groups, they did report that the high-fit subjects exhibited a reduced tolerance to 
LBNP.  With this data, Levine et al. concluded that the orthostatic intolerance in highly fit 
athletes may be a result of differences in cardiovascular variables, such as vascular 
conductance and stroke volume, that interact with baroreceptor function. Although, another 
possible mechanism might be an exclusive reduction in sensitivity of the aortic baroreflex.  
Williamson and Raven specifically sought to determine if the carotid baroreflex differed 
between 8 high- (age=26.7±3 yr; VO2max=64.5±2ml•kg-1•min-1) and 8 low-fit (age=28.3±3 yr; 
VO2max=39.8±4ml•kg-1•min-1) subjects, and further investigated whether there was a 
difference between the gains of the right and left sided carotid baroreflex.  They evaluated the 
RR interval response to various levels of neck suction/pressure, applied both unilaterally and 
bilaterally.  They then reported that there were no group differences in the gains of the right 
(5.3±1 vs. 4.5±1 ms•mmHg-1), left (3.3±1 vs. 3.6±2 ms•mmHg-1), and combined (6.4±2 vs. 
5.9±1 ms•mmHg-1) carotid baroreceptors.  Shin et al. also found no difference between high- 
(n=15; age=21.5±1 yr; VO2max= 61.3±4 ml•kg-1•min-1) and low-fit (n=15; age=22.1±2 yr; 
VO2max= 40.3±2 ml•kg-1•min-1) subjects in regards to BRS estimated by the cross-spectral 
technique.  In this study, the cross-spectrum of SBP and RR variations in the low and high 
frequency ranges were not significantly different between groups.  Shin et al. proposed that a 
possible reason for their findings was that the cross-spectral technique does not allow for a 
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differentiation between the carotid, aortic, and cardiopulmonary baroreceptors.  On the other 
hand, Barney et al. reported an enhanced responsiveness of the carotid baroreflex in high-fit 
subjects (n=11; age=24.3±1 yr; VO2max= 60.4±1 ml•kg-1•min-1) compared to sedentary 
controls (n=9; age=24.0±1 yr; VO2max= 39.3±2 ml•kg-1•min-1).  In this study, the high-fit 
subjects exhibited a significantly greater increase RR interval in response to –40 mmHg and –
20 mmHg of neck pressure, and also displayed a greater, although not statistically significant, 
decrease in RR interval in response to 35 mmHg.  Additionally, this group reported an 
augmented BRS, expressed as the slope derived by the change in RR interval to each neck 
pressure, in the high-fit compared to the sedentary group (4.0±0.4 vs. 2.5±0.3 ms/mmHg).  
Furthermore, they reported a significant positive relationship between VO2max and the carotid 
baroreflex slope (r=0.48).  With these data, Barney et al. concluded that the responsiveness of 
the carotid baroreflex is maintained in high-fit individuals, possibly as a result of augmented 
vagal outflow and/or enhanced cardiac responsiveness to vagal outflow.  Similarly, Savard 
and Lundie (1994) reported that the carotid baroreflex was significantly enhanced in a group 
of endurance-trained (n=7; VO2max >55ml•kg-1•min-1) compared to a group of sedentary 
subjects (n=8; VO2max <48 ml•kg-1•min-1).  In this study, the trained individuals demonstrated 
a greater maximal gain of the carotid baroreflex (9.3±5 ms•mmHg-1) relative to the sedentary 
subjects (4.3±3 ms•mmHg-1) in response to various levels of neck suction/pressure,    
 In contrast to the numerous studies that have evaluated the relationship between BRS 
and physical fitness in healthy, young adult males, only a few studies have specifically looked 
at this relationship in healthy, young females.  Hudson, Smith, and Raven (1987) evaluated 
this relationship in trained (n=8; age=23.0±3 yr; VO2max= 56.8±1 ml•kg-1•min-1) and 
untrained (n=8; age=25.9±2 yr; VO2max= 39.4±2 ml•kg-1•min-1) females using incremental 
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LBNP (0 to –50 torr).  In this study, no differences were noted in BRS, estimated by 
∆HR/∆SBP, between groups.  However, they did report that at –50 torr the trained subjects 
did not further enhance vasoconstriction, suggesting that fitness-related differences may have 
been present beyond –50 torr.  Additionally, Davy, Desouza, Jones, and Seals (1998) 
examined BRS by the sequence technique in sedentary (n=23; age=28±1 yr; VO2max= 35.3±1 
ml•kg-1•min-1) and physically active (n=22; age=31±1 yr; VO2max= 52.5±1 ml•kg-1•min-1) 
females.  In this investigation they reported significantly higher BRS in the physically active 
group (19±3 bpm/mmHg) compared to the sedentary subjects (11±2 bpm/mmHg).  
Furthermore, Davy et al. examined this relationship in older females and found similar results 
with the physically active females displaying a higher BRS than their sedentary counterparts 
(13±2 vs. 7±2 bpm/mmHg).  
 In addition to Davy et al. (1998), a few other studies have also examined this 
relationship in older adults and reported similar findings.  For example, Fortney et al. (1992) 
compared the CV responses of 9 trained (age=63.9±2 yr; VO2max= 52.4±2 ml•kg-1•min-1) and 
9 untrained (age=65.6±2 yr; VO2max= 31.0±3 ml•kg-1•min-1) older adults to graded LBNP.  In 
this study, the investigators reported that the trained individuals were better able to maintain 
cardiac output and MAP during LBNP, and exhibited smaller decreases in stroke volume, 
end-systolic volume, and end-diastolic volume.  Additionally, two of the nontrained subjects 
could not complete the entire LBNP protocol due to the presence of presyncopal symptoms.  
With these data, they concluded that aerobic fitness is associated with improved orthostatic 
responses in older adults.  Bowman et al. (1997a) reported similar findings while using the α–
index to compare BRS between a group of sedentary older adults (n=26; age=67±5 yr) and a 
group of older half-marathon runners (n=8; age=66±2 yr).  These investigators reported a 
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significantly higher HF component of the α–index in the runners compared to the sedentary 
individuals.  From these data, they concluded that the age-associated reduction in BRS is 
attenuated by endurance exercise training in older adults.  
Taken as a whole, a few conclusions can be drawn from these studies.  Those 
investigations that have specifically examined the aortic baroreflex, clearly have demonstrated 
an attenuated BRS in exercise-trained individuals.  On the other hand, it appears that the 
carotid baroreflex is not significantly different between subjects of various fitness levels.  
Additionally, the effect of fitness on the cardiopulmonary baroreceptors remains unclear.  
Some of the proposed mechanisms that may play a role in mediating BRS differences 
between high-fit and average-fit individuals include differences in blood volume and 
autonomic balance.  Together, the chronic expansion of total blood volume and increase in 
cardiac vagal modulation seen in endurance trained subjects will increase resting stroke 
volume by increasing cardiac preload and prolonging cardiac filling.  Consequently, there will 
be an increased stretch on the aortic baroreceptors, which may result in adaptation or down-
regulation.  Another possible mechanism is that the increased central blood volume in high-fit 
subjects may elicit afferent impulses from the cardiopulmonary baroreceptors, which has been 
shown to have an inhibitory effect on the arterial baroreflex (Billman, Dickey, Teoh, & Stone, 
1981).  Each of these would explain the findings of investigators who have reported a reduced 
arterial and aortic baroreflex in high-fit individuals.  Nevertheless, there still exists some 
controversy in the literature regarding the influence of fitness on BRS.  To gain a better 
understanding of this relationship, it may be more appropriate to examine the results of 
longitudinal studies that have investigated the effects of exercise training on BRS, as will be 
done in the following chapter. 
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Studies assessing muscle sympathetic nerve activity.  There have been only been a few studies 
that have examined the relationship between fitness and MSNA.  To make matters more 
difficult, the results of these studies still remain equivocal.  Svedenhag, Wallin, Sundlof, and 
Henriksson (1984) investigated this relationship by comparing a group (n=8) of trained 
cyclists (age=22±2 yr; VO2max=63.5±1.2 ml•kg-1•min-1) to a group (n=8) of age-matched 
control subjects (age=23±1 yr; VO2max=40.1±1.5 ml•kg-1•min-1).  The cyclists and controls 
exhibited similar levels of MSNA reported as either bursts/100 heart beats (34.8±7 vs. 34.2±7, 
respectively) or bursts/minute (20.3±4 vs. 22.4±4, respectively), prompting Svedenhag et al. 
to conclude that MSNA is unrelated to physical fitness.  Seals (1991) reported similar findings 
by comparing a group of endurance athletes (n=12; age=25±1 yr; VO2max= 60-75 ml•kg-
1
•min-1) to a group of untrained individuals (n=12; age=27±1 yr).  There were no differences 
in resting MSNA expressed as either bursts/min (athletes: 24±3; controls: 24±2) or bursts/100 
heart beats (athletes: 36±3; controls: 44±4).  Additionally, there were no group differences in 
MSNA, expressed as the percent increase of total minute activity, in response to graded 
LBNP at pressures of –5 (113±8 vs. 132±6), -10 (136±11 vs. 163±8), -15 (174±12 vs. 
210±19), and –20 mmHg (209±20 vs. 262±30) between athletes and controls, respectively.  
Seals also failed to find any differences between groups in the percent increase of total minute 
activity in response  to either isometric handgrip exercise at 30% maximal voluntary 
contraction (MVC) (athletes: 161±15; controls: 204±34) or the cold pressor test (athletes: 
300±29; controls: 255±39).  Conversely, in an older population, Ng, Callister, Johnson, & 
Seals (1994) reported opposite findings.  These investigators compared the MSNA of 16 
masters endurance athletes (age=66±1 yr; estimated VO2max~42±2 ml•kg-1•min-1) to that of a 
control group of similar age (n=15; age=65±1 yr; estimated VO2max~32±1 ml•kg-1•min-1).  
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The athletes exhibited significantly higher levels of MSNA at rest compared to the controls 
when expressed as either bursts/minute (43±2 vs. 32±3) or bursts/100 heart beats (75±4 vs. 
52±5).  Interestingly, there was also a significant group-by-gender interaction for MSNA such 
that the magnitude of difference between trained and untrained females was greater than that 
between trained and untrained males.  Ng et al. further measured MSNA during the 
administration of the cold pressor test and reported no group differences in MSNA, expressed 
as total activity (athletes: 792±143; controls: 592±121), while reporting a trend for the 
athletes to exhibit a greater percent increase in MSNA during the test (p=0.06).  Additionally, 
these investigators examined the MSNA response during isometric handgrip exercise to 
fatigue at 40% of their MVC.  The athletes exhibited greater MSNA, expressed as total 
activity during the handgrip exercise compared to the controls (821±183 vs. 797±164), 
whereas the percent increase in MSNA did not statistically differ between groups 
(athletes:200%; controls: 150%).  In a study that did not, per se, compare subjects of different 
fitness levels, but is worthy of discussion, Saito, Watanabe, and Mano (1993) evaluated the 
MSNA of dominant and nondominant arms of 10 subjects (age=20±2 yr) who were active in 
racket sports.  They reported no difference in the percent increase in MSNA between arms 
measured during either static handgrip exercise at an intensity of 25% MVC (dominant: 46%; 
nondominant: 46%), or during dynamic handgrip exercise performed at the same intensity at a 
rate of 1 Hz (dominant: 38%; nondominant: 36%).  However, in 5 subjects, MSNA was 
assessed during 10 minutes of submaximal dynamic handgrip exercise performed at a rate of 
1 Hz and an intensity of 0.9 Watts.  In these subjects, the MSNA response was significantly 
attenuated in the dominant arm relative to the nondominant.   
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 In conclusion, it appears that physical fitness plays a minor role in altering levels of 
MSNA in young adults.  Although Ng et al. (1994) reported higher resting MSNA in older 
athletes, this difference was gender-related with females demonstrating a greater separation 
among subjects of different fitness levels.  Additionally, since MSNA increases concurrently 
with age (Ng, Callister, Johnson, & Seals, 1993), it is difficult to compare these findings with 
other studies using younger subjects.  Nonetheless, there is a recognizable lack of research 
examining this relationship and more studies need to be performed before definite conclusions 
can be made. 
Summary.  In conclusion, there is some evidence to suggest aerobic fitness is related to 
autonomic control of the CV system.  Studies using both time and spectral indices of HRV 
have reported an augmented cardiac vagal modulation in high- compared to low-fit subjects.  
Furthermore, it appears that aerobic fitness is related to the NE response to submaximal 
exercise at a given absolute workload, as several studies have reported an attenuated response 
of NE in high- compared to low-fit individuals.  However, the influence of fitness on resting 
plasma NE and the NE response to exercise at the same relative intensity remains 
controversial.  Additionally, studies examining resting E and the E response to exercise have 
also provided inconclusive results regarding an effect of fitness.  Those studies that have used 
MSNA and CV reactivity to stress also remain equivocal.  Lastly, research suggests that aortic 
BRS is attenuated in high-fit subjects, while the influence of fitness on carotid and 
cardiopulmonary BRS is still controversial.       
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Influence of Endurance Exercise Training on Autonomic Regulation of the Cardiovascular 
System 
  
It has been well established that endurance exercise training induces many 
cardiovascular (Clausen, 1977; Ekblom, 1968; Saltin & Astrand, 1967) and metabolic 
adaptations (Holloszy & Booth, 1976).  These include an increase in aerobic capacity 
(VO2max) (Clausen, 1977), decreases in HR and BP at rest and during submaximal work 
(Clausen, 1977), favorable alterations in lipid profile, improved glucose tolerance, increased 
insulin sensitivity, a reduction in body fat, and an increase in lean body mass (Holloszy, & 
Booth, 1976).  In healthy young and middle-aged subjects, the training-induced increase in 
VO2max is primarily a consequence of an increase in maximal CO and, to a lesser extent, an 
increase in maximal (a-v)O2 difference.  This increase in CO is a result of an elevated SV at 
maximal exercise, as maximal HR is not significantly altered with training.  Spina (1999) 
suggested that the elevated maximal SV in the trained state is a result of: 1) an enhanced 
inotropic state; 2) a greater end-diastolic volume, via either acute changes in end-diastolic and 
stroke volume (Frank-Starling mechanism), or chronic left ventricular volume overload or 
eccentric hypertrophy; 3) a reduced left ventricular wall stress; or, 4) a combination of these 
variables.  The enhanced (a-v)O2 difference is mediated by increases in the aerobic capacity 
and capillary density of skeletal muscle, leading to an increased oxygen extraction of the 
muscle.  
 Some of these adaptations to endurance exercise training may be partly accounted for 
by training-induced changes in autonomic system activity.  Therefore, this section of the 
review will provide a comprehensive review of studies that have assessed measures of 
autonomic activity before and after an endurance exercise training protocol.    
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Studies assessing the CV response to laboratory stressors.  Studies assessing the effects of 
endurance exercise training on the CV response to laboratory stressors have yielded mixed 
conclusions.  A summary of results from such studies can be seen in Table 6.1.  Several 
investigators have provided results that support the hypothesis that endurance training 
attenuates the CV response to stressful stimuli (Blumenthal et al. 1988; Blumental et al. 1990; 
Bond et al. 1999; Cleroux, Peronnet, & de Champlain, 1985; De Geus, Van Doornen, & 
Orlebeke, 1993; Holmes & McGilley, 1987; Keller & Seraganian, 1984; Ketelhut, Franz, & 
Scholze, 1997; Rogers, Probst, Gruber, Berger, & Boone, 1996; Sherwood, Light, & 
Blumenthal, 1989; Sinyor, Golden, Steinert, & Seraganian, 1986; Stein, & Boutcher, 1992), 
while others have failed to produce such evidence (De Geus, Van Doornen, De Visser, & 
Orlebeke, 1990; Roskies et al. 1986; Sinyor, Peronnet, Brisson, & Seraganian, 1988; 
Sothmann, Hart, & Horn, 1992; Steptoe, Moses, Mathews, & Edwards, 1990).  Obviously, the 
conflicting results of these studies hinders one’s ability to draw clear conclusions regarding 
the effects of exercise training on CV reactivity.  However, by examining each study 
carefully, some conclusions can be made.  For example, most studies that have shown a 
beneficial effect of training on CV reactivity have used subjects with a pre-existing condition.  
Several studies have used subjects classified as having a type-A personality.  In this 
population, Blumenthal et al. (1988) reported that 12 weeks of walking/jogging at 70% 
VO2max attenuated the HR, SBP, DBP, and myocardial oxygen demand (MVO2) response to a 
mental arithmetic task.  In a separate study using the same training protocol, Blumental et al. 
(1990) demonstrated that endurance training resulted in decreased HR, DBP, and MVO2 
reactivity to the same mental arithmetic task in type A men.  Sherwood et al. (1989) further 
demonstrated that 12 weeks of aerobic training reduced DBP reactivity to a 5-minute  
Table A.6 
____________________________________________________________________________________________________________ 
Longitudinal Studies Assessing the Effects of Endurance Training on Cardiovascular Responses to Laboratory Stressors. 
____________________________________________________________________________________________________________ 
Author/Date  Training protocol      Stressor  Results 
   (mode; time period; frequency; duration; intensity) 
____________________________________________________________________________________________________________ 
Blumenthal et al. Walk/jog; 12-wk; 3x/wk; 30 min; 70% HRreserve  Mental arithmetic HR, DBP, & RPP reactivity  
(1990) ↓ post-training 
 
Blumenthal et al. Walk/jog; 12-wk; 3x/wk; 30 min; 70% HRreserve  Mental arithmetic HR, SBP, DBP, & RPP  
(1988) reactivity ↓ post-training 
 
Bond et al.  Jogging; 6-wk; 3x/wk; 35 min; 60-70% VO2peak   Cold pressor test SBP & MAP reactivity 
(1999)              ↓ post-training 
 
Cleroux et al.   Jogging; 20-wk; 3x/wk; 45 min; 60% VO2max  Video game  MAP reactivity 
(1985)              ↓ post-training 
 
de Geus et al.  Jogging; 7-wk; 4x/wk; 20-60 min; 70% VO2peak  Reaction time  No change in HR, BP, or   
(1990)           task   TPR reactivity 
 
____________________________________________________________________________________________________________ 
HR = heart rate   CO = cardiac output   CWCT = color word conflict test 
SBP = systolic blood pressure TPR = total peripheral resistance RPP = rate pressure product 
DBP = diastolic blood pressure E = epinephrine   ↓ = decrease 
MAP = mean arterial pressure NE = norepinephrine   ↑ = increase 
____________________________________________________________________________________________________________ 
Table con’d. 
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Table A.6  
____________________________________________________________________________________________________________ 
Author/Date  Training protocol      Stressor  Results 
   (mode; time period; frequency; duration; intensity) 
____________________________________________________________________________________________________________ 
de Geus et al.   Jogging; 8-mo; 4x/wk; 20-60 min; 70% VO2peak  Reaction time  TPR reactivity ↓ and CO 
(1993)           task   reactivity ↑ post-training 
 
Holmes et al.  Aerobic dance; 13-wk; 2x/wk; 50 min; 70% HRreserve Mental arithmetic HR reactivity ↓ in low-fit 
(1987)              subjects post training 
 
Keller &    calisthenics/running; 10-wk; 4x/wk; 30 min;   Stroop CWCT  Faster recovery of HR  
Seraganian (1984) unspecified intensity         post training    
 
Ketelhut et al.  Running; 18-mo; 2x/week; 1-hr; 70%HRmax  Cold pressor test DBP reactivity ↓ post  
(1997)              training   
 
Rogers et al.  Walk/jog; 8-wk; 3x/wk; 45 min; low group: 40-50%  Stroop CWCT  Low: ↓ MAP, SBP, & DBP 
(1996)    VO2max, moderate group: 70-80% VO2max      reactivity; Mod: ↓ DBP  
              reactivity 
 
Roskies et al.  Jogging; 30 sessions; 20-25 min; 50-85% HRreserve  Mental arithmetic No change in HR, SBP, or 
(1986)              DBP reactivity   
 
Sherwood et al. Walk/jog; 12-wk; 3x/wk; 30 min; 60-75%   Reaction time  DBP reactivity ↓ post-  
(1989)   HRmax.        task   training 
____________________________________________________________________________________________________________ 
Table con’d. 
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Table A.6  
____________________________________________________________________________________________________________ 
Author/Date  Training protocol      Stressor  Results 
   (mode; time period; frequency; duration; intensity) 
____________________________________________________________________________________________________________ 
 
Sinyor et al.   Jogging; 10-wk; 3x/wk; 60 min; 60% VO2max  Mental arithmetic Faster HR recovery post 
(1986)           Tone avoidance training 
 
Sinyor et al.  Jogging; 10-wk; 3x/wk; 60 min; 60% VO2max  Mental arithmetic No change in HR, E, or NE 
(1988)           Stroop CWCT  reactivity post training 
 
Sothmann et al.  Jogging; 16-wk; 3x/wk; 25-30 min; 70-75% VO2max  Stroop CWCT  No change in HR, E, or NE 
(1992)              reactivity post training 
 
Stein et al.  Walk/jog; 8-wk; 3x/week; 20-30 min; 60% HRreserve  Stroop CWCT  HR reactivity ↓ post training 
(1992) 
 
Steptoe et al.  Walk/jog; 10-wk; 4x/wk; 20-30 min; high group:  Problem solving No change in HR or BP   
(1990)   70-75% HRmax, moderate group: 60-65% HRmax.       reactivity in either group 
____________________________________________________________________________________________________________ 
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competition task in Type A men who were classified as borderline hypertensive.  
Additionally, De Geus et al. (1993) reported that 8 months of training reduced TPR reactivity 
in type-A males.  Other studies showing improvement following training have used 
hypertensive subjects.  For example, Cleroux et al. (1985) showed an improved MAP 
reactivity to video game stress in labile hypertensives after training.  Furthermore, Ketelhut et 
al. (1997) and Rogers et al. (1996) both reported a training-induced improvement of BP 
reactivity in this population.  Thus, these studies possibly suggest that exercise endurance 
training improves CV reactivity in subjects with a pre-existing condition.  Holmes and 
McGilley (1987) also provided data suggesting that training improves HR reactivity to the 
recall of digits backwards test of the Wechsler Adult Intelligence Scale in low-fit, but not 
high-fit, subjects, identified by their performance on a 12-minute walk/run test.  The data of 
Holmes and McGilley further support the hypothesis that a pre-existing condition (low fitness 
level) may account, in part, for training-induced improvements in CV reactivity.  
 Another factor that necessitates consideration is the volume of training.  With the 
exception of one study (Sothmann et al., 1992), all studies that have employed greater than 12 
weeks of training have shown improvement in CV reactivity, suggesting that there may be a 
training threshold for CV adaptation.  Although both Keller et al. (1984) and Sinyor et al. 
(1986) reported improvements in the HR recovery from a stressor following training periods 
of 9 and 10 weeks respectively, it should be noted that neither were able to show any 
improvements in the magnitude of the CV response to stress.  Additionally, Stein and 
Boutcher (1992) showed improvements in HR reactivity after training, but failed to 
demonstrate any beneficial effects on BP reactivity.  Lastly, Bond et al. (1999) reported that 6 
weeks of training yielded improvements in BP reactivity, but failed to show any effect on HR 
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or TPR reactivity.  Furthermore, it is difficult to compare this group’s results to others 
because this was the only study to examine training-induced alterations in CV reactivity in 
African-American women.  In conclusion, research is inconclusive as to the influence of 
exercise endurance training on CV reactivity.  When examining this issue, one must carefully 
consider the subject population and the specifics of the training protocol utilized.  Lastly, it is 
possible that other methodologies may be more sensitive in detecting autonomic changes 
induced by endurance training.  
Studies assessing plasma catecholamines.  As previously stated, SNS activity can be assessed 
by monitoring plasma catecholamine kinetics at rest and during physiological perturbations.  
Thus, several investigations have used this technique to gain a better understanding of 
autonomic changes induced by exercise endurance training.  Studies assessing the effects of 
exercise training on resting catecholamine levels have provided mixed results (Table 6.2).  
Some studies indicate that resting catecholamine concentration is unaffected by endurance 
training (Cousineau et al. 1977; Hartley et al. 1972a; Hartley et al. 1972b; Peronnet et al. 
1981; Greiwe, Hickner, Shah, Cryer, & Holloszy, 1999; Brundin & Cernigliaro, 1975; 
Cleroux, Peronnet, & De Champlain, 1984; Cleroux, Peronnet, &De Champlain, 1985; Ehsani 
et al. 1984; Hagberg et al. 1984; LeBlanc, Nadeau, Richard, & Tremblay, 1982; Lehmann, 
Dickhuth, Schmid, Porzig, & Keul, 1984; Schwartz, Jaeger, Veith, & Lakshminarayan, 1990; 
Svedenhag, Martinsson, Ekblom, & Hjemdahl, 1986; Winder et al. 1978), while others have 
reported a reduction (Bloom,  Johnson, Park, Rennie, & Sulaiman, 1972; Cooksey, Reilly, 
Brown, Bomze, & Cryer, 1978; Duncan et al. 1985; Jennings et al. 1986; Jost, Weiss, & 
Weicker, 1989; Jost, Weiss, & Weicker, 1990; Kiyonaga, Arakawa, Tanaka, & Shindo, 1985; 
McCrimmon, Cunningham, Rechnitzer, & Griffiths,  
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Table A.7 
______________________________________________________________________ 
Longitudinal Studies Assessing the Influence of Endurance Exercise Training on Resting 
Catecholamine Levels. 
______________________________________________________________________ 
Author/Date  Training Protocol     Findings 
   (mode; time period; frequency; duration; intensity) 
______________________________________________________________________ 
 
Brundin &   cycling; 2-mo; protocol unspecified   ↔ in NE or 
Cernigliaro (1975)        E 
 
Cleroux et al.  jogging; 20-wk; 3x/wk; 45 min; 60% VO2max ↔ in NE or 
(1985)          E 
 
Cleroux et al.  cycling or running 20-wk; 3x/wk; 20-45 min; cycle: ↓ E   
(1987)  60% HRreserve      ↔NE; run: 
          ↔NE or E 
 
Cooksey et al.  walk/jog; 12-wk; 3x/wk; 50 min; 60-70% HRmax ↔ in E; ↓ in 
(1978)          NE 
 
Cousineau et al. cycling/volleyball; 6-mo; 2-3x/wk; 50 min;  ↔ in E or  
(1977)   unspecified intensity     NE 
 
Duncan et al.  walk/jog; 16-wk; 3x/wk; 60 min; 70-80% HRmax ↔ in E; ↓ in  
(1985)          NE 
 
Ehsani et al.  walk/jog/cycle; 12-mo; 3-5x/wk; 30-60 min;  ↔ in NE or 
(1984)   50-90% VO2max     E 
 
Greiwe et al.  cycling/running; 10-wk; 6x/wk; 30-40 min; cycle: ↔ in NE or   
(1999)   90-100%VO2max, run: highest tolerable pace  E 
______________________________________________________________________ 
NE = norepinephrine  VO2 =  oxygen consumption 
E = epinephrine  HR = heart rate  
SP = spillover   ↔ = no change 
↓ = decrease 
______________________________________________________________________ 
table con’d. 
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Table A.7  
______________________________________________________________________ 
Author/Date  Training Protocol     Findings 
   (mode; time period; frequency; duration; intensity) 
______________________________________________________________________ 
Hagberg et al.  walk/jog/cycle; 8-mo; 3-5x/wk; 30-45 min;  ↔ in NE or 
(1984)   60-65% VO2max     E 
 
Hartley et al.  running/basketball/volleyball; 7-wk; 3x/wk;   ↔ in NE or 
(1972a)  3-hr; HR of 145-180 bpm    E 
 
Jennings et al.  cycling; 4-wk; 3x/wk or 7x/wk; 60-70% of  ↓ NE SP in  
(1986)   maximal work capacity    both  
 
Jost et al.  run/swim; 6-wk; 6-7x/wk; run: 95±6 km/wk,  run: ↓ NE   
(1990)   swim: 30.6±2 km/wk     swim: ↓ E 
 
Kiyonaga et al. cyling; 20-wk; 3x/wk; 60 min; workload was ↓ E &   
(1985)   set at 1st breaking point of lacate   NE 
 
McCrimmon et al. calisthenics/jog; 27-wk; frequency and duration  ↓ NE 
(1976)   unspecified; 65-70% VO2max 
 
Peronnet et al.  cycling; 20-wk; 3x/wk; 30-min; 80% HRmax  ↔ in NE 
(1981) 
 
Schwartz et al. walk/jog; 3-mo; 3x/wk; 40 min; 70-85%   ↔ in NE or 
(1990)   HRreserve      E 
 
Svedenhag et al. run/cycle; 4-mo; 4x/wk; duration &    ↔ in NE or  
(1986)   intensity unspecified     E 
 
Urata et al.  cycling; 10-wk; 3x/wk; 60 min; HR ~101 bpm ↔ in E; ↓ 
(1987)          in NE 
 
Winder et al.  cycling/run; 7-wk; 6x/wk; 30-40 min; cycle:  ↔ in NE or 
(1978)   90-100% VO2max, run: highest tolerable pace  E 
______________________________________________________________________ 
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1976; Urata, Tanabe, & Kiyonaga, 1987). The discrepancies in the findings of these studies 
possibly suggest that the catecholamine response to stressful stimuli (i.e. mental tasks, 
exercise) may be a better indicator of SNS drive, as levels may be too low during rest to 
accurately detect any changes due to training.  Accordingly, investigators have assessed the 
influence of endurance training on the catecholamine response to physiological perturbations.  
As in the previous chapter, time constraints limit this review to those studies that have used 
exercise and psychological stimuli as perturbations to elicit a catecholamine response.     
Studies that have utilized submaximal exercise to elicit a catecholamine response have 
used two basic techniques: 1) those that monitor catecholamine kinetics during the same 
absolute workload pre- and post-training; and, 2) those that monitor catecholamine kinetics 
during the same relative workload pre- and post-training.  Researchers using the former have 
provided evidence for a reduced catecholamine response to submaximal exercise following 
endurance training in healthy individuals (Greiwe et al. 1999; Hartley et al. 1972b; Peronnet 
et al. 1981; Winder et al. 1978; Winder et al. 1979).  Hartley et al. (1972b) reported that the 
NE response to 40 minutes of cycling at a specific workload (~75% of initial VO2max) was 
significantly attenuated following training (2.9±0.3 vs. 4.2±0.5 ug•l-1) in a group of young 
subjects (n=7; age=20-24 yr).  They further reported a reduced NE response to near-maximal 
exercise following training, although E levels were not different at any workload following 
training.  In this investigation, training elicited an increase in VO2max from 2.95 to 3.36 l•min-
1
, so the actual %VO2max at which the subjects were working during the 40 minutes of 
exercise was lower after training (61.3 vs. 72.6 %).  In an attempt to determine the time 
course of these changes, Winder et al. (1978) assessed the effects of a 7-week training 
protocol on the catecholamine response to cycle ergometry (95% of initial VO2max) in a group 
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of healthy males (n=6; age=30±1 yr), evaluating the subjects at weekly intervals.  Both the 
NE and E response to exercise at the same absolute workload were significantly reduced after 
only 1 week of training.  Both continued to decrease with training until a plateau was reached 
after the 3rd week, after which there were no further decreases despite intensity increases in 
the training protocol.  In a subsequent study using a similar training protocol, Winder et al. 
(1979) further reported that 9 weeks of training resulted in a decreased NE and E response to 
a given workload (850±74 kpm•min-1) of cycle ergometry exercise in what appears to be the 
same group of subjects.  Peronnet et al. reported similar findings in a group of healthy males 
(n=10; age=37±2 yr) following 20 weeks of training that elicited a significant increase in 
VO2max (33±2 vs. 42±1 ml•kg-1•min-1).  They noted a reduced plasma NE response (687±64 
vs. 1371±286 pg•ml-1) to cycling at a set submaximal workload (735±51 kg•m•min-1) post- 
compared to pre-training.  Most recently, Greiwe et al. (1999) reported that 10 weeks of 
training, sufficient to increase VO2max from 39.2±8 to 46.9±8 ml•kg-1•min-1, led to reductions 
in NE (956±170 vs. 1264±160 pg•ml-1) and E (76±9 vs. 146±26 pg•ml-1) at an identical 
workload to that before training in previously untrained subjects (n=9; age=28±8 yr).  These 
findings have also been extended to both the hypertensive population (Hagberg et al. 1984; 
Urata et al. 1987) and patients with heart disease (Cooksey et al. 1978; Cousineau et al 1977; 
Ehsani et al. 1984).   
Alternatively, the effect of endurance training on the catecholamine response to 
exercise at a percentage of a subject’s VO2max is still unclear.  Results of studies addressing 
this issue have been inconsistent, with some reporting no change (Brundin & Cernigliaro, 
1975; Peronnet et al. 1981;Winder et al. 1979), others reporting a decrease (Hartley et al. 
1972a), and others reporting an increase (Cleroux et al. 1987; Cooksey et al. 1978; Ehsani et 
 128 
al. 1984; Greiwe et al. 1999; Hagberg et al. 1984; Winder et al. 1978).  Greiwe et al. recently 
reported a significantly increased NE response to exercise intensities of 65, 70, 75, 80, and 
85% VO2max following 10 weeks of cycle ergometer training and running.  Although, the E 
response was not significantly different at any exercise intensity following training, there was 
a trend for the post-training E response to be greater at intensities of 80 and 85% VO2max.  
They hypothesized that the increased NE response was mediated by the use of a larger 
skeletal muscle mass resulting in a greater stimulation of afferent nerves.  Cleroux et al. 
reported that 20 weeks of cycling training (n=7; age=37±4 yr) did not influence the response 
to NE or E to cycling at 60% VO2max.  However, another group of subjects (n=5; age=32±4 
yr) that used running as the mode of training exhibited an elevated E response to cycling at 
60% VO2max, and nearly significantly elevated NE responses (~+1000 pg•ml-1).  Interestingly, 
the cycle ergometer training and running elicited improvements in VO2max of 13 and 21%, 
respectively.  Thus, the differences in findings between groups may be a result of different 
training effects of the 2 different exercise modalities.  Winder et al. (1978) demonstrated a 
significant increase in both the NE and E response to exercise at similar relative workloads 
following their training protocol.  They reported a NE concentration of 4.04±0.7 ng•ml-1 at 
approximately 100% VO2max after training compared to 2.95±0.3 ng•ml-1 at 95% VO2max prior 
to training.  Similar results were reported for plasma E (1.24±0.2 vs. 0.53±0.1 ng•ml-1).  
However, the use of slightly different workloads pre- and post-training (95 vs. 100% VO2max) 
makes it difficult to draw clear-cut conclusions from this investigation.  Hagberg et al. further 
reported an elevated NE response to exercise at 60% VO2max in young essential hypertensives 
(n=12; age=16±1 yr) following 8 months of training that was sufficient to increase VO2max 
from 41.0±3 to 46.5±3 ml•kg-1•min-1.  In patients with coronary artery disease (n=21; 
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age=50±8 yr), Ehsani et al. reported that 12 months of training that increased VO2max by 
42% resulted in an increase in the NE response to maximal exercise (3642±1500 vs. 
2049±704 pg•ml-1), although no changes in the E response were noted.  In a similar 
population (n=10; age=40-55 yr), Cooksey et al. also reported an increased NE (3003±101 vs 
2120±77 pg•ml-1) and E (323±23 vs. 155±15 pg•ml-1) response to maximal exercise 
following exercise training that significantly improved treadmill time to exhaustion (374±28 
to 567±33 seconds). 
Alternatively, Winder et al. (1979) reported no change in plasma NE or E at the same 
relative workload following 9 weeks of endurance training.  However, this group used 62% 
VO2max as the relative workload which may have been too low an intensity to detect any 
training-induced changes in the NE response.  Although Peronnet et al. did not report a 
significant change in the NE response to exercise at an intensity that elicited a HR of ~157 
bpm, it should be noted that NE was higher following training (1371±286 vs. 1729±371 
pg/ml).  Additionally, the intensity of HR~157 bpm may not have been sufficient to detect 
training-induced changes.  Similarly, Brundin & Cernigliaro failed to find any differences in 
the urinary NE and E response to exercise following 2 months of cycle ergometer training.  
However, there are several methodological concerns that should be addressed regarding their 
investigation.  In this study, urinary catecholamine levels were measured after the subjects 
cycled at a moderate intensity (HR ~ 140 beats•min-1) for 30 minutes, followed by a near 
maximal effort for 7 minutes.  Thus, the catecholamine concentrations that they measured 
actually reflected the response to maximal exercise.  Furthermore, their failure to report the 
workload at which the subjects were exercising at near-maximal effort prevents one from 
drawing definite conclusions.  Lastly, the training protocol utilized in this study was poorly 
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described with regards to frequency, duration, and intensity.  Nevertheless, if one examines 
Brundin and Cernigliaro’s data carefully, there was a slight, although not statistically 
significant, increase in the NE response to exercise following training (32±3.2 vs. 27 ±1.5 
ng•mg excreted creatinine-1), which is consistent with other investigations (Cleroux et al.; 
Cooksey et al.;  Ehsani et al.; Greiwe et al.; Hagberg et al.; Winder et al. 1978).  Although, 
Hartley et al.’s (1972a) finding of a reduced NE response at moderate and heavy exercise 
following training also remains controversial, it should be pointed out that the pre-training 
workloads (75 and 98% of VO2max), were slightly higher than the post-training workloads (71 
and 93% VO2max).  In conclusion, research suggests that endurance exercise training that 
elicits improvements in VO2max results in an attenuation of the catecholamine response to 
exercise at the same absolute workload.  Furthermore, although there is ample evidence that 
the catecholamine response to exercise at the same relative workload (i.e. percentage of 
VO2max) is elevated following training, there still exists some controversial data and more 
research must be done before definite conclusions can be made.   
Studies using the catecholamine response to psychological stimuli in humans have had 
little success in showing a training effect.  For example, Cleroux et al. (1984) demonstrated 
that 20 weeks of jogging (3x/wk; 45 min/day; 60% VO2max) resulted in no change in the E or 
NE response to a video game task.  Similarly, Sinyor, Peronnet, Brisson, & Seraganian (1988) 
found no changes in catecholamine reactivity to mental arithmetic tasks or to the Stroop 
CWCT following 10 weeks of jogging (3x/wk; 60 min/day; 60% VO2max).  Furthermore, 
Blumenthal et al. (1990) reported no changes in catecholamine reactivity to mental arithmetic 
following 12 weeks of training (walk/jog; 3x/wk; 30 min/day; 70% HRreserve). There is, 
however, some evidence to suggest that catecholamine reactivity is suppressed following 
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endurance training in rats (Cox, 1991).  Cox reported that 12 weeks of swimming (2-
hour/day) resulted in an attenuation of the NE response to 30 minutes of cutaneous tail shock. 
However, one must use caution when comparing animal studies with those done in humans 
because of the type of stress used (mental vs. shock) and the differences in training modalities 
(training studies in rats are consistently more vigorous than those in humans).       
Studies assessing the variability of heart rate and blood pressure.  Several recent studies have 
used HRV to make inferences about the influence of endurance exercise training on 
autonomic control of the heart.  An outline of these studies can be seen in Table 6.3.  In 
healthy individuals, several investigators have reported improvements of HRV indices with 
training (Al-Ani, Munir, White, Townend, & Coote, 1996; DeMeersman, 1992; Levy et al. 
1998; Schuit et al. 1999; Seals & Chase, 1989; Stein, Ehsani, Domitrovich, Kleiger, & 
Rottman, 1999).  In nine track athletes, De Meersman reported that 8-weeks of intense 
running significantly increased both VO2max (7.2%) and SDNN (23.1%).  In 11 young adult 
males, Al-Ani et al. reported that 6 weeks of cycle ergometer exercise was sufficient to reduce 
resting HR by 12 beats/min and increase VO2max (15%).  Furthermore, training resulted in 
increases in RSA, and LF and HF spectral power in 9 subjects.  However, in two others, 
opposite findings were reported.  It was concluded from this study that the reduction in resting 
HR was a result of increased cardiac vagal tone.  Seals and Chase examined the effects of a 
30-week training protocol on HRV in a group of middle-aged to older males (n=11) compared 
to a control group (n=8) of a similar age range.  Training resulted in a 25% increase in VO2max 
and a significant reduction in resting HR, while these variables were unchanged in the control 
group.  Additionally, exercise training resulted in a significant increase in SDNN and a 
nonsignificant increase in RSA.  Similar to Al-Ani, these researchers concluded that a 
Table A.8   
_____________________________________________________________________________________________________________________ 
Studies Examining the Influence of Endurance Exercise Training on Heart Rate Variability 
_____________________________________________________________________________________________________________________ 
Author/Date  Population (Age) Training Protocol     Findings 
      (mode; time period; frequency; duration; intensity) 
_____________________________________________________________________________________________________________________ 
 
Al-Ani et al.  Healthy  (20±1 yr) cycling; 6-wk; 7x/wk; 25-min; 85% HRmax   ↑RSA, ↑HF, ↑LF 
(1996) 
 
Bonaduce et al.  Cyclists (21±4 yr) cycling; 5-mo; 5x/wk; 4-hr; unspecified   ↔SDNN, ↔rMSSD, ↔pNN50,  
(1998)             ↔LF, ↔HF, ↔LF/HF   
 
Boutcher &   Healthy (46±1 yr) walk/jog; 8-wk; 3x/wk; 20-30 min; 60% HRreserve  ↔RSA, ↔HF, ↔LF  
Stein (1995) 
 
Coats et al.  Heart Failure  cycling; 8-wk; 5x/wk; 20 min; 60-80% HRmax  ↑SDNN, ↑HFnu, ↓LFnu 
(1992)   (62±2 yr) 
 
Davy et al.  Post-menopausal walk; 12-wk; 3-4x/wk; 30-45 min; 60-75% HRmax ↔SDNN, ↔TP, ↔LF, ↔HF 
(1997)   hypertensive (55±1 yr)  
 
Deligiannis et al.  Renal Disease  stepping/swimming/games; 6-mo; 3-4x/wk;   ↑SDNN, ↑ triangular index 
(1999)   (48±12 yr)   50-min; 60-70% HRmax 
____________________________________________________________________________________________________________________ 
RSA = respiratory sinus arrhythmia SDNN, SDANN, rMSSD, pNN50 = see text  
LF = low-frequency power  HF = high-frequency power 
TP = total power   nu = normalized units   
_____________________________________________________________________________________________________________________ 
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Table A.8   
_____________________________________________________________________________________________________________________ 
Author/Date  Population (Age) Training Protocol     Findings 
      (mode; time period; frequency; duration; intensity) 
_____________________________________________________________________________________________________________________ 
 
De Meersman  Healthy (18-22 yr) running; 8-wk; 7x/wk; 90-120 min; 75-90% HRmax ↑SDNN 
(1992) 
 
Fujimoto et al.  Post-MI (59±11 yr) cycling; 2-wk; 2x/day; 10-min;      ↑SDNN, ↑SDANN, ↑HF, ↓LF/HF  
(1999)      80% anaerobic threshold 
 
Gutin et al.  Obese children  Unspecified; 4-mo; 5x/wk; 40-min; HR~153 bpm ↑rMSSD, ↓LFnu, ↓LF/HF  
(1997)   (9.6±0.2 yr) 
 
Howorka et al.  Diabetic (50±9 yr) cycling; 12-wk; 2x/wk; 30-min; 65%HRreserve  ↑LF, ↑HF, ↑TP (except for those 
(1997)             with severe autonomic neuropathy 
 
Kiilavuori et al.  Heart Failure   cycling; 3-mo; 3x/wk; 30 min; 50-60% VO2peak  ↑HF, ↓LF/HF 
(1995)   (52±8 yr) 
 
La Rovere et al.  Post-MI (47±6 yr) cycling; 4-wk; unspecified frequency & duration; ↑ LF/HF during head-up tilt 
(1992)      75-95% anaerobic threshold 
 
Leitch et al.  Post-MI (56±1 yr) cycling; 6-wk; 3-4x/wk; 30-60 min;   ↑SDNN, ↑SDANN, ↑TP, ↑LF, ↑HF 
(1997)      70% HRmax 
 
Levy et al.  Healthy    walk/jog/cycling; 6-mo; 4-5x/wk; 45-min;  ↑SDNN in both age groups 
(1998)   (24-32 & 60-92 yr) 50-85% HRreserve 
____________________________________________________________________________________________________________________ 
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Table A.8  
_____________________________________________________________________________________________________________________ 
Author/Date  Population (Age) Training Protocol     Findings 
      (mode; time period; frequency; duration; intensity) 
_____________________________________________________________________________________________________________________ 
 
Maciel et al.  Healthy (29±1 yr) cycling; 10-wk; 5x/wk; 4 6-min periods at   ↔ RSA 
(1985)      60, 70, 80. 90% HRmax 
 
Malfatto et al.   Post-MI (52±7 yr) cycling; 8-wk; 5x/wk; 60-min; 80%HRmax  ↑SDNN, ↑rMSSD, ↑pNN50, ↓LF/HF 
(1996) 
 
Oya et al.   Post-MI (59±6 yr) cycling; 2-wk; 14x/wk; 30 min;     ↑HF   
(1999)      anaerobic threshold 
 
Radaelli et al.  Heart Failure   cycling; 5-wk; 5x/wk; 30 min; 60-70% VO2max  ↑HFnu; ↓LF/HF 
(1996)   (55+3 yr) 
 
Schuit et al.  Healthy (67±5 yr) walk/jog/games; 6-mo; 3x/wk; 45 min;   ↑SDNN, ↑very-LF, ↑LF 
(1999)      60-80% HRmax 
 
Seals & Chase  Healthy (53±2 yr) walk/jog; 30-wk; 3-4x/wk; 45-min; 80%HRreserve  ↑SDNN, ↔ RSA 
(1989) 
 
Stahle et al.  Post-MI (71±4 yr) cycling (intervals); 3-mo; 3x/wk; 50-min;   ↑SDNN, ↑SDANN  
(1999)      three 4-min peaks at >85% HRmax 
 
Stein et al.   Healthy (66±4 yr)  walk/jog/cycling/rowing; 9-mo; 5x/wk; 45-60 min;  ↑SDNN, ↑SDANN, ↑TP, ↔rMSSD,  
(1999)      60-85% VO2max      ↔pNN50, ↔LF, ↔HF 
_____________________________________________________________________________________________________________________ 
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training-induced increase in cardiac vagal tone was responsible for the post-training reduction 
in resting HR.  Levy et al. examined the effect of 6 months of endurance training on a group 
of young adults (24-32 yr; n=11) and a group of older adults (60-82 yr; n=13).  In this study, 
exercise training led to increases in VO2max of 21% and 17%, and reductions in resting HR of 
~9 and ~5 beats/min in the older and younger groups, respectively.  Furthermore, SDNN was 
increased by 68% and 17%, respectively, in the older and younger subjects.  With this data, it 
was concluded that there was a training induced increase in cardiac parasympathetic drive, as 
plasma catecholamine levels were unchanged with training.  Stein et al. examined the effects 
of a 9-month training protocol on HRV in a group of older men (n=7) and women (n=9).  
Training resulted in an increased VO2max of 30.5% and a slight nonsignificant reduction of 
resting HR (p=0.08).  Additionally, training resulted in significantly increased SDNN (13%), 
SDANN (11%), and TP (3%), although pNN50, rMSSD, LF, and HF were unchanged.  
Furthermore, a comparison (non-training) group was evaluated in this study and demonstrated 
no alterations in HRV indices over the course of the study.  Another study examining the 
effects of endurance training on HRV indices in older men (n=14) and women (n=13) was 
performed by Shuit et al.  In this investigation, 6-months of training resulted in a significant 
increase in VO2max in comparison to a control group of a similar age.  However, there was no 
difference in resting HR between pre- and post-training.  With regards to HRV, training 
resulted in higher SDNN, LF, and very-LF power, although pNN50 and HF were unchanged 
with training.       
 In contrast, a few studies in healthy individuals have failed to demonstrate an effect of 
endurance exercise training on HRV (Bonaduce et al. 1998; Boutcher & Stein, 1995; Maciel 
et al. 1985).  Maciel et al. examined the effect of 10-weeks of endurance training on the RSA 
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in a group of previously sedentary males (n=7).  Training led to a significant increase in 
VO2max (16%) and a ~11 beat/min decrease in resting HR.  However, this group failed to find 
a difference in RSA following training.  Interestingly, these investigators also used the vagal 
blocker atropine to further quantify any training-induced changes in sympathovagal balance 
and reported no pre-post differences in the HR response to atropine infusion.  Therefore, it is 
possible that the training protocol was insufficient to elicit alterations in autonomic balance.  
Bonaduce et al. studied the effects of 5-months of intensive cycle training on a group of high 
level cyclists (n=15).  There was a significant training-induced increase in VO2max (8%), along 
with a significant reduction in resting HR of ~5 beats/min following training.  However, there 
was no evidence of any training-induced alterations in HRV indices.  It should be noted that a 
possible confounding factor in this study was the initial fitness levels of the subjects (VO2max 
= 62±4 ml•kg-1•min-1).  Therefore, the high initial fitness level of these subjects possibly 
masked any training-related alterations in HRV parameters.  Boutcher and Stein also were 
unable to detect any training-related changes in RSA, LF, or HF in a group of sedentary 
middle aged men (n=19).  Although the 8-week training protocol used was sufficient to 
significantly increase VO2max, and reduce resting HR, these changes were minimal (11% and 
4%, respectfully).  Therefore, it may be possible that the training protocol was not intense 
enough to alter HRV indices.   
        The majority of intervention studies investigating the effect of endurance exercise 
training on HRV have been performed in clinical populations (Davy, Willis, & Seals, 1997; 
Deligiannis, Kouidi, & Tourkantonis, 1999; Fujimoto et al. 1999; Gutin, Owens, Slavens, 
Riggs, & Treiber, 1997; Howorka et al. 1997; Kiilavuori, Toivonen, Naveri, & Leinonen, 
1995; La Rovere, Mortara, Sandrone, & Lombardi, 1992; Leitch et al. 1997; Malfatto et al. 
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1996; Oya, Itoh, Kato, Tanabe, & Murayama, 1999; Radaelli et al. 1996; Stahle, Nordlander, 
& Bergfeldt, 1999).  Of these, many have examined the effects of exercise training on HRV 
indices in patients who have had a recent myocardial infarction (MI), as studies have 
indicated that this population exhibits significantly reduced cardiac variability (Task Force of 
the European Society of Cardiology & the North American Society of Pacing and 
Electrophysiology, 1996).  For the most part, the literature suggests that exercise training has 
a positive effect of HRV indices in this population.  For example, Malfatto et al. reported that 
8-weeks of exercise training favorably improved SDNN, pNN50, rMSSD, and the balance of 
LF to HF power in a group of post-MI patients (n=22), while a group of similar health status 
that did not train exhibited no changes.  Interestingly, after a one-year follow-up of these same 
patients, the training group still displayed enhanced HRV compared to the others.  Similarly, 
Stahle et al. found that 4 months of endurance exercise training increased SDNN and SDANN 
in patients (n=29) following an acute myocardial infarction, with no changes in a group of 
control subjects (n=36) of a similar age and health status. Furthermore, they also noted a 
training-related increase in total and HF power in the training group.  In another study, Oya et 
al. reported that 2-weeks of cycling (twice daily) was sufficient to improve HF power in a 
group of post-MI subjects (n=16), with no changes reported in a control group of similar 
health status (n=12).  However after 3 months of follow-up, there were no longer significant 
differences between groups indicating the importance of remaining physically active.  
Fujimoto et al. also reported that a group of subjects with a recent MI who underwent a 4-
week training protocol (n=20) exhibited higher HF and lower LF/HF compared to a control 
group of similar health status (n=20).  Each of the aforementioned studies suggests a 
beneficial effect of exercise training on HRV indices in subjects with a recent MI, therefore 
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potentially demonstrating a protective role of exercise training in this population.  However, 
Leitch et al. failed to demonstrate a significant difference between a group of post-MI patients 
who underwent 6-weeks of exercise training (n=26) and a group who did not (n=23).  
However, in this study both groups increased their HRV indices (SDNN, SDANN, TP, LF, & 
HF) over the 6-week period.  It should also be noted that the control group participated in a 
home-based walking program and therefore, actually did train.  Thus, this study demonstrates 
the importance of engaging in some type of activity following MI.  Lastly, La Rovere et al. 
reported that 4 weeks of exercise training resulted in an increased LF/HF during head-up tilt 
in a group of post-MI patients (n=11), while a control group of similar health status (n=11) 
did not show any such changes.  The authors concluded that this enhanced vagal withdrawal 
is possibly a result of an improved BRS following training.   
 Other investigators have examined the effects of exercise training on HRV in other 
clinical populations.  In patients with chronic heart failure (n=17), Coats et al. (1992) reported 
that 8-weeks of training improved vagal modulation of the heart, expressed by increases in 
SDNN and HFnu and decreases in LFnu.  Also in a heart failure population (New York Heart 
Association Class II and III), Kiilavuori et al. (1995) reported that 3 months of training led to 
improvements in HF and decreased LF/HF (n=8) during the day, while a control group of 
similar health status (n=12) exhibited no alterations in HF and an increase in LF/HF.  
However, there were no group differences in HRV at night.  With these data, the investigators 
suggested that lack of involvement in a structured exercise program may actually result in an 
unhealthy sympathovagal balance.  Additionally in this population (n=6), Radaelli et al. 
(1996) reported increased HFnu and reduced LF/HF following 5 weeks of home based cycle 
ergometer training.  In diabetic patients with various degrees of autonomic neuropathy, 
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Howorka et al. (1997) reported that 12 weeks of training increased TP, LF and HF in diabetics 
without (n=8), and those with early signs of neuropathy (n=8).  However, training had no 
effect on indices of HRV in those diabetics with severe neuropathies (n=6).  Thus, it was 
concluded from this study that exercise training has a beneficial effect on autonomic balance 
in diabetics with early or no signs of autonomic neuropathy.  In hemodialysis patients with 
end-stage renal disease, Deligiannis et al. (1999) demonstrated a positive effect of exercise 
training on HRV indices.  These investigators reported that 6 months of training resulted in 
increased SDNN and the triangular index (total number of RR intervals divided by the height 
of the histogram of all RR intervals) in a group of patients (n=30) compared to a control 
group of similar health status (n=30).  In post-menopausal hypertensive women (n=8), Davy 
et al. (1997) failed to report any significant changes in HRV following 12 weeks of training.  
The authors of this study then suggested that their lack of significant findings in HRV indices 
following training may have been due to an insufficient training stimulus.  Lastly, in a group 
of obese children (n=17) Gutin et al. (1997) reported that 4 months of training resulted in 
significant increases in rMSSD and decreases in LF normalized units and LF/HF compared to 
a control group of similar subjects (n=18).  With these data, the investigators concluded that 
exercise training enhances vagal modulation of the heart in this population.  In conclusion, the 
majority of studies that have examined the influence of physical training on HRV suggest that 
training has a beneficial effect on autonomic modulation of the heart.  Furthermore, it appears 
that changes in HRV following training are more pronounced in populations in which HRV is 
initially depressed. 
Studies assessing baroreflex sensitivity.  Longitudinal studies assessing the influence of 
exercise endurance training on BRS have produced inconclusive results.  Some researchers 
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have reported findings to suggest an attenuation of BRS following training (Bedford & 
Tipton, 1987; Negrao et al. 1993; Paynter, Tipton, & Tcheng, 1977; Raven & Stevens, 1990; 
Stevens, Foresman, Shi, Stern, & Raven, 1992; Tipton, Matthes, and Bedford, 1982), while 
others have reported either increases (Convertino et al. 1990; Grassi, Seravalle, Calhoun, & 
Mancia, 1994; Guo, Yi, Batchvarov, Gallagher, & Malik, 1999; Leitch et al. 1997; Pagani et 
al. 1988; Silva, Brum, Negrao, and Krieger, 1997 ) or no change (Bowman et al. 1997b; Davy 
et al. 1997; Lightfoot, Claytor, Torok, Journell, & Fortney, 1989; Seals & Chase, 1989; 
Sheldahl, Ebert, Cox, & Tristani, 1994) in BRS.  Some of the discrepancies of these studies 
may be related to methodological differences such as the technique used to assess BRS (i.e. 
LBNP, pharmacologic, spectral, etc.) and the duration of the training protocols, each of which 
will be discussed at the end of this section.   
Studies using an animal model have provided evidence for a training-induced 
reduction in BRS.  For example, in normal and sympathectomized rats, Paynter et al. reported 
that animals that were treadmill trained for 12 weeks (frequency: 4-6 days/week; duration: 80 
minutes; intensity: 22.8 meters/min at 9% grade) demonstrated a reduced ability to maintain 
BP in response to graded LBNP.  Tipton et al. also reported that treadmill trained rats (n=12; 
length: 12 weeks; frequency: 4-5 days/week; duration: 60-80 minutes; intensity: 50-75% 
VO2max) exhibited a greater and more rapid fall in BP in response to graded LBNP than 
untrained controls (n=12).  Similarly, Bedford and Tipton reported a blunted baroreflex in rats 
that were trained on a treadmill for 11-14 weeks (n=22) (frequency: 4-5 days/week; duration: 
40-50 minutes; intensity: 70-90% VO2max) compared to an untrained group (n=25).  Following 
training, both groups were anesthetized and a stimulus-response curve was constructed by 
plotting the change in femoral artery systolic BP elicited by alterations in carotid sinus 
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pressure.  The investigators reported a significantly flatter curve in the trained animals, with 
the baroreflex gain significantly lower in the trained group at pressures of 95-115 Torr (0.23 
vs. 0.34) and pressures of 175-195 Torr (0.38 vs. 0.60) compared to their untrained 
counterparts.  Additionally, Negrao et al. reported that 13 weeks of treadmill training 
(frequency: 5 days/week; duration: 60 minutes; intensity: 26.8 meters/minute at 15% grade) 
significantly attenuated BRS in rats (n=6) compared to nontraining controls (n=6).  They 
reported a training-induced reduction in the renal sympathetic nerve activity response to a 
nitroprusside-induced BP decrease, and also in the HR response to a PE-induced BP increase.  
Both of these alterations were in the direction to suggest a reduced sensitivity of the 
baroreflex in the trained animals.  On the other hand, in spontaneously hypertensive rats 
(n=9), Silva et al. reported that 12 weeks of treadmill training (frequency: 5 days/week; 
duration: 60 minutes; intensity: 50% VO2max) significantly improves BRS.  They reported that 
trained rats exhibited a significantly greater bradycardia in response to PE-induced BP 
increases of 8 and 15 mmHg compared to untrained controls (n=5).  Similarly, the trained rats 
displayed a greater tachycardic response to BP decreases of 7, 16, and 25 mmHg induced by 
nitroprusside.  Furthermore, the trained rats displayed a greater slope of the relationship 
between the changes in HR and BP in response to nitroprusside infusion.  Although the data 
of Silva et al. suggest a training induced increase in BRS, the fact that these animals were 
hypertensive makes it difficult to compare these findings to other studies, as it does not reflect 
the response of normotensive subjects. 
Studies using the human model have provided equivocal results.  For example, Raven 
and Stevens (1990) reported that subjects (n=7; age=28±4 yr) who participated in an 8 month 
endurance training protocol (mode: walking/jogging; frequency: 4 days/week; duration: 45 
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minutes; intensity: 1% < ventilatory threshold) had a reduced orthostatic tolerance.  Training 
was sufficient to increase VO2max (43.9 to 56.9 ml•kg-1•min-1) and blood volume (6.50 to 7.25 
L) and all subjects were less able to maintain BP in response to graded LBNP following 
training.  Additionally, Stevens, Foresman, Shi, Stern, and Raven (1992) used the exact same 
protocol in 8 males (age=27.6±4 yr) to evaluate the influence of endurance training on 
orthostatic tolerance and baroreceptor function.  They reported significant increases in VO2max 
(45.2±2.0 to 57.5±3.0 ml•kg-1•min-1), total blood volume (15.8%), and plasma volume 
(16.5%), while finding a significant decreased tolerance to LBNP (-24%).  They further 
reported that the factors accounting for reduced orthostatic tolerance were reductions in the 
responses of peripheral vascular resistance (R2=0.85) and SBP (R2=1.0) to graded LBNP, and 
the increase in total blood volume (R2=0.98).  Thus, these two investigations suggest that 8 
months of endurance exercise training result in an attenuation of the baroreflex control of the 
CV system. 
However, several other studies in humans have reported that endurance training has a 
minimal effect on BRS.  For example, Lightfoot et al. (1989) used LBNP and neck 
pressure/suction to compare BRS between 8 males (22±1 yr) who underwent a 10-week 
endurance training program (mode: running/cycling; frequency: 4 days/week; duration: 20-30 
minutes; intensity: 85% VO2max) and a control group of 7 males of similar age (27±6 yr).  
Training led to an increase in VO2max (46.0±2.0 to 55.0±2.0 ml•kg-1•min-1), while the control 
group exhibited no changes.  Following the training period, there were no group differences in 
the HR, BP, or forearm blood flow response to LBNP.  Similarly, there were no group 
differences in the HR response to changes in carotid sinus pressure induced by neck 
pressure/suction.  In 11 older subjects (age=53±2 yr), Seals and Chase (1989) reported that 30 
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weeks of endurance training (mode: walk/jog; frequency: 3 days/week; duration: 30 minutes; 
intensity: 70% HRreserve), which was sufficient to elicit a 25% increase in VO2max, resulted in 
no alterations in carotid BRS, defined by the RR interval response to neck suction/pressure, 
relative to a control group (n=8; age=54±3 yr).  However, they did report that training 
resulted in a significant reduction in the increase of forearm vascular resistance in response to 
graded LBNP.  Sheldahl et al. (1994) studied the effect of a 12 week endurance training 
protocol (mode: running/cycling; frequency: 3 days/week; duration: 40 minutes; intensity: 70-
85% HRmax) on BRS in 10 middle-aged males (54±8 yr).  However, although training elicited 
a significant increase in VO2max  (30.0±2.0 to 35.0±2.0 ml•kg-1•min-1), the RR interval and 
MSNA response to either sodium nitroprusside or PE remained unchanged following training, 
suggesting no training-induced alterations in BRS.  Davy et al. (1997) used sequence analysis 
to study the effects of a 12 week walking protocol (frequency: 3-4 days/week; duration: 30-45 
minutes; intensity: 60-75% HRmax) on BRS in sedentary, hypertensive post-menopausal 
women (n=8; age=55±1 yr).  They reported no training-induced difference in BRS (pre: 10±2 
ms•mmHg-1; post: 13±2 ms•mmHg-1), although there was also no change in fitness level as 
identified by VO2max (pre: 23.0±1.0 ml•kg-1•min-1; post: 24.0±1.0 ml•kg-1•min-1).  Therefore, 
it is difficult to compare this study to others, as the training protocol was not likely intense 
enough to elicit any CV adaptations.  In a group of older subjects (n=20; age=66±4 yr), 
Bowman et al. (1997b) examined the effect of a 6-week of endurance training protocol (mode: 
cycling; frequency: 2 days/week; duration; 30 minutes; intensity: 70-80% HRmax) on BRS, 
expressed by the α–index.  Although the training stimulus was sufficient to increase VO2max 
by 25%, there was no effect of training on the α–index of mid-frequency power (pre: 6.5±4; 
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post: 6.2±3 ms•mmHg-1) or HF power (pre: 8.5±5; post: 9.9±4 ms•mmHg-1), suggesting no 
difference in BRS.  
Other studies have reported findings to suggest that endurance training significantly 
improves baroreflex control of the CV system.  Convertino et al. (1990) examined the effect 
of 10 weeks of endurance training (mode: cycling; frequency: 4 days/week; duration: 30 
minutes; intensity: 70-80% VO2max) on the hemodynamic response to graded LBNP in 
previously sedentary subjects (n=16; age=36±1 yr) and in a nontraining, age-matched control 
group (n=8).  This group reported that training significantly increased VO2max (40.8 to 48.0 
ml•kg-1•min-1), SDNN (59.4±8 to 74.0±8 ms), and blood volume (63.6±2 to 69.3±3 ml•kg-1), 
while no similar changes were reported in the control group.  They further reported no change 
in the carotid BRS determined by neck pressure/suction, but reported a significantly greater 
tolerance to LBNP (28%).  With this data, they concluded that exercise endurance training 
significantly improves CV fitness without compromising baroreceptor function.  However, 
they also reported a reduced slope of the linear relationship between peripheral venous 
pressure and forearm vascular resistance in the trained group, which would suggest a 
reduction in baroreflex control of vascular resistance.  However, the investigators elaborated 
very little on this finding.  Pagani et al. (1988) looked at the effect of a 6-month endurance 
training protocol (mode: calisthenics/jogging; frequency: 5 days/week; duration: 40 minutes; 
intensity: unspecified) on the BRS of 11 mildly hypertensive subjects (age=32±2 yr), 
expressed by both the sequence and the cross-spectral techniques.  Although no measures of 
fitness were reported as an indication of CV adaptations elicited by the protocol, the authors 
reported that training resulted in a significant elevation of the slope of the RR-SBP 
relationship during a PE-induced pressure increase (14.7±2 vs. 19.5±3 ms•mmHg-1).  
 145 
Furthermore, they reported an increase in BRS expressed by the α-indices in both the LF 
(10.4±1 vs. 15.4±3 ms•mmHg-1) and HF (12.2±1 vs. 21.5±3 ms•mmHg-1) power ranges.  
Grassi et al. (1994) studied the effects of a 10-week endurance training protocol (mode: 
running; frequency: 5 days/week; duration: 2 hours) on the HR and MSNA responses to PE-
induced increases and nitroprusside-induced decreases in BP in a group of 9 previously 
sedentary subjects (age=16±1 yr).  Training resulted in an 18% increase in VO2max, and 
further resulted in a greater reduction in the HR and MSNA response to PE-induced increases 
in BP (-8.6±1 vs. –6.1±1 beats/minute and -78±5 vs. -54±5%, respectively).  Similarly, 
training resulted in greater increases in HR and MSNA in response to nitroprusside-induced 
decreases in BP (18.6±3 vs. 12.4±2 beats/minute and 128.1±26 vs. 63.2±11%, respectively).  
Additionally, there were no alterations in any of these parameters in a group of 4 age-matched 
control subjects that were measured simultaneously.  Guo et al. (1999) assessed BRS, 
expressed by the slope of the change in RR interval to that of SBP during the Valsalva 
maneuver, before, during, and after a 6-month training protocol (mode: various; frequency: 3 
days/week; duration: total of 2.5 hr/week; intensity: “mild”).  Although there were no 
differences in baseline values between the subjects who underwent this training program 
(n=20; age=41±8 yr) and a control group (n=10; age=39±8 yr), the training group exhibited 
an increased BRS at 3 (+92%) and 6 months (+169%), while BRS was unaltered in the 
controls.  Lastly, in a previously mentioned study of patients with a recent myocardial 
infarction (n=26; age=56±1 yr), Leitch et al. (1997) examined the influence of a 6-week 
training protocol (mode: cycling; frequency: 3-4 days/week; duration: 30-60 minutes; 
intensity: 70% HRmax) on BRS, estimated by the sequence technique.  In response to PE 
infusion, they were able to show a greater increase in BRS compared to a control group of 
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similar health status (n=23; age=59±1 yr), who participated only in a home-based walking 
program (+3.4±1 vs. +1.7±1 ms•mmHg-1).       
Although the results of these studies evaluating the influence of endurance training on 
BRS appear to be inconclusive, a few factors must be considered in these investigations.  For 
instance, the majority of training protocols have been less than 6 months in duration.  
Therefore, it is possible that several of the studies that found no differences in BRS following 
training did not allow for a complete adaptation of the baroreceptors.  Although most were 
sufficient in length to significantly improve VO2max, it is possible that fitness, per se, is not 
related to BRS.  It may be that other CV adaptations that occur over longer periods of training 
are responsible for some of the differences in BRS between chronically trained endurance 
athletes and sedentary individuals that were previously mentioned.  Thus, the studies that have 
involved longer periods of training (>6 months) may be more valid.  Another factor that 
demands consideration when examining these studies is the technique used to assess BRS.  As 
mentioned earlier, LBNP results in both a central hypovolemia and hypotension which likely 
stimuates both the arterial and cardiopulmonary baroreceptors.  Conversely, neck 
pressure/suction primarily activates the carotid baroreflex.  Additionally, the sequence and 
cross-spectral techniques do not differentiate between different populations of baroreceptors.  
Thus, one must carefully critique the methodology used in evaluating BRS, as it is very 
possible that endurance training has differential effects on each. 
Looking specifically at those studies with training periods greater than 6 months, those 
that used LBNP suggest an attenuated BRS (Raven & Stevens, 1990; Seals & Chase, 1989; 
Stevens et al. 1992).  Furthermore, Seals and Chase found no differences in carotid BRS, 
therefore suggesting an attenuation of the aortic and/or cardiopulmonary baroreflex.  One 
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possible mechanism that may play a role in altering BRS is blood volume, although this 
variable was reported only in a small portion of investigations.  Although blood volume may 
increase significantly over short periods of exercise training, it is possible that chronically 
elevated blood volume results in alterations of BRS that occur over a time course of months to 
years.  A slight elevation in blood volume would have a direct impact on the baroreceptors, 
namely the aortic.  A continuous pumping of an increased blood volume through the aortic 
arch may lead to a loss in sensitivity of the aortic baroreflex.  Methodological differences may 
also partially explain the findings of Pagani et al. (1988) and Guo et al. (1999) who used the 
cross-spectral and sequence techniques, respectively, and reported a training-induced increase 
in BRS.  If the findings of these investigators were a result of increased cardiopulmonary 
baroreceptor sensitivity, it may be that the arterial baroreflex was actually reduced, as 
increased cardiopulmonary baroreceptor activation has been demonstrated to reduce arterial 
BRS (Billman et al. 1981).  This then would fit nicely with the data of investigators reporting 
reduced BRS (Raven & Stevens; Seals & Chase; Stevens et al. 1992), However, these 
hypotheses are purely speculatory, and more longitudinal research should be initiated on this 
subject matter.  
Studies assessing muscle sympathetic nerve activity.  There exist few longitudinal studies that 
have examined the influence of exercise endurance training on MSNA.  Svedenhag et al. 
(1984) was the first to study the effects of an endurance training protocol on MSNA.  In 5 
untrained subjects (age=23.6±1 yr), they reported that 8 weeks of cycling at an intensity of 
75% VO2max (frequency: 4 days/week; duration: 40 minutes) did not significantly alter resting 
MSNA expressed as either bursts/min (pre: 24±5; post: 23±4) or bursts/100 heart beats (pre: 
38±9; post: 39±7).  However, although the training stimulus elicited a significant increase in 
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VO2max, the change was relatively small (~7%), therefore leading to the possibility that the 
stimulus may have not been sufficient to alter MSNA.  Still, Sheldahl et al. (1994) reported 
similar findings following a 12-week training protocol (mode: running/cycling; frequency: 3 
days/week; duration: 40 minutes; intensity: 70-85% HRmax) in 10 males (age=54±8 yr).  In 
this study, training resulted in an increase in VO2max (~17%), but there was no change in 
resting MSNA (23.4±2 vs. 23.6±2 bursts/min).  Additionally, they found no training-related 
changes in the MSNA response to 3 minutes of isometric handgrip exercise at 25 % MVC 
(6.8±2 vs. 4.7±3), the cold pressor test (6.1±3 vs. 8.3±3), or 7 degree head-up tilt (2.1±2 vs. 
0.8±2).  Additionally, in a study presented in an abstract, Ray, Pace, and Clary (1992) 
reported no change in resting MSNA following 6 weeks of one-legged training on a cycle 
ergometer (frequency: 4 days/week; duration: 40 minutes; intensity: 70% VO2peak) in 5 males 
(age=19-23 yr) relative to a control group (n=5) within the same age range.  However, the 
VO2peak of the trained leg reportedly increased by 20%.  Conversely, Grassi, Seravalle, 
Calhoun, and Mancia (1994) reported that a 10-week running protocol (frequency: 5 
days/week; duration: 2 hours) significantly increased VO2max (16%) and decreased resting 
MSNA (21 vs. 14 bursts/min) in a group of 9 subjects (age=17±1 yr) compared to a control 
group consisting of 4 subjects (24 vs. 23 bursts/min).  The results of these longitudinal studies 
are obviously inconclusive, with most suggesting that MSNA is unaffected by exercise 
endurance training.  However, these studies are limited by the length of there training 
protocols.  It may be that longer training protocols (>12-weeks) that elicit greater 
improvements in CV fitness may provide different results.  Nevertheless, more longitudinal 
studies need to be performed before definite conclusions can be drawn.    
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Summary.  In conclusion, there is evidence to suggest a significant effect of endurance 
exercise training on autonomic regulation of the CV system.  Studies using HRV have 
reported a shift towards increased vagal control of HR in as little as 6 weeks of training in 
healthy and as little as 2 weeks of training in diseased populations. Regarding the effects of 
training on plasma catecholamines, it appears as though exercise training reduces the 
catecholamine response to exercise at the same absolute workload, while the effect of training 
on the catecholamine response to exercise at a given percentage of VO2max remains debatable.  
Additionally, the effect of training on resting catecholamine concentration and the 
catecholamine response to a psychological challenge are not well established.  Studies 
examining the influence of training on the CV response to stress have provided mixed results, 
although it appears that those studies that have used training protocols greater than 12 weeks 
and/or those that have studied subjects with some pre-existing condition have shown the most 
promise.  Similarly, the influence of training on BRS is not well established, although it is 
possible that it may require extended periods of training to elicit changes in baroreceptors 
function.  Furthermore, it is likely that different populations of baroreceptors do not respond 
in a similar fashion to exercise training.  Lastly, few studies have looked specifically at the 
influence of training on MSNA and are not conclusive.   
Summary and Conclusions 
 The CV system is tightly regulated by the ANS in order to maintain homeostasis and 
to respond to constant physiological challenges.  The ANS allows the CV system to respond 
favorably to these challenges by regulating cardiac and vascular tone quickly and efficiently.  
Autonomic outflow is controlled by the brain stem, spinal cord, portions of the cerebral 
cortex, hypothalamus, and by reflex mechanisms that transmit information to these control 
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centers.  The two components of the ANS, the SNS and PNS, have preganglionic nerve fibers 
that transmit impulses that exit the CNS and synapse with postganglionic fibers in the 
periphery that relay the impulses to target organs.  Subsequently, the response that occurs at a 
target organ is dependent on both the type and concentration of its receptors.   
 Several techniques have been developed to evaluate autonomic function.  These 
include the variability of HR and BP, examination of plasma catecholamines, MSNA, SSR, 
CV reactivity, and BRS.  The use of these techniques, along with a few others, has allowed 
investigators to make inferences about autonomic modulation under various conditions and 
furthermore, about the effect of longitudinal interventions on the ANS.  Additionally, there 
are several factors that can influence autonomic activity, and thus, must be controlled for 
during experimental conditions.  These include, but are not limited to, age, race, gender, and 
environmental influences such as temperature and altitude.  Other factors, not included in this 
review include personality type and the presence of various diseases.   
 An acute bout of rhythmic exercise involving large muscle groups is associated with 
changes in autonomic regulation of the CV system.  In general, there is a withdrawal of vagal 
efferent activity at the onset of an acute bout of rhythmic exercise.  The immediate reduction 
in cardiac vagal modulation is likely mediated via central command due to the rapidity at 
which this vagal withdrawal occurs.  However, it there is other data to suggest that an 
immediate resetting of the arterial baroreflex can result in an error signal also eliciting a vagal 
withdrawal.  Subsequently, as exercise intensity increases there is a gradual increase in 
sympathetic outflow mediated by further baroreflex resetting and muscle mechano- and 
metaboreceptors.   
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 Many studies have examined the relationship between peak aerobic power and 
autonomic regulation of the CV system.  Those investigations that have used CV reactivity as 
an indicator of autonomic integrity have provided mixed results.  Many of these discrepancies 
are possibly the result of the use of different classifications of physical fitness and different 
methods of evaluating fitness.  Furthermore, many of these studies did not control for initial 
group differences in CV reactivity or did adjust for initial differences when they were not 
present.  Nevertheless, although investigators have extensively examined the relationship 
between aerobic power and CV reactivity, there is still little consensus in the literature.  Thus, 
it is likely that CV reactivity is not sensitive enough to detect autonomic differences in 
subjects of varying fitness levels.  Investigators searching for a relationship between fitness 
and resting plasma catecholamines have failed to find such a relationship.  However, studies 
have shown that there is an attenuated NE response to exercise at identical submaximal 
workloads in high- compared to lower-fit subjects.  Conversely, there is no consensus on the 
influence of fitness on the catecholamine response to exercise at the same relative intensity.  
Additionally, those studies that have reported high-fit subjects exhibit attenuated NE 
reactivity to psychological stimuli have used control groups with very low levels of physical 
fitness, while those using control groups of moderate-to-high fitness levels have shown no 
such association.  On the other hand, the E response to psychological stimuli does not appear 
to be related to aerobic power.  Studies that have used HRV to examine the relationship 
between fitness and autonomic activity have provided evidence for a strong positive 
relationship.  Both time and spectral indices of HRV have been significantly correlated with 
aerobic power, suggesting that high levels of fitness are associated with an enhanced vagal 
modulation of the heart.  Thus, this measure appears to be sensitive to fitness-related 
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differences in cardiac autonomic regulation.  Additionally, several investigators have searched 
for an association between BRS and physical fitness.  Although these data are somewhat 
controversial, it appears as though the aortic baroreflex is most influenced by fitness level, 
while the carotid and cardiopulmonary baroreceptors are not greatly affected.  Alternatively, 
only a few studies have examined the influence of aerobic power on MSNA and there is no 
general consensus on this matter.   
 Endurance exercise training results in several CV adaptations that may be accounted 
for, in part, by changes in autonomic regulation.  Studies that have used CV reactivity as an 
index of autonomic control have provided mixed results regarding an influence on training on 
ANS function.  However, it appears as though most studies that used subjects with a pre-
existing condition (e.g. type-A personality, hypertension) showed a beneficial effect of 
training on CV reactivity.  Additionally, the majority of studies that used training protocols 
greater than 12 weeks in length showed an attenuation of CV reactivity, although a few 
studies have found improvements with protocols of shorter durations.  Those investigations 
that have examined the influence of exercise training on resting plasma catecholamines have 
been inconclusive with some reporting a reduction and others reporting no effect.  Therefore, 
it is possible that the catecholamine response to physiological perturbations may be a more 
sensitive measure of ANS activity.  Accordingly, investigators have reported that the 
catecholamine response to exercise at a given workload is lower following participation in an 
endurance training protocol.  Alternatively, the influence of exercise training on the 
catecholamine response to exercise at a percentage of one’s VO2max is still unclear, although 
several studies have reported an increased catecholamine response following training.  
Furthermore, studies have reported no effect of exercise training on the catecholamine 
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response to psychological stimuli.  Several investigators using HRV have reported an 
enhanced cardiac vagal modulation following an exercise training protocol in both healthy 
and diseased populations.  Research still remains controversial regarding the influence of 
exercise training on BRS.  Animal models have provided evidence for a reduced BRS 
following a training protocol.  However, studies in humans have provided inconclusive 
results.  Differences in the findings of these studies are possibly the result of different 
techniques of measurement and/or differences in the length of the training protocols.  
Additionally, it is possible that it requires extended periods of training (longer than any 
longitudinal study to date) to elicit pronounced alterations in BRS.  Lastly, the majority of 
investigations have found no influence of exercise training on resting MSNA.   
 Although there has been an extensive amount of research regarding the influence of 
peak aerobic power and endurance exercise training on autonomic control of the CV system, 
there still remain several areas that warrant further investigation.  For example, although 
several studies have reported that exercise training influences autonomic control of the 
circulation, the time course of these changes remains elusive.  It would be of interest to the 
scientific and medical fields to elucidate the chronology of such alterations.  If a training 
threshold could be identified at which autonomic alterations take place, it may greatly impact 
the manner in which exercise training is prescribed to both healthy and diseased populations.  
Additionally, although several investigations have addressed the influence of fitness and 
exercise training on BRS in healthy young and older adults, no study has looked at this 
relationship in an African American population.  Since this population has a greater incidence 
of hypertension relative to Caucasians, it would be of interest to see if their baroreceptors are 
affected differentially.        
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 In conclusion, it appears that both peak aerobic power and endurance exercise training 
influence autonomic control of the CV system.  Additionally, some techniques appear to be 
more sensitive than others in demonstrating relationships between these variables.  
Furthermore, the extent to which peak aerobic power influences autonomic control appears to 
be related the factors including the technique used to assess peak aerobic power and the range 
of fitness levels of the subjects examined, while the extent to which exercise training 
influences autonomic regulation appears to be related to the specifics of the training protocol 
(i.e. length, mode, frequency, intensity, duration).  
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CONSENT FORM 
 
1. Study Title: Time Course of Alterations in Cardiac Autonomic Modulation Induced 
by Endurance Exercise Training 
 
2.   Performance Sites: Huey P. Long Field House, Dept. of Kinesiology, 
Cardiopulmonary Physiology Laboratory, Louisiana State University. 
 
3.   Contacts: The following investigators are available for questions at the telephone 
numbers and email addresses listed below: 
 
 Principal Investigator: 
  
Robert H. Wood, Ph.D.  (225) 578-9142 
 Department of Kinesiology    rwood@lsu.edu 
  
Co-Investigators: 
  
C. Matthew Lee, B.S.   (225) 578-2036 
 Department of Kinesiology  clee11@lsu.edu 
  
Michael Welsch, Ph.D.  (225) 578-9143 
 Department of Kinesiology  mwelsch@lsu.edu 
 
4.   Purpose of the Study: The purpose of this investigation will be to examine the time 
course of EKG changes induced by 2 weeks of exercise training. 
  
5.   Subjects:  
A. Inclusion Criteria: All volunteers will be healthy adults without any overt signs of 
disease such as diabetes, heart disease, high blood pressure, or lung problems. 
B: Exclusion Criteria: Individuals with any current medical problems (including 
those listed above) or infection. Any individual on medication known to affect the 
heart and blood vessels.   
C: Maximum Number of Subjects: A total of 30 volunteers between the ages of 18 
and 30 will be asked to participate in this study.   
 
6.   Study Procedures: The proposed study consists of either 6 or 10 visits to the 
laboratory over a 2-week period.  Each visit is expected to last approximately 60-90 
minutes.   
 
Session one: During this session, the experiment will be explained to the participant 
and written informed consent will be obtained.  The participant will also be asked to 
answer questions regarding his health history and history of physical activity.  The 
participant will be measured for height and weight and body fat percent will be 
estimated using “skin-fold” techniques. The participant will then be asked to lie on an 
examination table while investigators will be collecting EKG data, which will require 
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the placement of three electrodes on the participant’s torso. EKG data will be collected 
for 5-minutes as the participant continues to breathe at a comfortable rate and also 
during a subsequent 5-minute period in which the participant will be asked to breathe 
in such a fashion that they inhale and exhale once every 5 seconds. Lastly, the 
participant will ride a stationary bicycle while the investigators gradually increase the 
resistance against which the participant is working until either the participant asks to 
stop or the investigators determine that the test should be stopped.  Throughout the 
bicycle test the participant will be asked to breathe through a mouthpiece, and the 
investigators will obtain measurements of heart rate and rhythm by analyzing the 
participant’s “EKG” and blood pressure using a standard blood pressure cuff. 
Following this session, participants will be assigned to one of two treatment groups: 
 
Group 1. Will engage in cycling exercise four times per week (Monday, Tuesday, 
Thursday, and Friday) for the subsequent two weeks 
Group 2. Will serve as a control group and be asked not to alter their previous level of 
physical activity for the subsequent two weeks            
 
Participants in both groups will then be asked to report to the laboratory 4 times during 
the subsequent 2 weeks (Monday and Thursday). During these sessions EKG data will 
be collected (as previously described) for 5-minutes as the participant rests in a supine 
position and breathes at a comfortable rate and then during a 5-minute period in which 
the participant will be asked to breathe in such a fashion that they inhale and exhale 
once every 5 seconds. 
Participants in Group 1 will additionally be asked to engage in exercise on a stationary 
bicycle following the EKG collection. Furthermore, Group 1 participants will be asked 
to report to the laboratory on Tuesday and Friday for an identical exercise session. 
This exercise will consist of the participant riding a stationary bicycle for 40-minutes 
which will be divided into three periods described below. 
 
- 5-minutes of cycling with no added resistance. 
- 30-minutes of cycling at an intensity equal to approximately 80-85% of the 
participant’s maximal capacity. 
- 5-minutes of cycling with no added resistance. 
   
Post-testing session: The post-testing session will take place on the following 
Monday. This session will be a replication of session one. 
 
7.   Benefits: Participation in this study may provide a few benefits to the 
participants. These include the health benefits associated with regular physical 
exercise and the acquisition of information regarding the participant’s level of physical 
fitness.  
 
8.   Risks/Discomforts: There is minimal risk associated with the above procedures.  
The risks are as follows: 
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Exercise Testing/Training: The risks of exercise testing and training include 
heightened heart rate and blood pressure, muscle soreness or stiffness, muscle injuries, 
heart attack, stroke, and in rare instances, death.  Studies of exercise testing in healthy 
populations reveal one hospitalization per 187,500 tests (0.001%). 
 
Blood Pressure: There are no real risks associated with the measurement of blood 
pressure.  However, in rare instances some participants report discomfort when having 
blood pressure measured.  Therefore, if the participant desires to stop the blood 
pressure measurement, the cuff will be removed immediately. 
 
9.  Measures Taken to Reduce Risk: The risks in this study will be minimized as a 
result of proper evaluation, education, and appropriate assessment of the responses to 
exercise and the presence of well-trained personnel capable of and experienced in 
monitoring responses to exercise. 
 
10.  Right to Refuse:  Participation in this study is completely voluntary and participants 
may withdraw at any time without penalty.   
 
11.  Privacy: Though the results of this study may be published, the privacy of participants 
will be protected and their identities will remain confidential. All subject records will 
be kept in a locked file located in a secured lab.  The only persons with entry into the 
laboratory will be the investigators.  No publication arising as the result of this 
investigation will indicate the names or identities of the participants. Thus, participant 
data will be kept confidential unless release is legally compelled. 
 
12. Financial Information: There is no monetary cost to participate in this study nor will 
any payment be rendered to participants.  
 
13.  Withdrawal: Participants may voluntarily withdraw from this study at any time 
without penalty. The participant’s records, however, will be kept with those of others 
in a locked file in a secured laboratory. 
 
14.  Removal: Participants may be removed from the study under the investigators 
discretion. Conditions warranting removal from the study include: a) fulfillment of all 
of the study requirements, b) failure of the participant to comply with the requirements 
of the study, and/or c) the participant developing a condition listed in the exclusion 
criteria.   
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 The study has been discussed with me and all my questions have been answered. 
I may direct additional questions regarding study specifics to Robert H. Wood, Ph.D. 
(225) 578-9142. If I have questions about subjects’ rights or other concerns, I can contact 
Robert C. Mathews, Chairman, LSU Institutional Review Board, (225) 578-8692. I agree 
to participate in the study described above and acknowledge the researchers’ obligation 
to provide me with a copy of this consent form if signed by me. 
 
 
____________________________________________________________ 
 Participant’s signature      Date 
 
____________________________________________________________ 
 Witness signature      Date  
 
____________________________________________________________ 
 Investigator’s signature     Date 
 
 
 193 
Appendix C 
 
SAS Programs 
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Program C.1 
 
Program for Independent T-Test on Age and Height 
 
dm ’log;clear;out;clear’; 
data X; 
input group depvar; 
cards; 
 
; 
proc ttest data=X; 
class group; 
var depvar; 
run; 
quit; 
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Program C.2 
 
Program for Repeated Measures ANOVA on Descriptive or Physiological Indices  
 
dm ’log;clear;out;clear’; 
data X; 
input subj group $ pre post; 
cards; 
 
; 
proc glm data=X; 
class group; 
model pre post = group / nouni; 
repeated time 2 (0 1); 
means group; 
run; 
proc means data=X mean std; 
class group; 
var pre post; 
run; 
quit; 
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Program C.3 
 
Program to Test for Simple Effects of Descriptive or Physiological Indices 
 
dm ’log;clear;out;clear’; 
data X; 
infile cards missover; 
input pre post; 
cards; 
 
; 
proc means data=X; 
run; 
Proc glm data=X; 
model pre post =/ nouni; 
repeated time 2 contrast (1) / summary; 
run; 
quit; 
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Program C.4 
 
Program for Repeated Measures ANOVA on HRV or Arterial Pressure During Each Testing 
Session 
 
dm ’log;clear;out;clear’; 
data X; 
input group pb sb tilt after; 
cards; 
 
; 
proc sort data=X; 
by group; 
run; 
proc means data=X mean std; 
by group; 
run; 
proc glm data=X; 
class group; 
model pb sb tilt after = group / nouni; 
repeated time 4 contrast (1) / summary; 
repeated time 4 contrast (2) / summary; 
repeated time 4 contrast (3) / summary; 
run; 
quit; 
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Program C.5 
 
Program to Test for Simple Effects of HRV or Arterial Pressure Variables During Each 
Testing Session 
 
dm ’log;clear;out;clear’; 
data X; 
infile cards missover; 
input cond1-cond4; 
cards; 
 
; 
proc means data=X; 
run; 
proc glm data=X; 
model cond1-cond4 =/ nouni; 
repeated time 4 contrast (1) / summary; 
repeated time 4 contrast (2) / summary; 
repeated time 4 contrast (3) / summary; 
run; 
quit; 
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Program C.6 
 
Program for Repeated Measures ANOVA on HRV or Arterial Pressure Variables During 
Each Condition 
 
dm ’log;clear;out;clear’; 
data X; 
input group T1 T2 T3 T4 T5; 
cards; 
 
; 
proc sort data=X; 
by group; 
run; 
proc means data=X mean std; 
by group; 
run; 
proc glm data=X; 
class group; 
model T1 T2 T3 T4 T5 = group / nouni; 
repeated time 5 contrast (1) / summary; 
run; 
quit; 
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Program C.7 
 
Program to Test for Simple Effects of HRV or Arterial Pressure Variables During Each 
Condition 
 
dm ’log;clear;out;clear’; 
data X; 
infile cards missover; 
input test1-test5; 
cards; 
 
; 
proc means data=X; 
run; 
proc glm data=X; 
model test1-test5 =/ nouni; 
repeated time 5 contrast (1) / summary; 
run; 
quit; 
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ANOVA Tables 
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Table D.1 
 
ANOVA Summary Table for Body Weight 
 
Source 
 
Df Sum of Squares Mean Square F-Value P-Value 
Between subjects 
 
23 46611.98    
  Group (A) 
 
1 652.69 652.69 0.31 0.5818 
  Residual between 
 
22 45959.29 2089.06   
Within subjects 
 
24 19.5    
  Time (B) 
 
1 2.52 2.52 3.84 0.0630 
  A X B Interaction 
 
1 2.52 2.52 3.84 0.0630 
  Residual within 
 
22 14.46 0.6572   
Total 
 
47 46631.48    
 
 
 
Table D.2 
 
ANOVA Summary Table for the Sum of Skinfolds 
 
Source 
 
Df Sum of Squares Mean Square F-Value P-Value 
Between subjects 
 
23 93354.31    
  Group (A) 
 
1 5271.02 5271.02 1.32 0.2635 
  Residual between 
 
22 88083.29 4003.79   
Within subjects 
 
24 1175.5    
  Time (B) 
 
1 256.69 256.69 6.8 0.0161 
  A X B Interaction 
 
1 88.02 88.02 2.33 0.1411 
  Residual within 
 
22 830.79 37.76   
Total 
 
47 94529.81    
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Table D.3 
 
ANOVA Summary Table for Percent Body Fat 
 
Source 
 
Df Sum of Squares Mean Square F-Value P-Value 
Between subjects 
 
23 1507.85    
  Group (A) 
 
1 73.71 73.71 1.13 0.2992 
  Residual between 
 
22 1434.14 65.19   
Within subjects 
 
24 16.36    
  Time (B) 
 
1 4.13 4.13 8.21 0.0090 
  A X B Interaction 
 
1 1.17 1.17 2.32 0.1421 
  Residual within 
 
22 11.06 0.5029   
Total 
 
47 1524.21    
 
 
 
Table D.4 
 
ANOVA Summary Table for the Physical Activity Questionnaire 
 
Source 
 
Df Sum of Squares Mean Square F-Value P-Value 
Between subjects 
 
23 20025703    
  Group (A) 
 
1 12668191.37 12668191.37 37.88 0.0001 
  Residual between 
 
22 7357512.03 334432.37   
Within subjects 
 
24 26745287    
  Time (B) 
 
1 13550253.96 13550253.96 5644.34 0.0001 
  A X B Interaction 
 
1 13142219.09 13142219.09 5474.37 0.0001 
  Residual within 
 
22 52814.99 2400.68   
Total 
 
47 46770990    
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Table D.5 
 
ANOVA Summary Table for VO2 (ml•kg-1•min-1) at Rest 
 
Source 
 
Df Sum of Squares Mean Square F-Value P-Value 
Between subjects 
 
23 103.88    
  Group (A) 
 
1 12.81 12.81 3.10 0.0924 
  Residual between 
 
22 91.07 4.14   
Within subjects 
 
24 39.1    
  Time (B) 
 
1 7.52 7.52 5.24 0.0320 
  A X B Interaction 
 
1 0.03000 0.03000 0.02 0.8863 
  Residual within 
 
22 31.55 1.43   
Total 
 
47 142.98    
 
 
 
Table D.6 
 
ANOVA Summary Table for VO2 (l•min-1) at Rest 
 
Source 
 
Df Sum of Squares Mean Square F-Value P-Value 
Between subjects 
 
23 0.92272    
  Group (A) 
 
1 0.02862 0.0862 0.70 0.4104 
  Residual between 
 
22 0.8941 0.04064   
Within subjects 
 
24 0.254218    
  Time (B) 
 
1 0.04915 0.04915 5.29 0.0313 
  A X B Interaction 
 
1 0.0007680 0.0007680 0.08 0.7764 
  Residual within 
 
22 0.2043 0.009286   
Total 
 
47 1.176938    
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Table D.7 
 
ANOVA Summary Table for VE at Rest 
 
Source 
 
Df Sum of Squares Mean Square F-Value P-Value 
Between subjects 
 
23 590.71    
  Group (A) 
 
1 1.65 1.65 0.06 0.8062 
  Residual between 
 
22 589.06 26.78   
Within subjects 
 
24 138.22    
  Time (B) 
 
1 31.52 31.52 6.58 0.0177 
  A X B Interaction 
 
1 1.30 1.30 0.27 0.6076 
  Residual within 
 
22 105.40 4.79   
Total 
 
47 728.93    
 
 
 
Table D.8 
 
ANOVA Summary Table for RF at Rest 
 
Source 
 
Df Sum of Squares Mean Square F-Value P-Value 
Between subjects 
 
23 682.25    
  Group (A) 
 
1 6.75 6.75 0.22 0.6438 
  Residual between 
 
22 675.50 30.70   
Within subjects 
 
24 213.00    
  Time (B) 
 
1 33.33 33.33 4.37 0.0483 
  A X B Interaction 
 
1 12.00 12.00 1.57 0.2227 
  Residual within 
 
22 167.67 7.62   
Total 
 
47 895.25    
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Table D.9 
 
ANOVA Summary Table for TV at Rest 
 
Source 
 
Df Sum of Squares Mean Square F-Value P-Value 
Between subjects 
 
23 3.1538    
  Group (A) 
 
1 0.001801 0.001801 0.01 0.9118 
  Residual between 
 
22 3.152 0.1433   
Within subjects 
 
24 1.0617    
  Time (B) 
 
1 0.3034 0.3034 8.81 0.0071 
  A X B Interaction 
 
1 0.0004201 0.0004201 0.01 0.9131 
  Residual within 
 
22 0.7579 0.03445   
Total 
 
47 4.2155    
 
 
 
Table D.10 
 
ANOVA Summary Table for VCO2 at Rest 
 
Source 
 
Df Sum of Squares Mean Square F-Value P-Value 
Between subjects 
 
23 0.6754    
  Group (A) 
 
1 0.002700 0.002700 0.09 0.7691 
  Residual between 
 
22 0.6727 0.03058   
Within subjects 
 
24 0.2341    
  Time (B) 
 
1 0.07053 0.07053 9.49 0.0055 
  A X B Interaction 
 
1 0.00000833 0.00000833 0.00 0.9736 
  Residual within 
 
22 0.1636 0.007434   
Total 
 
47 0.9095    
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Table D.11 
 
ANOVA Summary Table for RQ at Rest 
 
Source 
 
Df Sum of Squares Mean Square F-Value P-Value 
Between subjects 
 
23 0.36442    
  Group (A) 
 
1 0.06092 0.06092 4.42 0.0473 
  Residual between 
 
22 0.3035 0.01380   
Within subjects 
 
24 0.1728    
  Time (B) 
 
1 0.005002 0.005002 0.66 0.4247 
  A X B Interaction 
 
1 0.001519 0.001519 0.20 0.6584 
  Residual within 
 
22 0.1663 0.007560   
Total 
 
47 0.5372    
 
 
 
Table D.12 
 
ANOVA Summary Table for Heart Rate at Rest 
 
Source 
 
Df Sum of Squares Mean Square F-Value P-Value 
Between subjects 
 
23 7852.98    
  Group (A) 
 
1 892.69 892.69 2.82 0.1072 
  Residual between 
 
22 6960.29 316.38   
Within subjects 
 
24 1339.5    
  Time (B) 
 
1 17.52 17.52 0.29 0.5931 
  A X B Interaction 
 
1 11.02 11.02 0.18 0.6713 
  Residual within 
 
22 1310.96 59.59   
Total 
 
47 9192.48    
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Table D.13 
 
ANOVA Summary Table for VO2 (ml•kg-1•min-1) During Peak Exercise 
 
Source 
 
Df Sum of Squares Mean Square F-Value P-Value 
Between subjects 
 
23 397.11    
  Group (A) 
 
1 27.30 27.30 1.62 0.2158 
  Residual between 
 
22 369.81 16.81   
Within subjects 
 
24 112.42    
  Time (B) 
 
1 5.60 5.60 1.96 0.1750 
  A X B Interaction 
 
1 44.08 44.08 15.46 0.0007 
  Residual within 
 
22 62.74 2.85   
Total 
 
47 509.53    
 
 
 
Table D.14 
 
ANOVA Summary Table for VO2 (l•min-1) During Peak Exercise 
 
Source 
 
Df Sum of Squares Mean Square F-Value P-Value 
Between subjects 
 
23 10.012    
  Group (A) 
 
1 0.2595 0.2595 0.59 0.4524 
  Residual between 
 
22 9.752 0.4433   
Within subjects 
 
24 0.8163    
  Time (B) 
 
1 0.01972 0.01972 0.83 0.3728 
  A X B Interaction 
 
1 0.2723 0.2723 11.42 0.0027 
  Residual within 
 
22 0.5243 0.0238   
Total 
 
47 10.83    
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Table D.15 
 
ANOVA Summary Table for VE During Peak Exercise 
 
Source 
 
Df Sum of Squares Mean Square F-Value P-Value 
Between subjects 
 
23 19157.9    
  Group (A) 
 
1 1691.00 1691.00 2.13 0.1586 
  Residual between 
 
22 17466.90 793.95   
Within subjects 
 
24 5180.88    
  Time (B) 
 
1 13.13 13.13 0.09 0.7727 
  A X B Interaction 
 
1 1789.74 1789.74 11.66 0.0025 
  Residual within 
 
22 3378.01 153.55   
Total 
 
47 24338.78    
 
 
 
Table D.16 
 
ANOVA Summary Table for RF During Peak Exercise 
 
Source 
 
Df Sum of Squares Mean Square F-Value P-Value 
Between subjects 
 
23 2330.48    
  Group (A) 
 
1 38.52 38.52 0.37 0.5494 
  Residual between 
 
22 2291.96 104.18   
Within subjects 
 
24 463.5    
  Time (B) 
 
1 2.52 2.52 0.13 0.7169 
  A X B Interaction 
 
1 50.02 50.02 2.68 0.1160 
  Residual within 
 
22 410.96 18.68   
Total 
 
47 2793.98    
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Table D.17 
 
ANOVA Summary Table for TV During Peak Exercise 
 
Source 
 
Df Sum of Squares Mean Square F-Value P-Value 
Between subjects 
 
23 18.1144    
  Group (A) 
 
1 0.3144 0.3144 0.39 0.5394 
  Residual between 
 
22 17.80 0.8089   
Within subjects 
 
24 1.553    
  Time (B) 
 
1 0.0002125 0.0002125 0.00 0.9524 
  A X B Interaction 
 
1 0.2729 0.2729 4.68 0.0416 
  Residual within 
 
22 1.28 0.05827   
Total 
 
47 19.6675    
 
 
 
Table D.18 
 
ANOVA Summary Table for VCO2 During Peak Exercise 
 
Source 
 
Df Sum of Squares Mean Square F-Value P-Value 
Between subjects 
 
23 16.487    
  Group (A) 
 
1 0.5970 0.5970 0.83 0.3731 
  Residual between 
 
22 15.89 0.7221   
Within subjects 
 
24 2.735    
  Time (B) 
 
1 0.02516 0.02516 0.30 0.5899 
  A X B Interaction 
 
1 0.8600 0.8600 10.22 0.0042 
  Residual within 
 
22 1.85 0.08411   
Total 
 
47 19.222    
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Table D.19 
 
ANOVA Summary Table for RQ During Peak Exercise 
 
Source 
 
Df Sum of Squares Mean Square F-Value P-Value 
Between subjects 
 
23 0.1923    
  Group (A) 
 
1 0.001519 0.001519 0.18 0.6796 
  Residual between 
 
22 0.1908 0.008672   
Within subjects 
 
24 0.08715    
  Time (B) 
 
1 0.0002521 0.0002521 0.07 0.7971 
  A X B Interaction 
 
1 0.005002 0.005002 1.34 0.2588 
  Residual within 
 
22 0.08190 0.003723   
Total 
 
47 0.2795    
 
 
 
Table D.20 
 
ANOVA Summary Table for Heart Rate During Peak Exercise 
 
Source 
 
Df Sum of Squares Mean Square F-Value P-Value 
Between subjects 
 
23 3730.31    
  Group (A) 
 
1 275.52 275.52 1.75 0.1989 
  Residual between 
 
22 3454.79 157.04   
Within subjects 
 
24 583.5    
  Time (B) 
 
1 6.02 6.02 0.24 0.6281 
  A X B Interaction 
 
1 28.52 28.52 1.14 0.2966 
  Residual within 
 
22 548.96 24.95   
Total 
 
47 4313.81    
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Table D.21 
 
ANOVA Summary Table for the Mean RR Interval During Test 1 
 
Source 
 
Df Sum of Squares Mean Square F-Value P-Value 
Between subjects 
 
23 1318503.64    
  Group (A) 
 
1 81718.59 81718.59   
  Residual between 
 
22 1236785.05 56217.50 1.45 0.2408 
Within subjects 
 
72 1266651.98    
  Time (B) 
 
3         1003900.70 334633.57 95.51 0.0001 
  A X B Interaction 
 
3 31509.94 10503.31 3.00 0.0368 
  Residual within 
 
66 231241.34 3503.66   
Total 
 
95 2585155.62    
 
 
 
Table D.22 
 
ANOVA Summary Table for SDNN During Test 1 
 
Source 
 
Df Sum of Squares Mean Square F-Value P-Value 
Between subjects 
 
23 54638.01    
  Group (A) 
 
1 1195.75 1195.75 0.49 0.4903 
  Residual between 
 
22 53442.26 2429.19   
Within subjects 
 
72 22094.69    
  Time (B) 
 
3   6240.19 2080.06 9.12 0.0001 
  A X B Interaction 
 
3 800.24 266.75 1.17 0.3281 
  Residual within 
 
66 15054.26 228.09   
Total 
 
95 76732.7    
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Table D.23 
 
ANOVA Summary Table for lnTP During Test 1. 
 
Source 
 
Df Sum of Squares Mean Square F-Value P-Value 
Between subjects 
 
23 46.04    
  Group (A) 
 
1 2.0796 2.0796 1.04 0.3187 
  Residual between 
 
22 43.96 1.998   
Within subjects 
 
72 23.94    
  Time (B) 
 
3         4.782 1.594 5.67 0.0016 
  A X B Interaction 
 
3 0.61723 0.2057 0.73 0.5363 
  Residual within 
 
66 18.54 0.2809   
Total 
 
95 69.98    
 
 
 
Table D.24 
 
ANOVA Summary Table for lnLF During Test 1 
 
Source 
 
Df Sum of Squares Mean Square F-Value P-Value 
Between subjects 
 
23 40.92    
  Group (A) 
 
1 0.5092 0.5092 0.28 0.6038 
  Residual between 
 
22 40.413 1.837   
Within subjects 
 
72 34.31    
  Time (B) 
 
3         1.762 0.5872 1.24 0.3021 
  A X B Interaction 
 
3 1.309 0.4364 0.92 0.4352 
  Residual within 
 
66 31.24 0.4733   
Total 
 
95 75.23    
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Table D.25 
 
ANOVA Summary Table for lnHF During Test 1 
 
Source 
 
Df Sum of Squares Mean Square F-Value P-Value 
Between subjects 
 
23 53.87    
  Group (A) 
 
1 2.510 2.510 1.07 0.3111 
  Residual between 
 
22 51.36 2.335   
Within subjects 
 
72 77.88    
  Time (B) 
 
3         73.17 24.39 60.28 0.0001 
  A X B Interaction 
 
3 2.011 0.6703 1.66 0.1848 
  Residual within 
 
66 26.70 0.4046   
Total 
 
95 131.75    
 
 
 
Table D.26 
 
ANOVA Summary Table for lnLF/lnHF During Test 1 
 
Source 
 
Df Sum of Squares Mean Square F-Value P-Value 
Between subjects 
 
23 0.8655    
  Group (A) 
 
1 0.0277 0.0277 0.73 0.4027 
  Residual between 
 
22 0.8378 0.0381   
Within subjects 
 
72 5.59    
  Time (B) 
 
3         4.001 1.333 56.02 0.0001 
  A X B Interaction 
 
3 0.01596 0.005318 0.22 0.8798 
  Residual within 
 
66 1.5716 0.02381   
Total 
 
95 6.45    
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Table D.27 
 
ANOVA Summary Table for lnLFNU During Test 1 
 
Source 
 
Df Sum of Squares Mean Square F-Value P-Value 
Between subjects 
 
23 4.615    
  Group (A) 
 
1 0.1822 0.1822 0.90 0.3520 
  Residual between 
 
22 4.4328 0.2015   
Within subjects 
 
72 18.25    
  Time (B) 
 
3         11.95 3.984 42.48 0.0001 
  A X B Interaction 
 
3 0.1074 0.0358 0.38 0.7664 
  Residual within 
 
66 6.1903 0.09379   
Total 
 
95 22.86    
 
 
 
Table D.28 
 
ANOVA Summary Table for lnHFNU During Test 1 
 
Source 
 
Df Sum of Squares Mean Square F-Value P-Value 
Between subjects 
 
23 7.569    
  Group (A) 
 
1 0.1969 0.1969 0.59 0.4515 
  Residual between 
 
22 7.372 0.3351   
Within subjects 
 
72 47.81    
  Time (B) 
 
3         34.19 11.40 55.78 0.0001 
  A X B Interaction 
 
3 0.1399 0.04667 0.23 0.8763 
  Residual within 
 
66 13.48 0.2043   
Total 
 
95 55.38    
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Table D.29 
 
ANOVA Summary Table for lnHF/lnTP During Test 1 
 
Source 
 
Df Sum of Squares Mean Square F-Value P-Value 
Between subjects 
 
23 0.2784    
  Group (A) 
 
1 0.002326 0.002326 0.19 0.6710 
  Residual between 
 
22 0.2761 0.01255   
Within subjects 
 
72 1.308    
  Time (B) 
 
3         0.9426 0.3142 59.13 0.0001 
  A X B Interaction 
 
3 0.01502 0.005005 0.94 0.4255 
  Residual within 
 
66 0.3507 0.005314   
Total 
 
95 1.587    
 
 
 
Table D.30 
 
ANOVA Summary Table for the Mean RR Interval During Test 2 
 
Source 
 
Df Sum of Squares Mean Square F-Value P-Value 
Between subjects 
 
23 1143664.0    
  Group (A) 
 
1 115492.73 115492.73 2.47 0.1302 
  Residual between 
 
22 1028171.35 46735.06   
Within subjects 
 
72 1414509.0    
  Time (B) 
 
3         1144857.07 381619.02 97.62 0.0001 
  A X B Interaction 
 
3 11652.49 3884.16 0.99 0.4014 
  Residual within 
 
66 257999.55 3909.08   
Total 
 
95 2558173.1    
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Table D.31 
 
ANOVA Summary Table for SDNN During Test 2 
 
Source 
 
Df Sum of Squares Mean Square F-Value P-Value 
Between subjects 
 
23 55689.57    
  Group (A) 
 
1 144.72 144.72 0.06 0.8130 
  Residual between 
 
22 55544.85 2524.77   
Within subjects 
 
72 34149.43    
  Time (B) 
 
3         11459.33 3819.78 11.80 0.0001 
  A X B Interaction 
 
3 1320.97 440.32 1.36 0.2627 
  Residual within 
 
66 21369.13 323.77   
Total 
 
95 89839.00    
 
 
 
Table D.32 
 
ANOVA Summary Table for lnTP During Test 2 
 
Source 
 
Df Sum of Squares Mean Square F-Value P-Value 
Between subjects 
 
23 30.72    
  Group (A) 
 
1 0.08687 0.08687 0.06 0.8051 
  Residual between 
 
22 30.63 1.39   
Within subjects 
 
72 34.85    
  Time (B) 
 
3         9.80 3.267 8.84 0.0001 
  A X B Interaction 
 
3 0.6488 0.2163 0.59 0.6269 
  Residual within 
 
66 24.40 0.3697   
Total 
 
95 65.57    
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Table D.33 
 
ANOVA Summary Table for lnLF During Test 2 
 
Source 
 
Df Sum of Squares Mean Square F-Value P-Value 
Between subjects 
 
23 38.11    
  Group (A) 
 
1 0.002808 0.002808 0.00 0.9682 
  Residual between 
 
22 38.11 1.73   
Within subjects 
 
72 40.50    
  Time (B) 
 
3         10.51 3.504 7.81 0.0002 
  A X B Interaction 
 
3 0.3799 0.1266 0.28 0.8381 
  Residual within 
 
66 29.61 0.4487   
Total 
 
95 78.61    
 
 
 
Table D.34 
 
ANOVA Summary Table for lnHF During Test 2 
 
Source 
 
Df Sum of Squares Mean Square F-Value P-Value 
Between subjects 
 
23 55.09    
  Group (A) 
 
1 0.9832 0.9832 0.40 0.5337 
  Residual between 
 
22 54.11 2.459   
Within subjects 
 
72 122.85    
  Time (B) 
 
3         88.52 29.51 58.04 0.0001 
  A X B Interaction 
 
3 0.7739 0.2580 0.51 0.6785 
  Residual within 
 
66 33.56 0.5084   
Total 
 
95 177.95    
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Table D.35 
 
ANOVA Summary Table for lnLF/lnHF During Test 2 
 
Source 
 
Df Sum of Squares Mean Square F-Value P-Value 
Between subjects 
 
23 1.023    
  Group (A) 
 
1 0.01837 0.01837 0.40 0.5326 
  Residual between 
 
22 1.005 0.04568   
Within subjects 
 
72 5.65    
  Time (B) 
 
3         4.012 1.337 55.68 0.0001 
  A X B Interaction 
 
3 0.0496 0.01654 0.69 0.5623 
  Residual within 
 
66 1.59 0.024   
Total 
 
95 6.675    
 
 
 
Table D.36 
 
ANOVA Summary Table for lnLFNU During Test 2 
 
Source 
 
Df Sum of Squares Mean Square F-Value P-Value 
Between subjects 
 
23 6.844    
  Group (A) 
 
1 0.2842 0.2842 0.95 0.3397 
  Residual between 
 
22 6.56 0.2984   
Within subjects 
 
72 24.09    
  Time (B) 
 
3         16.48 5.49 48.39 0.0001 
  A X B Interaction 
 
3 0.1225 0.04083 0.36 0.7823 
  Residual within 
 
66 7.492 0.1135   
Total 
 
95 30.94    
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Table D.37 
 
ANOVA Summary Table for lnHFNU During Test 2 
 
Source 
 
Df Sum of Squares Mean Square F-Value P-Value 
Between subjects 
 
23 6.619    
  Group (A) 
 
1 0.1644 0.1644 0.56 0.4621 
  Residual between 
 
22 6.455 0.2934   
Within subjects 
 
72 38.60    
  Time (B) 
 
3         28.34 9.45 62.18 0.0001 
  A X B Interaction 
 
3 0.2305 0.0768 0.51 0.6797 
  Residual within 
 
66 10.03 0.1519   
Total 
 
95 45.22    
 
 
 
Table D.38 
 
ANOVA Summary Table for lnHF/lnTP During Test 2 
 
Source 
 
Df Sum of Squares Mean Square F-Value P-Value 
Between subjects 
 
23 0.2846    
  Group (A) 
 
1 0.0109 0.0109 0.87 0.3603 
  Residual between 
 
22 0.2737 0.01244   
Within subjects 
 
72 1.29    
  Time (B) 
 
3         0.9918 0.3306 74.15 0.0001 
  A X B Interaction 
 
3 0.00499 0.00166 0.37 0.7727 
  Residual within 
 
66 0.2943 0.004459   
Total 
 
95 1.58    
 
 
 
 221 
Table D.39 
 
ANOVA Summary Table for the Mean RR Interval During Test 3 
 
Source 
 
Df Sum of Squares Mean Square F-Value P-Value 
Between subjects 
 
23 1142226.9    
  Group (A) 
 
1 85346.03 85346.03 1.78 0.1962 
  Residual between 
 
22 1056880.99 48040.05   
Within subjects 
 
72 1481470.0    
  Time (B) 
 
3         1170211.05 390070.35 87.00 0.0001 
  A X B Interaction 
 
3 15329.75 5109.92 1.14 0.3396 
  Residual within 
 
66 295929.28 4483.78   
Total 
 
95 2623697.0    
 
 
 
Table D.40 
 
ANOVA Summary Table for SDNN During Test 3 
 
Source 
 
Df Sum of Squares Mean Square F-Value P-Value 
Between subjects 
 
23 57036.66    
  Group (A) 
 
1 508.81 508.81 0.20 0.6607 
  Residual between 
 
22 56527.85 2569.45   
Within subjects 
 
72 48383.97    
  Time (B) 
 
3         7568.93 2522.98 4.16 0.0092 
  A X B Interaction 
 
3 789.39 263.13 0.43 0.7294 
  Residual within 
 
66 40025.65 606.45   
Total 
 
95 105420.63    
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Table D.41 
 
ANOVA Summary Table for lnTP During Test 3 
 
Source 
 
Df Sum of Squares Mean Square F-Value P-Value 
Between subjects 
 
23 48.92    
  Group (A) 
 
1 0.08667 0.08667 0.04 0.8452 
  Residual between 
 
22 48.83 2.22   
Within subjects 
 
72 32.88    
  Time (B) 
 
3         2.339 0.7798 1.71 0.1743 
  A X B Interaction 
 
3 0.3687 0.1229 0.27 0.8476 
  Residual within 
 
66 30.17 0.4570   
Total 
 
95 81.79    
 
 
 
Table D.42 
 
ANOVA Summary Table for lnLF During Test 3 
 
Source 
 
Df Sum of Squares Mean Square F-Value P-Value 
Between subjects 
 
23 55.36    
  Group (A) 
 
1 0.01563 0.01563 0.01 0.9379 
  Residual between 
 
22 55.34 2.52   
Within subjects 
 
72 39.25    
  Time (B) 
 
3         3.848 1.2827 2.39 0.0763 
  A X B Interaction 
 
3 0.02298 0.00766 0.01 0.9976 
  Residual within 
 
66 35.38 0.5361   
Total 
 
95 94.61    
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Table D.43 
 
ANOVA Summary Table for lnHF During Test 3 
 
Source 
 
Df Sum of Squares Mean Square F-Value P-Value 
Between subjects 
 
23 90.65    
  Group (A) 
 
1 0.02683 0.02683 0.01 0.9364 
  Residual between 
 
22 90.62 4.12   
Within subjects 
 
72 115.12    
  Time (B) 
 
3         79.21 26.40 51.62 0.0001 
  A X B Interaction 
 
3 2.15 0.7164 1.40 0.2505 
  Residual within 
 
66 33.76 0.5115   
Total 
 
95 205.77    
 
 
 
Table D.44 
 
ANOVA Summary Table for lnLF/lnHF During Test 3 
 
Source 
 
Df Sum of Squares Mean Square F-Value P-Value 
Between subjects 
 
23 0.9463    
  Group (A) 
 
1 0.00001534 0.00001534 0.00 0.9851 
  Residual between 
 
22 0.9463 0.04301   
Within subjects 
 
72 6.60    
  Time (B) 
 
3         4.68 1.56 60.65 0.0001 
  A X B Interaction 
 
3 0.2156 0.0719 2.79 0.0470 
  Residual within 
 
66 1.70 0.02572   
Total 
 
95 7.54    
 
 
 
 224 
Table D.45 
 
ANOVA Summary Table for lnLFNU During Test 3 
 
Source 
 
Df Sum of Squares Mean Square F-Value P-Value 
Between subjects 
 
23 6.32    
  Group (A) 
 
1 0.1395 0.1395 0.50 0.4882 
  Residual between 
 
22 6.18 0.2807   
Within subjects 
 
72 22.46    
  Time (B) 
 
3         15.03 5.010 45.63 0.0001 
  A X B Interaction 
 
3 0.1799 0.05995 0.55 0.6525 
  Residual within 
 
66 7.2455 0.1098   
Total 
 
95 28.77    
 
 
 
Table D.46 
 
ANOVA Summary Table for lnHFNU During Test 3 
 
Source 
 
Df Sum of Squares Mean Square F-Value P-Value 
Between subjects 
 
23 7.679    
  Group (A) 
 
1 0.007168 0.007168 0.02 0.8873 
  Residual between 
 
22 7.672 0.3487   
Within subjects 
 
72 50.98    
  Time (B) 
 
3         37.88 12.63 60.76 0.0001 
  A X B Interaction 
 
3 1.16 0.3878 2.14 0.1032 
  Residual within 
 
66 11.94 0.1810   
Total 
 
95 58.66    
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Table D.47 
 
ANOVA Summary Table for lnHF/lnTP During Test 3 
 
Source 
 
Df Sum of Squares Mean Square F-Value P-Value 
Between subjects 
 
23 0.3664    
  Group (A) 
 
1 0.002419 0.002419 0.15 0.7059 
  Residual between 
 
22 0.3640 0.01655   
Within subjects 
 
72 1.38    
  Time (B) 
 
3         1.083 0.3609 87.92 0.0001 
  A X B Interaction 
 
3 0.02760 0.009199 2.24 0.0916 
  Residual within 
 
66 0.2709 0.004105   
Total 
 
95 1.75    
 
 
 
Table D.48 
 
ANOVA Summary Table for the Mean RR Interval During Test 4 
 
Source 
 
Df Sum of Squares Mean Square F-Value P-Value 
Between subjects 
 
23 1661740.8    
  Group (A) 
 
1 9341.96 9341.96 0.12 0.7277 
  Residual between 
 
22 1652398.84 75109.04   
Within subjects 
 
72 1350896.3    
  Time (B) 
 
3         1108992.51 369664.17 105.24 0.0001 
  A X B Interaction 
 
3 10068.51 3356.17 0.96 0.4191 
  Residual within 
 
66 231835.28 3512.66   
Total 
 
95 3012637.1    
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Table D.49 
 
ANOVA Summary Table for SDNN During Test 4 
 
Source 
 
Df Sum of Squares Mean Square F-Value P-Value 
Between subjects 
 
23 64467.1    
  Group (A) 
 
1 624.24 624.24 0.22 0.6473 
  Residual between 
 
22 63842.86 2901.95   
Within subjects 
 
72 40246.63    
  Time (B) 
 
3         8275.23 2758.41 5.87 0.0013 
  A X B Interaction 
 
3 960.20 320.07 0.68 0.5667 
  Residual within 
 
66 31011.20 469.87   
Total 
 
95 104713.73    
 
 
 
Table D.50 
 
ANOVA Summary Table for lnTP During Test 4 
 
Source 
 
Df Sum of Squares Mean Square F-Value P-Value 
Between subjects 
 
23 39.53    
  Group (A) 
 
1 0.02851 0.02851 0.02 0.9009 
  Residual between 
 
22 39.50 1.80   
Within subjects 
 
72 28.05    
  Time (B) 
 
3         4.519 1.506 4.31 0.0077 
  A X B Interaction 
 
3 0.4717 0.1572 0.45 0.7182 
  Residual within 
 
66 23.06 0.3494   
Total 
 
95 67.58    
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Table D.51 
 
ANOVA Summary Table for lnLF During Test 4 
 
Source 
 
Df Sum of Squares Mean Square F-Value P-Value 
Between subjects 
 
23 49.29    
  Group (A) 
 
1 0.1431 0.1431 0.06 0.8026 
  Residual between 
 
22 49.15 2.23   
Within subjects 
 
72 36.98    
  Time (B) 
 
3         7.327 2.44 5.50 0.0020 
  A X B Interaction 
 
3 0.3491 0.1164 0.26 0.8524 
  Residual within 
 
66 29.30 0.4439   
Total 
 
95 86.27    
 
 
 
Table D.52 
 
ANOVA Summary Table for lnHF During Test 4 
 
Source 
 
Df Sum of Squares Mean Square F-Value P-Value 
Between subjects 
 
23 73.53    
  Group (A) 
 
1 0.6326 0.6326 0.19 0.6664 
  Residual between 
 
22 72.90 3.31   
Within subjects 
 
72 126.16    
  Time (B) 
 
3         78.13 26.04 36.55 0.0001 
  A X B Interaction 
 
3 0.9999 0.3333 0.47 0.7058 
  Residual within 
 
66 47.03 0.7126   
Total 
 
95 199.69    
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Table D.53 
 
ANOVA Summary Table for lnLF/lnHF During Test 4 
 
Source 
 
Df Sum of Squares Mean Square F-Value P-Value 
Between subjects 
 
23 1.40    
  Group (A) 
 
1 0.08555 0.08555 1.44 0.2429 
  Residual between 
 
22 1.31 0.0594   
Within subjects 
 
72 6.618    
  Time (B) 
 
3         4.26 1.419 39.94 0.0001 
  A X B Interaction 
 
3 0.01248 0.004159 0.12 0.9498 
  Residual within 
 
66 2.346 0.03554   
Total 
 
95 8.01    
 
 
 
Table D.54 
 
ANOVA Summary Table for lnLFNU During Test 4 
 
Source 
 
Df Sum of Squares Mean Square F-Value P-Value 
Between subjects 
 
23 8.42    
  Group (A) 
 
1 0.2476 0.2476 0.67 0.4228 
  Residual between 
 
22 8.17 0.3711   
Within subjects 
 
72 27.79    
  Time (B) 
 
3         16.24 5.413 31.25 0.0001 
  A X B Interaction 
 
3 0.1230 0.04101 0.24 0.8704 
  Residual within 
 
66 11.43 0.1732   
Total 
 
95 36.21    
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Table D.55 
 
ANOVA Summary Table for lnHFNU During Test 4 
 
Source 
 
Df Sum of Squares Mean Square F-Value P-Value 
Between subjects 
 
23 9.45    
  Group (A) 
 
1 0.4569 0.4569 1.12 0.3019 
  Residual between 
 
22 8.994 0.4088   
Within subjects 
 
72 44.01    
  Time (B) 
 
3         29.31 9.77 44.15 0.0001 
  A X B Interaction 
 
3 0.08562 0.02854 0.13 0.9426 
  Residual within 
 
66 14.61 0.2213   
Total 
 
95 53.46    
 
 
 
Table D.56 
 
ANOVA Summary Table for lnHF/lnTP During Test 4 
 
Source 
 
Df Sum of Squares Mean Square F-Value P-Value 
Between subjects 
 
23 0.341    
  Group (A) 
 
1 0.01628 0.01628 1.10 0.3050 
  Residual between 
 
22 0.3248 0.01476   
Within subjects 
 
72 1.53    
  Time (B) 
 
3         0.9906 0.3302 41.28 0.0001 
  A X B Interaction 
 
3 0.006508 0.002169 0.27 0.8459 
  Residual within 
 
66 0.5279 0.007999   
Total 
 
95 1.87    
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Table D.57 
 
ANOVA Summary Table for the Mean RR Interval During Test 5 
 
Source 
 
Df Sum of Squares Mean Square F-Value P-Value 
Between subjects 
 
23 1486607.4    
  Group (A) 
 
1 48732.39 48732.39 0.75 0.3972 
  Residual between 
 
22 1437875.04 65357.96   
Within subjects 
 
72 1553676.8    
  Time (B) 
 
3         1089171.41 363057.14 54.74 0.0001 
  A X B Interaction 
 
3 26769.76 8923.25 1.35 0.2672 
  Residual within 
 
66 437735.68 6632.36   
Total 
 
95 3040284.2    
 
 
 
Table D.58 
 
ANOVA Summary Table for SDNN During Test 5 
 
Source 
 
Df Sum of Squares Mean Square F-Value P-Value 
Between subjects 
 
23 68118.05    
  Group (A) 
 
1 578.05 578.05 0.19 0.6686 
  Residual between 
 
22 67540.20 3070.01   
Within subjects 
 
72 57947.49    
  Time (B) 
 
3         8550.72 2850.24 3.92 0.0123 
  A X B Interaction 
 
3 1378.42 549.47 0.63 0.5973 
  Residual within 
 
66 48018.35 727.55   
Total 
 
95 126065.54    
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Table D.59 
 
ANOVA Summary Table for lnTP During Test 5 
 
Source 
 
Df Sum of Squares Mean Square F-Value P-Value 
Between subjects 
 
23 39.07    
  Group (A) 
 
1 0.6221 0.6221 0.36 0.5568 
  Residual between 
 
22 38.45 1.75   
Within subjects 
 
72 22.88    
  Time (B) 
 
3         4.27 1.42 5.34 0.0024 
  A X B Interaction 
 
3 1.005 0.3350 1.26 0.2967 
  Residual within 
 
66 17.60 0.2667   
Total 
 
95 61.95    
 
 
 
Table D.60 
 
ANOVA Summary Table for lnLF During Test 5 
 
Source 
 
Df Sum of Squares Mean Square F-Value P-Value 
Between subjects 
 
23 43.90    
  Group (A) 
 
1 1.305 1.305 0.67 0.4205 
  Residual between 
 
22 42.59 1.94   
Within subjects 
 
72 28.26    
  Time (B) 
 
3  4.304 1.435 4.05 0.0105 
  A X B Interaction 
 
3 0.6066 0.2022 0.57 0.6358 
  Residual within 
 
66 23.35 0.3538   
Total 
 
95 72.16    
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Table D.61 
 
ANOVA Summary Table for lnHF During Test 5 
 
Source 
 
Df Sum of Squares Mean Square F-Value P-Value 
Between subjects 
 
23 50.74    
  Group (A) 
 
1 0.2840 0.2840 0.12 0.7283 
  Residual between 
 
22 50.46 2.294   
Within subjects 
 
72 73.14    
  Time (B) 
 
3         62.33 20.78 44.20 0.0001 
  A X B Interaction 
 
3 9.79 3.26 6.94 0.0004 
  Residual within 
 
66 31.02 0.4700   
Total 
 
95 123.88    
 
 
 
Table D.62 
 
ANOVA Summary Table for lnLF/lnHF During Test 5 
 
Source 
 
Df Sum of Squares Mean Square F-Value P-Value 
Between subjects 
 
23 0.767    
  Group (A) 
 
1 0.09991 0.09991 3.30 0.0831 
  Residual between 
 
22 0.6669 0.0303   
Within subjects 
 
72 3.73    
  Time (B) 
 
3         2.218 0.7394 47.55 0.0001 
  A X B Interaction 
 
3 0.4849 0.1616 10.39 0.0001 
  Residual within 
 
66 1.0262 0.01555   
Total 
 
95 4.50    
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Table D.63 
 
ANOVA Summary Table for lnLFNU During Test 5 
 
Source 
 
Df Sum of Squares Mean Square F-Value P-Value 
Between subjects 
 
23 7.53    
  Group (A) 
 
1 0.4956 0.4956 1.55 0.2261 
  Residual between 
 
22 7.0309 0.3196   
Within subjects 
 
72 29.48    
  Time (B) 
 
3         16.82 5.608 33.66 0.0001 
  A X B Interaction 
 
3 1.6663 0.5554 3.33 0.0246 
  Residual within 
 
66 10.996 0.1666   
Total 
 
95 37.01    
 
 
 
Table D.64 
 
ANOVA Summary Table for lnHFNU During Test 5 
 
Source 
 
Df Sum of Squares Mean Square F-Value P-Value 
Between subjects 
 
23 7.08    
  Group (A) 
 
1 0.9432 0.9432 3.38 0.0796 
  Residual between 
 
22 6.14 0.2791   
Within subjects 
 
72 32.55    
  Time (B) 
 
3         18.67 6.225 41.46 0.0001 
  A X B Interaction 
 
3 3.968 1.323 8.81 0.0001 
  Residual within 
 
66 9.9098 0.1501   
Total 
 
95 39.63    
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Table D.65 
 
ANOVA Summary Table for lnHF/lnTP During Test 5 
 
Source 
 
Df Sum of Squares Mean Square F-Value P-Value 
Between subjects 
 
23 0.2351    
  Group (A) 
 
1 0.02448 0.02448 2.56 0.1240 
  Residual between 
 
22 0.2106 0.009571   
Within subjects 
 
72 1.25    
  Time (B) 
 
3         0.7404 0.2468 42.80 0.0001 
  A X B Interaction 
 
3 0.1247 0.04158 7.21 0.0003 
  Residual within 
 
66 0.3806 0.005767   
Total 
 
95 1.48    
 
 
 
Table D.66  
 
ANOVA Summary Table for SBP During Test 1 
 
Source 
 
Df Sum of Squares Mean Square F-Value P-Value 
Between subjects 
 
23 10216.96    
  Group (A) 
 
1 135.38 135.38 0.30 0.5922 
  Residual between 
 
22 10081.58 458.25   
Within subjects 
 
72 2069.01    
  Time (B) 
 
3         81.46 27.15 0.91 0.4392 
  A X B Interaction 
 
3 26.13 8.71 0.29 0.8303 
  Residual within 
 
66 1961.42 29.72   
Total 
 
95 12285.97    
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Table D.67 
 
ANOVA Summary Table for DBP During Test 1 
 
Source 
 
Df Sum of Squares Mean Square F-Value P-Value 
Between subjects 
 
23 2688.96    
  Group (A) 
 
1 210.04 210.04 1.86 0.1860 
  Residual between 
 
22 2478.92 112.68   
Within subjects 
 
72 3875.01    
  Time (B) 
 
3         2236.46 745.49 30.16 0.0001 
  A X B Interaction 
 
3 7.13 2.38 0.10 0.9619 
  Residual within 
 
66 1631.42 24.72   
Total 
 
95 6563.97    
 
 
 
Table D.68 
 
ANOVA Summary Table for MAP During Test 1 
 
Source 
 
Df Sum of Squares Mean Square F-Value P-Value 
Between subjects 
 
23 2827.63    
  Group (A) 
 
1 183.36 183.36 1.53 0.2298 
  Residual between 
 
22 2644.27 120.19   
Within subjects 
 
72 2077.31    
  Time (B) 
 
3         849.77 283.26 15.30 0.0001 
  A X B Interaction 
 
3 6.01 2.00 0.11 0.9550 
  Residual within 
 
66 1221.53 18.51   
Total 
 
95 4904.94    
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Table D.69 
 
ANOVA Summary Table for SBP During Test 2 
 
Source 
 
Df Sum of Squares Mean Square F-Value P-Value 
Between subjects 
 
23 7619.62    
  Group (A) 
 
1 222.04 222.04 0.66 0.4251 
  Residual between 
 
22 7397.58 336.25   
Within subjects 
 
72 2415.0    
  Time (B) 
 
3         505.13 168.38 5.92 0.0012 
  A X B Interaction 
 
3 33.79 11.26 0.40 0.7561 
  Residual within 
 
66 1876.08 28.43   
Total 
 
95 10034.62    
 
 
 
Table D.70 
 
ANOVA Summary Table for DBP During Test 2 
 
Source 
 
Df Sum of Squares Mean Square F-Value P-Value 
Between subjects 
 
23 3638.0    
  Group (A) 
 
1 216.00 216.00 1.39 0.2512 
  Residual between 
 
22 3422.00 155.55   
Within subjects 
 
72 7258.67    
  Time (B) 
 
3         2960.67 986.89 50.18 0.0001 
  A X B Interaction 
 
3 39.33 13.11 0.67 0.5755 
  Residual within 
 
66 1298.00 19.67   
Total 
 
95 10896.67    
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Table D.71 
 
ANOVA Summary Table for MAP During Test 2 
 
Source 
 
Df Sum of Squares Mean Square F-Value P-Value 
Between subjects 
 
23 3848.08    
  Group (A) 
 
1 218.00 218.00 1.32 0.2627 
  Residual between 
 
22 3630.08 165.00   
Within subjects 
 
72 1820.11    
  Time (B) 
 
3         851.59 283.86 19.87 0.0001 
  A X B Interaction 
 
3 25.47 8.49 0.59 0.6211 
  Residual within 
 
66 943.05 14.29   
Total 
 
95 5668.19    
 
 
 
Table D.72 
 
ANOVA Summary Table for SBP During Test 3 
 
Source 
 
Df Sum of Squares Mean Square F-Value P-Value 
Between subjects 
 
23 9685.34    
  Group (A) 
 
1 416.67 416.67 0.99 0.3308 
  Residual between 
 
22 9268.67 421.3   
Within subjects 
 
72 2002.0    
  Time (B) 
 
3         33.33 11.11 0.38 0.7678 
  A X B Interaction 
 
3 38.67 12.89 0.44 0.7246 
  Residual within 
 
66 1930.00 24.24   
Total 
 
95 11687.34    
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Table D.73 
 
ANOVA Summary Table for DBP During Test 3 
 
Source 
 
Df Sum of Squares Mean Square F-Value P-Value 
Between subjects 
 
23 3397.84    
  Group (A) 
 
1 42.67 42.67 0.28 0.6022 
  Residual between 
 
22 3355.17 152.51   
Within subjects 
 
72 4150.0    
  Time (B) 
 
3         2983.50 994.50 59.30 0.0001 
  A X B Interaction 
 
3 59.67 19.89 1.19 0.3219 
  Residual within 
 
66 1106.83 16.77   
Total 
 
95 7547.84    
 
 
 
Table D.74 
 
ANOVA Summary Table for MAP During Test 3 
 
Source 
 
Df Sum of Squares Mean Square F-Value P-Value 
Between subjects 
 
23 4643.15    
  Group (A) 
 
1 124.42 124.42 0.61 0.4447 
  Residual between 
 
22 4518.73 205.40   
Within subjects 
 
72 2015.87    
  Time (B) 
 
3         1255.50 418.50 38.45 0.0001 
  A X B Interaction 
 
3 41.94 13.98 1.28 0.2871 
  Residual within 
 
66 718.43 10.89   
Total 
 
95 6659.02    
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Table D.75 
 
ANOVA Summary Table for SBP During Test 4 
 
Source 
 
Df Sum of Squares Mean Square F-Value P-Value 
Between subjects 
 
23 9546.96    
  Group (A) 
 
1 84.38 84.38 0.20 0.6622 
  Residual between 
 
22 9462.58 430.12   
Within subjects 
 
72 2891.0    
  Time (B) 
 
3         86.79 28.93 0.71 0.5516 
  A X B Interaction 
 
3 101.13 33.71 0.82 0.4858 
  Residual within 
 
66 2703.08 40.96   
Total 
 
95 12437.96    
 
 
 
Table D.76 
 
ANOVA Summary Table for DBP During Test 4 
 
Source 
 
Df Sum of Squares Mean Square F-Value P-Value 
Between subjects 
 
23 4121.34    
  Group (A) 
 
1 28.17 28.17 0.15 0.7010 
  Residual between 
 
22 4093.17 186.05   
Within subjects 
 
72 3772.0    
  Time (B) 
 
3         2735.67 911.89 58.57 0.0001 
  A X B Interaction 
 
3 8.83 2.94 0.19 0.9034 
  Residual within 
 
66 1027.50 15.57   
Total 
 
95 7893.34    
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Table D.77 
 
ANOVA Summary Table for MAP During Test 4 
 
Source 
 
Df Sum of Squares Mean Square F-Value P-Value 
Between subjects 
 
23 4523.22    
  Group (A) 
 
1 43.54 43.54 0.21 0.6483 
  Residual between 
 
22 4479.68 203.62   
Within subjects 
 
72 2044.91    
  Time (B) 
 
3         1149.18 383.06 28.30 0.0001 
  A X B Interaction 
 
3 2.45 0.8154 0.06 0.9805 
  Residual within 
 
66 893.28 13.53   
Total 
 
95 6568.13    
 
 
 
Table D.78 
 
ANOVA Summary Table for SBP During Test 5 
 
Source 
 
Df Sum of Squares Mean Square F-Value P-Value 
Between subjects 
 
23 10993.63    
  Group (A) 
 
1 1305.38 1305.38 2.96 0.0992 
  Residual between 
 
22 9688.25 440.38   
Within subjects 
 
72 1729.0    
  Time (B) 
 
3         204.79 68.26 3.05 0.0346 
  A X B Interaction 
 
3 47.46 15.82 0.71 0.5512 
  Residual within 
 
66 1476.75 22.38   
Total 
 
95 12722.63    
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Table D.79 
 
ANOVA Summary Table for DBP During Test 5 
 
Source 
 
Df Sum of Squares Mean Square F-Value P-Value 
Between subjects 
 
23 2810.96    
  Group (A) 
 
1 126.04 126.04 1.03 0.3206 
  Residual between 
 
22 2684.92 122.04   
Within subjects 
 
72 4027.0    
  Time (B) 
 
3         2800.46 933.49 50.75 0.0001 
  A X B Interaction 
 
3 12.46 4.15 0.23 0.8782 
  Residual within 
 
66 1214.08 18.40   
Total 
 
95 6837.96    
 
 
 
Table D.80 
 
ANOVA Summary Table for MAP During Test 5 
 
Source 
 
Df Sum of Squares Mean Square F-Value P-Value 
Between subjects 
 
23 4067.22    
  Group (A) 
 
1 381.01 381.01 2.27 0.1458 
  Residual between 
 
22 3686.21 167.56   
Within subjects 
 
72 1904.22    
  Time (B) 
 
3         933.75 311.25 21.36 0.0001 
  A X B Interaction 
 
3 8.53 2.84 0.20 0.8994 
  Residual within 
 
66 961.94 14.57   
Total 
 
95 5971.44    
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Table D.81 
 
ANOVA Summary Table for Mean RR Interval During PB 
 
Source 
 
Df Sum of Squares Mean Square F-Value P-Value 
Between subjects 
 
23 1189423.94    
  Group (A) 
 
1 18736.5 18736.5 0.35 0.559 
  Residual between 
 
22 1170687.44 53213.07   
Within subjects 
 
96 480948.35    
  Time (B) 
 
4 36457.54 9114.38 1.84 0.1277 
  A X B Interaction 
 
4 9351.75 2337.94 0.47 0.7556 
  Residual within 
 
88 435139.06 4944.76   
Total 
 
119 1670372.29    
 
 
 
Table D.82 
 
ANOVA Summary Table for SDNN During PB 
 
Source 
 
Df Sum of Squares Mean Square F-Value P-Value 
Between subjects 
 
23 150002.87    
  Group (A) 
 
1 231.10 231.10 0.03 0.8555 
  Residual between 
 
22 149771.77 6807.81   
Within subjects 
 
96 28145.63    
  Time (B) 
 
4 4214.26 1053.57 4.25 0.0034 
  A X B Interaction 
 
4 2129.07 532.27 2.15 0.0815 
  Residual within 
 
88 21802.30 247.75   
Total 
 
119 178148.5    
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Table D.83 
 
ANOVA Summary Table for lnTP During PB 
 
Source 
 
Df Sum of Squares Mean Square F-Value P-Value 
Between subjects 
 
23 74.59    
  Group (A) 
 
1 0.358 0.358 0.11 0.7476 
  Residual between 
 
22 74.23 3.37   
Within subjects 
 
96 24.36    
  Time (B) 
 
4 0.594 0.149 0.56 0.6897 
  A X B Interaction 
 
4 0.579 0.145 0.55 0.6999 
  Residual within 
 
88 23.19 0.264   
Total 
 
119 98.95    
 
 
 
Table D.84 
 
ANOVA Summary Table for lnLF During PB 
 
Source 
 
Df Sum of Squares Mean Square F-Value P-Value 
Between subjects 
 
23 63.10    
  Group (A) 
 
1 0.073 0.073 0.03 0.8748 
  Residual between 
 
22 63.03 2.865   
Within subjects 
 
96 29.48    
  Time (B) 
 
4 0.366 0.091 0.29 0.8847 
  A X B Interaction 
 
4 1.21 0.303 0.96 0.4361 
  Residual within 
 
88 27.90 0.317   
Total 
 
119 92.58    
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Table D.85 
 
ANOVA Summary Table for lnHF During PB 
 
Source 
 
Df Sum of Squares Mean Square F-Value P-Value 
Between subjects 
 
23 128.05    
  Group (A) 
 
1 0.187 0.187 0.03 0.8592 
  Residual between 
 
22 127.86 5.81   
Within subjects 
 
96 34.25    
  Time (B) 
 
4 1.533 0.383 1.06 0.3802 
  A X B Interaction 
 
4 0.965 0.241 0.67 0.6154 
  Residual within 
 
88 31.75 0.361   
Total 
 
119 162.30    
 
 
 
Table D.86 
 
ANOVA Summary Table for lnLF/lnHF During PB 
 
Source 
 
Df Sum of Squares Mean Square F-Value P-Value 
Between subjects 
 
23 0.895    
  Group (A) 
 
1 0.007 0.007 0.18 0.6776 
  Residual between 
 
22 0.888 0.04   
Within subjects 
 
96 0.622    
  Time (B) 
 
4 0.034 0.008 1.45 0.2244 
  A X B Interaction 
 
4 0.073 0.018 3.13 0.0187 
  Residual within 
 
88 0.515 0.006   
Total 
 
119 1.52    
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Table D.87 
 
ANOVA Summary Table for lnLFNU During PB 
 
Source 
 
Df Sum of Squares Mean Square F-Value P-Value 
Between subjects 
 
23 30.68    
  Group (A) 
 
1 0.015 0.015 0.01 0.9179 
  Residual between 
 
22 30.66 1.394   
Within subjects 
 
96 14.33    
  Time (B) 
 
4 1.26 0.315 2.41 0.055 
  A X B Interaction 
 
4 1.55 0.388 2.97 0.0238 
  Residual within 
 
88 11.52 0.131   
Total 
 
119 45.01    
 
 
 
Table D.88 
 
ANOVA Summary Table for lnHFNU During PB 
 
Source 
 
Df Sum of Squares Mean Square F-Value P-Value 
Between subjects 
 
23 4.81    
  Group (A) 
 
1 0.082 0.082 0.38 0.5438 
  Residual between 
 
22 4.73 0.215   
Within subjects 
 
96 3.59    
  Time (B) 
 
4 0.152 0.038 1.08 0.3733 
  A X B Interaction 
 
4 0.333 0.083 2.36 0.0594 
  Residual within 
 
88 3.10 0.035   
Total 
 
119 8.40    
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Table D.89 
 
ANOVA Summary Table for lnHF/lnTP During PB 
 
Source 
 
Df Sum of Squares Mean Square F-Value P-Value 
Between subjects 
 
23 0.300    
  Group (A) 
 
1 0.00003 0.00003 0.00 0.961 
  Residual between 
 
22 0.29981 0.01362   
Within subjects 
 
96 0.270    
  Time (B) 
 
4 0.0146 0.00365 1.43 0.2308 
  A X B Interaction 
 
4 0.03084 0.007711 3.02 0.022 
  Residual within 
 
88 0.22463 0.00255269   
Total 
 
119 0.570    
 
 
 
Table D.90 
 
ANOVA Summary Table for Mean RR Interval During SB1 
 
Source 
 
Df Sum of Squares Mean Square F-Value P-Value 
Between subjects 
 
23 1769894.70    
  Group (A) 
 
1 140847.66 140847.66 1.9 0.1817 
  Residual between 
 
22 1629047.00 74047.59   
Within subjects 
 
96 534379.93    
  Time (B) 
 
4 11392.61 2848.15 0.50 0.7361 
  A X B Interaction 
 
4 21283.87 5320.97 0.93 0.4485 
  Residual within 
 
88 501703.45 5701.18   
Total 
 
119 2304274.60    
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Table D.91 
 
ANOVA Summary Table for SDNN During SB1 
 
Source 
 
Df Sum of Squares Mean Square F-Value P-Value 
Between subjects 
 
23 85873.18    
  Group (A) 
 
1 1848.60 1848.60 0.48 0.4939 
  Residual between 
 
22 84024.58 3819.30   
Within subjects 
 
96 23478.40    
  Time (B) 
 
4 842.94 210.74 0.84 0.5039 
  A X B Interaction 
 
4 540.19 135.05 0.54 0.7083 
  Residual within 
 
88 22095.27 251.08   
Total 
 
119 109351.58    
 
 
 
Table D.92 
 
ANOVA Summary Table for lnTP During SB1 
 
Source 
 
Df Sum of Squares Mean Square F-Value P-Value 
Between subjects 
 
23 46.84    
  Group (A) 
 
1 2.492 2.492 1.24 0.2782 
  Residual between 
 
22 44.35 2.015   
Within subjects 
 
96 27.19    
  Time (B) 
 
4 0.7834 0.1959 0.68 0.6082 
  A X B Interaction 
 
4 1.0367 0.2592 0.90 0.4683 
  Residual within 
 
88 25.37 0.2883   
Total 
 
119 74.03    
 
 
 
 248 
Table D.93 
 
ANOVA Summary Table for lnLF During SB1 
 
Source 
 
Df Sum of Squares Mean Square F-Value P-Value 
Between subjects 
 
23 74.69    
  Group (A) 
 
1 1.488 1.488 0.45 0.5106 
  Residual between 
 
22 73.20 3.327   
Within subjects 
 
96 40.95    
  Time (B) 
 
4 1.154 0.2885 0.65 0.6257 
  A X B Interaction 
 
4 0.9669 0.2417 0.55 0.7011 
  Residual within 
 
88 38.83 0.4412   
Total 
 
119 115.64    
 
 
 
Table D.94 
 
ANOVA Summary Table for lnHF During SB1 
 
Source  
 
Df Sum of Squares Mean Square F-Value P-Value 
Between subjects 
 
23 85.04    
  Group (A) 
 
1 9.658 9.658 2.82 0.1073 
  Residual between 
 
22 75.38 3.426   
Within subjects 
 
96 33.44    
  Time (B) 
 
4 0.7620 0.1904 0.53 0.7112 
  A X B Interaction 
 
4 1.265 0.3163 0.89 0.4757 
  Residual within 
 
88 31.41 0.3569   
Total 
 
119 118.48    
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Table D.95 
 
ANOVA Summary Table for lnLF/lnHF During SB1 
 
Source 
 
Df Sum of Squares Mean Square F-Value P-Value 
Between subjects 
 
23 1.1664    
  Group (A) 
 
1 0.1600 0.1600 3.50 0.0748 
  Residual between 
 
22 1.0064 0.04574   
Within subjects 
 
96 1.12    
  Time (B) 
 
4 0.01370 0.003424 0.27 0.8942 
  A X B Interaction 
 
4 0.009518 0.002379 0.19 0.9429 
  Residual within 
 
88 1.1008 0.01251   
Total 
 
119 2.29    
 
 
 
Table D.96 
 
ANOVA Summary Table for lnLFNU During SB1 
 
Source 
 
Df Sum of Squares Mean Square F-Value P-Value 
Between subjects 
 
23 7.848    
  Group (A) 
 
1 1.0066 1.0066 3.24 0.0857 
  Residual between 
 
22 6.8414 0.3110   
Within subjects 
 
96 7.59    
  Time (B) 
 
4 0.09474 0.02368 0.28 0.8910 
  A X B Interaction 
 
4 0.02357 0.005892 0.07 0.9911 
  Residual within 
 
88 7.4764 0.08496   
Total 
 
119 15.44    
 
 
 
 250 
Table D.97 
 
ANOVA Summary Table for lnHFNU During SB1 
 
Source 
 
Df Sum of Squares Mean Square F-Value P-Value 
Between subjects 
 
23 12.76    
  Group (A) 
 
1 0.7825 0.7825 1.44 0.2433 
  Residual between 
 
22 11.98 0.5444   
Within subjects 
 
96 11.23    
  Time (B) 
 
4 0.1211 0.03027 0.24 0.9142 
  A X B Interaction 
 
4 0.06760 0.01690 0.13 0.9691 
  Residual within 
 
88 11.038 0.1254   
Total 
 
119 23.99    
 
 
 
Table D.98 
 
ANOVA Summary Table for lnHF/lnTP During SB1 
 
Source 
 
Df Sum of Squares Mean Square F-Value P-Value 
Between subjects 
 
23 0.4811    
  Group (A) 
 
1 0.06839 0.06839 3.65 0.0694 
  Residual between 
 
22 0.4127 0.01876   
Within subjects 
 
96 0.3057    
  Time (B) 
 
4 0.01152 0.002880 0.88 0.4792 
  A X B Interaction 
 
4 0.006261 0.001565 0.48 0.7514 
  Residual within 
 
88 0.2879 0.003271   
Total 
 
119 0.7868    
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Table D.99 
 
ANOVA Summary Table for Mean RR Interval During TILT 
 
Source 
 
Df Sum of Squares Mean Square F-Value P-Value 
Between subjects 
 
23 1031373.90    
  Group (A) 
 
1 18349.17 18349.17 0.40 0.5344 
  Residual between 
 
22 1013024.71 46046.58   
Within subjects 
 
96 625008.30    
  Time (B) 
 
4 10796.79 2699.20 0.39 0.8135 
  A X B Interaction 
 
4 8994.60 2248.65 0.33 0.8592 
  Residual within 
 
88 605216.72 6877.46   
Total 
 
119 1656382.20    
 
 
 
Table D.100 
 
ANOVA Summary Table for SDNN During TILT 
 
Source 
 
Df Sum of Squares Mean Square F-Value P-Value 
Between subjects 
 
23 76738.25    
  Group (A) 
 
1 1296.79 1296.79 0.38 0.5449 
  Residual between 
 
22 75441.46 3429.16   
Within subjects 
 
96 27291.23    
  Time (B) 
 
4 2008.09 502.02 1.78 0.1403 
  A X B Interaction 
 
4 445.53 111.38 0.39 0.8120 
  Residual within 
 
88 24837.61 282.25   
Total 
 
119 104029.48    
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Table D.101 
 
ANOVA Summary Table for lnTP During TILT 
 
Source 
 
Df Sum of Squares Mean Square F-Value P-Value 
Between subjects 
 
23 65.16    
  Group (A) 
 
1 0.3451 0.3451 0.12 0.7354 
  Residual between 
 
22 64.81 2.946   
Within subjects 
 
96 25.17    
  Time (B) 
 
4 1.8514 0.4628 1.77 0.1412 
  A X B Interaction 
 
4 0.3593 0.08982 0.34 0.8473 
  Residual within 
 
88 22.96 0.2609   
Total 
 
119 90.33    
 
 
 
Table D.102 
 
ANOVA Summary Table for lnLF During TILT 
 
Source 
 
Df Sum of Squares Mean Square F-Value P-Value 
Between subjects 
 
23 83.91    
  Group (A) 
 
1 0.04157 0.04157 0.01 0.9178 
  Residual between 
 
22 83.87 3.812   
Within subjects 
 
96 25.44    
  Time (B) 
 
4 0.9506 0.2376 0.88 0.4794 
  A X B Interaction 
 
4 0.7183 0.1796 0.66 0.6180 
  Residual within 
 
88 23.77 0.2701   
Total 
 
119 109.35    
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Table D.103 
 
ANOVA Summary Table for lnHF During TILT 
 
Source 
 
Df Sum of Squares Mean Square F-Value P-Value 
Between subjects 
 
23 122.38    
  Group (A) 
 
1 3.002 3.002 0.55 0.4648 
  Residual between 
 
22 119.38 5.426   
Within subjects 
 
96 165.45    
  Time (B) 
 
4 5.197 1.299 3.37 0.0129 
  A X B Interaction 
 
4 3.952 0.9880 2.56 0.0438 
  Residual within 
 
88 33.92 0.3855   
Total 
 
119 287.83    
 
 
 
Table D.104 
 
ANOVA Summary Table for lnLF/lnHF During TILT 
 
Source 
 
Df Sum of Squares Mean Square F-Value P-Value 
Between subjects 
 
23 3.91    
  Group (A) 
 
1 0.1714 0.1714 1.01 0.3263 
  Residual between 
 
22 3.7405 0.1700   
Within subjects 
 
96 5.08    
  Time (B) 
 
4 0.6387 0.1597 3.61 0.0090 
  A X B Interaction 
 
4 0.5423 0.1356 3.06 0.0206 
  Residual within 
 
88 3.8956 0.04427   
Total 
 
119 8.99    
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Table D.105 
 
ANOVA Summary Table for lnLFNU During TILT 
 
Source 
 
Df Sum of Squares Mean Square F-Value P-Value 
Between subjects 
 
23 1.59    
  Group (A) 
 
1 0.1270 0.1270 1.91 0.1811 
  Residual between 
 
22 1.465 0.06657   
Within subjects 
 
96 2.27    
  Time (B) 
 
4 0.4127 0.1032 6.34 0.0002 
  A X B Interaction 
 
4 0.4238 0.1060 6.51 0.0001 
  Residual within 
 
88 1.4325 0.01628   
Total 
 
119 3.86    
 
 
 
Table D.106 
 
ANOVA Summary Table for lnHFNU During TILT 
 
Source 
 
Df Sum of Squares Mean Square F-Value P-Value 
Between subjects 
 
23 23.61    
  Group (A) 
 
1 1.3747 1.375 1.36 0.2561 
  Residual between 
 
22 22.24 1.011   
Within subjects 
 
96 35.39    
  Time (B) 
 
4 4.1825 1.0456 4.07 0.0045 
  A X B Interaction 
 
4 4.4062 1.1015 4.29 0.0032 
  Residual within 
 
88 22.62 0.257   
Total 
 
119 59.01    
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Table D.107 
 
ANOVA Summary Table for lnHF/lnTP During TILT 
 
Source 
 
Df Sum of Squares Mean Square F-Value P-Value 
Between subjects 
 
23 0.8916    
  Group (A) 
 
1 0.03454 0.03454 0.89 0.3566 
  Residual between 
 
22 0.8571 0.03896   
Within subjects 
 
96 0.6508    
  Time (B) 
 
4 0.07641 0.01910 3.38 0.0128 
  A X B Interaction 
 
4 0.07651 0.01912 3.38 0.0127 
  Residual within 
 
88 0.4979 0.005658   
Total 
 
119 1.542    
 
 
 
Table D.108 
 
ANOVA Summary Table for Mean RR Interval During SB2 
 
Source 
 
Df Sum of Squares Mean Square F-Value P-Value 
Between subjects 
 
23 2203039.5    
  Group (A) 
 
1 209039.76 209039.76 2.31 0.1431 
  Residual between 
 
22 1993999.78 90636.35   
Within subjects 
 
96 552252.90    
  Time (B) 
 
4 24859.79 6214.95 1.06 0.3833 
  A X B Interaction 
 
4 9358.85 2339.71 0.40 0.8100 
  Residual within 
 
88 518034.26 5886.75   
Total 
 
119 2755292.40    
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Table D.109 
 
ANOVA Summary Table for SDNN During SB2 
 
Source 
 
Df Sum of Squares Mean Square F-Value P-Value 
Between subjects 
 
23 45331.77    
  Group (A) 
 
1 199.38 199.38 0.10 0.7582 
  Residual between 
 
22 45132.39 2051.47   
Within subjects 
 
96 32745.74    
  Time (B) 
 
4 1864.40 466.10 1.40 0.2402 
  A X B Interaction 
 
4 1610.13 402.53 1.21 0.3122 
  Residual within 
 
88 29271.21 332.63   
Total 
 
119 78077.51    
 
 
 
Table D.110 
 
ANOVA Summary Table for lnTP During SB2 
 
Source 
 
Df Sum of Squares Mean Square F-Value P-Value 
Between subjects 
 
23 33.60    
  Group (A) 
 
1 0.06499 0.06499 0.04 0.8383 
  Residual between 
 
22 33.54 1.52   
Within subjects 
 
96 28.35    
  Time (B) 
 
4 0.8866 0.2216 0.73 0.5732 
  A X B Interaction 
 
4 0.7796 0.1949 0.64 0.6334 
  Residual within 
 
88 26.68 0.3032   
Total 
 
119 61.95    
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Table D.111 
 
ANOVA Summary Table for lnLF During SB2 
 
Source 
 
Df Sum of Squares Mean Square F-Value P-Value 
Between subjects 
 
23 31.88    
  Group (A) 
 
1 0.0008209 0.0008209 0.00 0.9812 
  Residual between 
 
22 31.88 1.45   
Within subjects 
 
96 34.10    
  Time (B) 
 
4 1.933 0.4831 1.33 0.2660 
  A X B Interaction 
 
4 0.1431 0.03577 0.10 0.9827 
  Residual within 
 
88 32.02 0.3639   
Total 
 
119 65.98    
 
 
 
Table D.112 
 
ANOVA Summary Table for lnHF During SB2 
 
Source 
 
Df Sum of Squares Mean Square F-Value P-Value 
Between subjects 
 
23 41.05    
  Group (A) 
 
1 0.7697 0.7697 0.42 0.5235 
  Residual between 
 
22 40.28 1.831   
Within subjects 
 
96 33.66    
  Time (B) 
 
4 1.7531 0.4383 1.22 0.3069 
  A X B Interaction 
 
4 0.3624 0.0906 0.25 0.9072 
  Residual within 
 
88 31.54 0.3584   
Total 
 
119 74.71    
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Table D.113 
 
ANOVA Summary Table for lnLF/lnHF During SB2 
 
Source 
 
Df Sum of Squares Mean Square F-Value P-Value 
Between subjects 
 
23 1.20    
  Group (A) 
 
1 0.03310 0.03310 0.62 0.4383 
  Residual between 
 
22 1.1686 0.05312   
Within subjects 
 
96 0.7720    
  Time (B) 
 
4 0.08442 0.02111 2.75 0.0328 
  A X B Interaction 
 
4 0.01337 0.00334 0.44 0.7820 
  Residual within 
 
88 0.6742 0.007662   
Total 
 
119 1.974    
 
 
 
Table D.114 
 
ANOVA Summary Table for lnLFNU During SB2 
 
Source 
 
Df Sum of Squares Mean Square F-Value P-Value 
Between subjects 
 
23 9.63    
  Group (A) 
 
1 0.2345 0.2345 0.55 0.4666 
  Residual between 
 
22 9.395 0.4271   
Within subjects 
 
96 7.81    
  Time (B) 
 
4 0.7099 0.1775 2.25 0.0698 
  A X B Interaction 
 
4 0.1641 0.0410 0.52 0.7208 
  Residual within 
 
88 6.934 0.0788   
Total 
 
119 17.44    
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Table D.115 
 
ANOVA Summary Table for lnHFNU During SB2 
 
Source 
 
Df Sum of Squares Mean Square F-Value P-Value 
Between subjects 
 
23 13.50    
  Group (A) 
 
1 0.1779 0.1779 0.29 0.5933 
  Residual between 
 
22 13.32 0.6055   
Within subjects 
 
96 8.56    
  Time (B) 
 
4 0.8497 0.2124 2.47 0.0506 
  A X B Interaction 
 
4 0.1326 0.03316 0.39 0.8188 
  Residual within 
 
88 7.577 0.0861   
Total 
 
119 22.06    
 
 
 
Table D.116 
 
ANOVA Summary Table for lnHF/lnTP During SB2 
 
Source 
 
Df Sum of Squares Mean Square F-Value P-Value 
Between subjects 
 
23 0.3922    
  Group (A) 
 
1 0.007168 0.007168 0.41 0.5288 
  Residual between 
 
22 0.3850 0.01750   
Within subjects 
 
96 0.3345    
  Time (B) 
 
4 0.01447 0.003620 1.03 0.3952 
  A X B Interaction 
 
4 0.01147 0.002867 0.82 0.5173 
  Residual within 
 
88 0.3086 0.003507   
Total 
 
119 0.7267    
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Appendix E 
 
Additional Data 
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Table E.1 
 
HRV Indices During PB Across Time (Mean, sd)      
 
 
  Group 
 
 EX 
 
CT 
 T1 
 
T2 T3 T4 T5 T1 T2 T3 T4 T5 
Mean RR  
(ms) 
 
925.88 
137.3 
923.64 
112.6 
958.3 
100.7 
958.33 
123.4 
985.34 
148.6 
956.56 
105.5 
969.42 
102.5 
998.23 
97.2 
965.22 
161.1 
987.06 
99.8 
SDNN 
(ms)  
 
74.3 
32 
77.0 
38 
91.0 
50 
91.8 
52 
99.3 
56* 
81.7 
29 
84.3 
29 
82.9 
32 
79.4 
32 
91.1 
29* 
lnTP 
(lnms2) 
 
7.43 
1.1 
7.72 
0.8 
7.62 
1.0 
7.74 
0.9 
7.66 
0.9 
7.71 
0.8 
7.70 
0.9 
7.71 
1.2 
7.68 
0.9 
7.92 
0.5 
lnLF 
(lnms2) 
 
6.01 
0.9 
6.03 
0.8 
6.05 
0.8 
6.05 
0.7 
5.87 
0.8 
6.26 
0.6 
5.96 
1.0 
5.97 
1.4 
5.89 
1.2 
6.2 
0.7 
lnHF 
(lnms2) 
 
6.73 
1.1 
6.92 
1.1 
6.81 
1.5 
6.84 
1.4 
7.3 
1.2 
6.99 
0.9 
7.05 
0.9 
6.96 
1.5 
6.95 
1.2 
7.04 
0.9 
lnLFNU  
(ln%)  
 
3.45 
0.5 
3.29 
0.7 
3.36 
0.7 
3.31 
0.8 
2.89 
0.8* 
3.43 
0.4 
3.19 
0.5 
3.26 
0.5 
3.19 
0.6 
3.36 
0.5 
lnHFNU 
(ln%) 
 
4.17 
0.2 
4.17 
0.3 
4.14 
0.3 
4.09 
0.4 
4.32 
0.2 
4.16 
0.3 
4.28 
0.2 
4.25 
0.2 
4.24 
0.2 
4.19 
0.2 
lnLF/ 
lnHF  
 
0.90 
0.1 
0.89 
0.1 
0.91 
0.1 
0.91 
0.2 
0.82 
0.1* 
0.90 
0.1 
0.85 
0.1 
0.86 
0.1 
0.85 
0.1 
0.89 
0.1 
LnHF/ 
lnTP  
 
0.90 
0.1 
0.89 
0.1 
0.89 
0.1 
0.88 
0.1 
0.95 
0.1* 
0.91 
0.1 
0.92 
0.1 
0.89 
0.1 
0.90 
0.1 
0.88 
0.1 
Mean RR = mean RR interval    TP = total power 
SDNN = standard deviation of normal RR intervals  LF = low-frequency power 
HF = high-frequency power    NU = normalized units 
ln = natural logarithm     ms = milliseconds 
* = p<0.05 vs. T1 for respective group 
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Table E.2 
 
HRV Indices During SB1 Across Time (Mean, sd) 
 
 
Group 
 
 
 
EX CT 
 
 
T1 T2 T3 T4 T5 T1 T2 T3 T4 T5 
Mean RR 
(ms) 
 
948.3 
140 
951.8 
115 
971.8 
145 
982.9 
155 
983.2 
167 
1028.8 
124 
1051.3 
138 
1053.5 
100 
1004.7 
156 
1042.2 
140 
SDNN 
(ms) 
 
72.5 
33 
77.5 
36 
78.4 
30 
85.9 
30 
79.8 
32 
85.4 
29 
89.3 
28 
83.4 
35 
87.5 
33 
87.8 
23 
lnTP 
(lnms2) 
 
7.33 
0.9 
7.59 
0.8 
7.61 
0.7 
7.66 
0.7 
7.58 
0.6 
7.84 
0.7 
7.93 
0.6 
7.65 
1.2 
7.77 
0.8 
8.02 
0.9 
lnLF 
(lnms2) 
 
6.27 
1.2 
6.62 
0.9 
6.43 
0.7 
6.54 
0.9 
6.31 
0.7 
6.71 
0.8 
6.83 
1.0 
6.44 
1.5 
6.58 
1.1 
6.72 
1.1 
lnHF 
(lnms2) 
 
5.8 
1.0 
6.22 
1.0 
6.14 
1.2 
6.03 
1.2 
5.84 
1.2 
6.60 
0.8 
6.66 
0.5 
6.45 
1.2 
6.49 
0.8 
6.66 
0.8 
lnLFNU 
(ln%) 
 
4.07 
0.2 
4.06 
0.2 
3.99 
0.3 
4.07 
0.3 
4.06 
0.3 
3.88 
0.4 
3.92 
0.4 
3.83 
0.4 
3.88 
0.5 
3.84 
0.5 
lnHFNU 
(ln%) 
 
3.61 
0.5 
3.66 
0.3 
3.70 
0.5 
3.56 
0.5 
3.59 
0.44 
3.77 
0.5 
3.75 
0.5 
3.84 
0.5 
3.79 
0.4 
3.78 
0.5 
lnLF/ 
lnHF 
 
 
1.08 
0.1 
1.07 
0.1 
1.07 
0.2 
1.11 
0.2 
1.10 
0.1 
1.03 
0.1 
1.03 
0.1 
0.99 
0.1 
1.02 
0.1 
1.01 
0.1 
lnHF/ 
lnTP 
 
 
0.79 
0.1 
0.82 
0.1 
0.80 
0.1 
0.78 
0.1 
0.77 
0.1 
0.84 
0.1 
0.84 
0.1 
0.84 
0.1 
0.84 
0.1 
0.83 
0.1 
Mean RR = mean RR interval    TP = total power 
SDNN = standard deviation of normal RR intervals  LF = low-frequency power 
HF = high-frequency power    NU = normalized units 
ln = natural logarithm     ms = milliseconds 
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Table E.3 
 
HRV Indices During TILT Across Time (Mean, sd) 
 
 
Group 
 
 
 
EX CT 
 
 
T1 T2 T3 T4 T5 T1 T2 T3 T4 T5 
Mean RR 
(ms) 
 
759.7 
108 
736.0 
83 
768.2 
137 
775.4 
126 
773.2 
142 
776.2 
104 
787.0 
131 
797.7 
130 
773.6 
131 
801.7 
108 
SDNN 
(ms) 
 
64.4 
31 
63.5 
28 
69.4 
21 
71.6 
30 
79.7 
50 
62.1 
26 
60.7 
25 
63.8 
26 
61.3 
26 
68.0 
29 
lnTP 
(lnms2) 
 
7.10 
0.9 
7.13 
0.9 
7.48 
0.6 
7.40 
1.1 
7.42 
1.0 
7.16 
1.0 
7.05 
0.8 
7.28 
0.8 
7.15 
0.9 
7.36 
0.9 
lnLF 
(lnms2) 
 
6.51 
0.9 
6.19 
1.0 
6.45 
0.8 
6.42 
1.2 
6.18 
0.9 
6.32 
1.2 
6.22 
0.9 
6.44 
0.8 
6.2 
1.0 
6.38 
1.1 
lnHF 
(lnms2)  
 
4.62 
1.1 
4.58 
1.2 
4.81 
1.2 
4.63 
1.6 
5.58 
1.1* 
4.62 
1.1 
4.53 
1.3 
4.34 
1.0 
4.52 
1.1 
4.62 
1.0 
lnLFNU 
(ln%)  
 
4.42 
0.2 
4.40 
0.1 
4.39 
0.2 
4.41 
0.2 
4.12 
0.2* 
4.39 
0.2 
4.39 
0.2 
4.46 
0.1 
4.40 
0.1 
4.41 
0.1 
lnHFNU 
(ln%)  
 
2.53 
0.7 
2.78 
0.5 
2.75 
0.6 
2.62 
0.7 
3.52 
0.5* 
2.69 
0.7 
2.71 
0.6 
2.36 
0.8 
2.72 
0.6 
2.65 
0.6 
lnLF/ 
lnHF  
 
1.46 
0.3 
1.40 
0.2 
1.38 
0.2 
1.48 
0.4 
1.12 
0.1* 
1.40 
0.2 
1.44 
0.3 
1.54 
0.3 
1.42 
0.3 
1.41 
0.2 
lnHF/ 
lnTP  
 
0.65 
0.1 
0.64 
0.1 
0.64 
0.1 
0.62 
0.2 
0.75 
0.1* 
0.64 
0.1 
0.63 
0.1 
0.59 
0.1 
0.63 
0.1 
0.62 
0.1 
Mean RR = mean RR interval    TP = total power 
SDNN = standard deviation of normal RR intervals  LF = low-frequency power 
HF = high-frequency power    NU = normalized units 
ln = natural logarithm     ms = milliseconds 
* = p<0.05 vs. T1 for respective group 
 
 
Table E.4 
 
HRV Indices During SB2 Across Time (Mean, sd) 
 
 
 Group 
 
 
EX CT 
 
 
T1 T2 T3 T4 T5 T1 T2 T3 T4 T5 
Mean 
RR (ms) 
 
987.2 
160 
1009.0 
107 
1036.2 
165 
1039.5 
166 
1025.0 
185 
1092.9 
142 
1090.2 
142 
1123.5 
98 
1091.5 
145 
1116.0 
159 
 
SDNN 
(ms) 
 
80.1 
21 
95.4 
32 
94.4 
31 
89.8 
25 
101.2 
30 
90.3 
19 
88.9 
14 
84.7 
31 
90.6 
25 
93.5 
27 
lnTP 
(lnms2) 
 
7.56 
0.7 
7.94 
0.8 
7.90 
0.7 
7.82 
0.8 
7.96 
0.6 
7.89 
0.6 
7.94 
0.6 
7.74 
1.1 
7.88 
0.6 
7.96 
0.8 
lnLF 
(lnms2) 
 
6.38 
0.6 
6.83 
0.6 
6.53 
0.6 
6.69 
0.7 
6.58 
0.5 
6.47 
0.8 
6.71 
0.8 
6.50 
1.2 
6.73 
0.6 
6.57 
0.6 
lnHF 
(lnms2) 
 
6.51 
0.7 
6.62 
1.0 
6.59 
0.8 
6.54 
1.0 
6.96 
0.8 
6.75 
0.6 
6.90 
0.6 
 
6.73 
1.0 
6.72 
0.8 
6.93 
0.7 
lnLFNU 
(ln%) 
 
3.79 
0.3 
3.94 
0.4 
3.83 
0.3 
3.89 
0.4 
3.63 
0.4 
3.68 
0.5 
3.75 
0.4 
3.73 
0.4 
3.82 
0.4 
3.67 
0.3 
lnHFNU 
(ln%) 
 
3.93 
0.4 
3.73 
0.4 
3.89 
0.4 
3.75 
0.5 
4.01 
0.4 
3.96 
0.4 
3.94 
0.4 
3.95 
0.6 
3.81 
0.6 
4.03 
0.3 
lnLF/ 
lnHF  
 
0.99 
0.1 
1.05 
0.1 
1.00 
0.1 
1.04 
0.2 
0.96 
0.1 
0.96 
0.1 
0.98 
0.1 
0.97 
0.1 
1.01 
0.2 
0.95 
0.1 
lnHF/ 
lnTP 
 
0.87 
0.1 
0.83 
0.1 
0.83 
0.1 
0.84 
0.1 
0.88 
0.1 
0.86 
0.1 
0.87 
0.1 
0.87 
0.1 
0.85 
0.1 
0.87 
0.1 
Mean RR = mean RR interval
TP = total power 
SDNN = standard deviation 
of normal RR intervals 
LF = low-frequency power 
HF = high-frequency power 
NU = normalized units 
ln = natural logarithm 
ms = milliseconds 
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Table E.5 
 
Blood Pressure During PB Across Time (Mean, sd) 
 
 
 Group 
 
 
EX CT 
 
 
T1 T2 T3 T4 T5 T1 T2 T3 T4 T5 
SBP 
(mmHg) 
118.2 
11 
116.6 
8 
116.3 
10 
115.8 
13 
120.8 
10 
117.3 
12 
115.7 
13 
112.8 
11 
111.5 
9 
112.3 
10 
DBP 
(mmHg) 
76.5 
6 
76.2 
7 
75.3 
9 
75.3 
9 
74.8 
7 
74.0 
6 
73.7 
8 
73.2 
7 
75.2 
6 
73.3 
6 
MAP 
(mmHg) 
90.4 
6 
89.7 
7 
89.0 
8 
88.8 
10 
90.2 
7 
88.4 
6 
87.7 
8 
86.4 
7 
87.3 
6 
86.3 
6 
SBP = systolic blood pressure 
DBP = diastolic blood pressure 
MAP = mean arterial pressure 
 
 
Table E.6 
 
Blood Pressure During SB1 Across Time (Mean, sd) 
 
 
 Group 
 
 
EX CT 
 
 
T1 T2 T3 T4 T5 T1 T2 T3 T4 T5 
SBP 
(mmHg) 
117.3 
11 
117.7 
5 
116.8 
11 
112.7 
13 
120.8 
12 
115.3 
12 
113.8 
10 
112.0 
12 
111.3 
13 
111.8 
12 
DBP 
(mmHg) 
76.8 
8 
77.0 
6 
72.8 
8 
74.2 
8 
75.3 
8 
73.0 
7.6 
71.8 
6 
73.2 
6 
72.8 
6 
72.5 
6 
MAP 
(mmHg) 
90.3 
8 
90.5 
5 
87.5 
9 
87.0 
9 
90.5 
8 
87.1 
5 
85.8 
6 
86.1 
8 
85.7 
7 
85.6 
6 
SBP = systolic blood pressure 
DBP = diastolic blood pressure 
MAP = mean arterial pressure 
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Table E.7 
 
Blood Pressure During TILT Across Time (Mean, sd) 
 
 
 Group 
 
 
EX CT 
 
 
T1 T2 T3 T4 T5 T1 T2 T3 T4 T5 
SBP 
(mmHg) 
116.8 
11 
112.2 
6 
116.2 
11 
114.0 
10 
116.3 
13 
113.5 
12 
108.7 
12 
110.3 
12 
111.0 
12 
110.0 
11 
DBP 
(mmHg) 
87.8 
6 
88.3 
8 
87.5 
7 
86.8 
10 
87.3 
8 
84.8 
8 
85.8 
8 
84.0 
7 
85.8 
6 
85.7 
7 
MAP 
(mmHg) 
97.5 
7 
96.3 
7 
97.0 
7 
95.9 
9 
97.0 
9 
94.4 
8 
93.4 
9 
92.8 
8 
94.2 
6 
93.8 
8 
SBP = systolic blood pressure 
DBP = diastolic blood pressure 
MAP = mean arterial pressure 
 
 
Table E.8 
 
Blood Pressure During SB2 Across Time (Mean, sd) 
 
 
 Group 
 
 
EX CT 
 
 
T1 T2 T3 T4 T5 T1 T2 T3 T4 T5 
SBP 
(mmHg) 
118.3 
10 
116.8 
10 
114.7 
11 
113.8 
11 
119.5 
10 
115.0 
14 
113.0 
13 
112.2 
12 
115.0 
13 
113.8 
12 
DBP 
(mmHg) 
76.7 
6.9 
74.5 
7 
71.8 
6 
74.5 
8 
75.7 
5 
74.2 
7 
72.7 
8 
71.8 
5 
72.7 
7 
72.5 
5 
MAP 
(mmHg) 
90.5 
6 
 
88.6 
8 
 
86.1 
7 
 
87.6 
8 
 
90.3 
6 
 
87.8 
6 
86.1 
8 
85.3 
7 
86.8 
6 
86.2 
6 
SBP = systolic blood pressure 
DBP = diastolic blood pressure 
MAP = mean arterial pressure 
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Table E.9 
 
Descriptive Statistics for the Participants (Mean, sd) 
 
Group Age 
(yr) 
 
Height 
(inches) 
Weight 
(kg) 
SSF 
(mm) 
Body Fat 
(%) 
PAQ 
(kcal•week-1) 
 
 
  Pre Post Pre Post Pre Post Pre Post 
EX 
 
 
23.1 
3 
69.6 
2 
82.6 
16 
82.2 
16 
136.6 
55 
129.3 
51* 
18.1 
6 
17.2 
6* 
1685.8 
387 
3795.0 
406* 
CT 
 
 
23.1 
4 
69.1 
4 
79.1 
13 
79.1 
13 
 
112.9 
37 
111.0 
34* 
15.3 
5 
15.0 
5* 
1704.9 
428 
1721.0 
419.6 
SSF = sum of skinfolds 
PAQ = physical activity questionnaire 
* = p<0.05 vs. pre for respective group 
 
Table E.10 
 
Physiological Indices at Rest and During Peak Exercise (Mean, sd) 
 
Group VO2  
(ml•kg-1•min-1) 
 
VO2  
(l•min-1) 
VE 
(l•min-1) 
RF 
(breaths•min-1) 
VT 
(l•breath-1) 
VCO2 
(l•min-1) 
RQ 
 
HR 
(beats•min-1) 
 
 
Pre Post Pre Post Pre Post Pre Post Pre Post Pre Post Pre Post Pre Post 
EX 
(Rest) 
 
4.62 
1.1 
5.36 
1.4* 
0.38 
0.1 
0.44 
0.2* 
15.7 
4.1 
17.0 
4.6* 
20.6 
4.9 
17.9 
3.4* 
0.88 
0.3 
1.03 
0.3* 
0.38 
0.1 
0.46 
0.2* 
1.04 
0.1 
1.07 
0.1 
83.1 
12 
83.3 
14 
CT 
(Rest) 
 
5.60 
1.8 
6.44 
2.1* 
0.43 
0.2 
0.50 
0.2* 
15.0 
2.5 
16.9 
4.4* 
18.8 
3.9 
18.2 
5.1* 
0.88 
0.3 
1.05 
0.3* 
0.40 
0.1 
0.47 
0.1* 
0.98 
0.1‡ 
0.99 
0.1‡ 
73.5 
15 
75.7 
14 
EX 
(Peak) 
 
33.48 
3.7 
36.07 
3.2* 
2.73 
0.4 
2.92 
0.5* 
113.3 
21 
126.6 
24* 
41.2 
8 
43.7 
8 
2.83 
0.7 
2.98 
0.7* 
3.62 
0.4 
3.93 
0.7 
1.33 
0.1 
1.35 
0.1 
184.4 
10 
185.3 
10 
CT 
(Peak) 
 
33.88 
3.0 
32.65 
2.6 
2.73 
0.6 
2.62 
0.5 
113.6 
24 
108.5 
17 
41.4 
8 
39.8 
8 
2.82 
0.6 
2.66 
0.6 
3.66 
0.8 
3.44 
0.7 
1.34 
0.1 
1.31 
0.1 
181.2 
10 
178.9 
8 
VO2 = oxygen consumption   VCO2 = volume of expired carbon dioxide 
VE = minute ventilation    RQ = respiratory quotient 
RF = respiratory frequency   HR = heart rate 
VT = tidal volume 
* = p<0.05 vs. pre for respective group 
‡ = p<0.05 vs. EX 
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Table E.11 
 
HRV During Test 1 (Mean, sd) 
 
 Group 
 
 
EX CT 
 
 
PB SB1 Tilt SB2 
 
PB SB1 Tilt SB2 
 
Mean RR 
(ms)  
 
925.88 
137.3 
948.3 
140 
759.7 
108* 
987.2 
160 
956.56 
105.5†‡ 
1028.8 
124‡ 
776.2 
104* 
1092.9 
142 
SDNN 
(ms)  
 
74.3 
32 
72.5 
33 
64.4 
31* 
80.1 
21 
81.7 
29 
85.4 
29 
62.1 
26* 
90.3 
19 
lnTP 
(lnms2)  
 
7.43 
1.1 
7.33 
0.9 
7.10 
0.9* 
7.56 
0.7 
7.71 
0.8 
7.84 
0.7 
7.16 
1.0* 
7.89 
0.6 
lnLF 
(lnms2) 
 
6.01 
0.9 
6.27 
1.2 
6.51 
0.9 
6.38 
0.6 
6.26 
0.6 
6.71 
0.8 
6.32 
1.2 
6.47 
0.8 
lnHF 
(lnms2)  
 
6.73 
1.1† 
5.8 
1.0 
4.62 
1.1* 
6.51 
0.7† 
6.99 
0.9† 
6.60 
0.8 
4.62 
1.1* 
6.75 
0.6† 
lnLFNU 
(ln%)  
 
3.45 
0.5†‡ 
4.07 
0.2‡ 
4.42 
0.2* 
3.79 
0.3 
3.43 
0.4†‡ 
3.88 
0.4‡ 
4.39 
0.2* 
3.68 
0.5 
lnHFNU 
(ln%)  
 
4.17 
0.2†‡ 
3.61 
0.5‡ 
2.53 
0.7* 
3.93 
0.4 
4.16 
0.3†‡ 
3.77 
0.5‡ 
2.69 
0.7* 
3.96 
0.4 
lnLF/ 
lnHF  
 
0.90 
0.1†‡ 
1.08 
0.1‡ 
1.46 
0.3* 
0.99 
0.1 
0.90 
0.1†‡ 
1.03 
0.1‡ 
1.40 
0.2* 
0.96 
0.1 
lnHF/ 
lnTP  
 
0.90 
0.1†‡ 
0.79 
0.1‡ 
0.65 
0.1* 
0.87 
0.1 
0.91 
0.1†‡ 
0.84 
0.1‡ 
0.64 
0.1* 
0.86 
0.1 
Mean RR = mean RR interval    TP = total power 
SDNN = standard deviation of normal RR intervals  LF = low-frequency power 
HF = high-frequency power    NU = normalized units 
ln = natural logarithm     ms = milliseconds 
* = p<0.05 vs. other 3 conditions for specified group 
† = p<0.05 vs. SB1 for specified group 
‡ = p<0.05 vs. SB2 for specified group 
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Table E.12 
 
HRV During Test 2 (Mean, sd) 
 
 Group 
 
 
EX CT 
 
 
PB SB1 Tilt SB2 
 
PB SB1 Tilt SB2 
 
Mean RR 
(ms)  
 
923.64 
112.6†‡ 
951.8 
115‡ 
736.0 
83* 
1009.0 
107 
969.42 
102.5†‡ 
1051.3 
138‡ 
787.0 
131* 
1090.2 
142 
SDNN 
(ms)  
 
77.0 
38‡ 
77.5 
36 
63.5 
28* 
95.4 
32 
84.3 
29‡ 
89.3 
28 
60.7 
25* 
88.9 
14 
lnTP 
(lnms2)  
 
7.72 
0.8 
7.59 
0.8 
7.13 
0.9* 
7.94 
0.8 
7.70 
0.9 
7.93 
0.6 
7.05 
0.8* 
7.94 
0.6 
lnLF 
(lnms2)  
 
6.03 
0.8†‡ 
6.62 
0.9 
6.19 
1.0†‡ 
6.83 
0.6 
5.96 
1.0†‡ 
6.83 
1.0 
6.22 
0.9†‡ 
6.71 
0.8 
lnHF 
(lnms2)  
 
6.92 
1.1† 
6.22 
1.0 
4.58 
1.2* 
6.62 
1.0† 
7.05 
0.9† 
6.66 
0.5 
4.53 
1.3* 
6.90 
0.6† 
 
lnLFNU 
(ln%)  
 
3.29 
0.7†‡ 
4.06 
0.2 
4.40 
0.1* 
3.94 
0.4 
3.19 
0.5†‡ 
3.92 
0.4 
4.39 
0.2* 
3.75 
0.4 
lnHFNU 
(ln%)  
 
4.17 
0.3†‡ 
3.66 
0.3 
2.78 
0.5* 
3.73 
0.4 
4.28 
0.2†‡ 
3.75 
0.5 
2.71 
0.6* 
3.94 
0.4 
lnLF/ 
lnHF  
 
0.89 
0.1†‡ 
1.07 
0.1 
1.40 
0.2* 
1.05 
0.1 
0.85 
0.1†‡ 
1.03 
0.1 
1.44 
0.3* 
0.98 
0.1 
lnHF/ 
lnTP †† 
 
0.89 
0.1†‡ 
0.82 
0.1 
0.64 
0.1* 
0.83 
0.1 
0.92 
0.1†‡ 
0.84 
0.1 
0.63 
0.1* 
0.87 
0.1 
Mean RR = mean RR interval    TP = total power 
SDNN = standard deviation of normal RR intervals  LF = low-frequency power 
HF = high-frequency power    NU = normalized units 
ln = natural logarithm     ms = milliseconds 
* = p<0.05 vs. other 3 conditions for specified group 
† = p<0.05 vs. SB1 for specified group 
‡ = p<0.05 vs. SB2 for specified group 
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Table E.13 
 
HRV During Test 3 (Mean, sd) 
  
 Group 
 
 
EX CT 
 
 
PB SB1 Tilt SB2 
 
PB SB1 Tilt SB2 
 
Mean RR 
(ms)  
 
958.3 
100.7‡ 
971.8 
145‡ 
768.2 
137* 
1036.2 
165 
998.23 
97.2‡ 
1053.5 
100‡ 
797.7 
130* 
1123.5 
98 
SDNN 
(ms)  
 
91.0 
50 
78.4 
30 
69.4 
21* 
94.4 
31 
82.9 
32 
83.4 
35 
63.8 
26* 
84.7 
31 
lnTP 
(lnms2) 
 
7.62 
1.0 
7.61 
0.7 
7.48 
0.6 
7.90 
0.7 
7.71 
1.2 
7.65 
1.2 
7.28 
0.8 
7.74 
1.1 
lnLF 
(lnms2) 
 
6.05 
0.8 
6.43 
0.7 
6.45 
0.8 
6.53 
0.6 
5.97 
1.4 
6.44 
1.5 
6.44 
0.8 
6.50 
1.2 
lnHF 
(lnms2)  
 
6.81 
1.5† 
6.14 
1.2 
4.81 
1.2* 
6.59 
0.8† 
6.96 
1.5† 
6.45 
1.2 
4.34 
1.0* 
6.73 
1.0† 
lnLFNU 
(ln%)  
 
3.36 
0.7†‡ 
3.99 
0.3 
4.39 
0.2* 
3.83 
0.3 
3.26 
0.5†‡ 
3.83 
0.4 
4.46 
0.1* 
3.73 
0.4 
lnHFNU 
(ln%)  
 
4.14 
0.3†‡ 
3.70 
0.5 
2.75 
0.6* 
3.89 
0.4 
4.25 
0.2†‡ 
3.84 
0.5 
2.36 
0.8* 
3.95 
0.6 
lnLF/ 
lnHF  
 
0.91 
0.1† 
1.07 
0.2 
1.38 
0.2* 
1.00 
0.1 
0.86 
0.1 
0.99 
0.1 
1.54 
0.3* 
0.97 
0.1 
lnHF/ 
lnTP  
 
0.89 
0.1† 
0.80 
0.1 
0.64 
0.1* 
0.83 
0.1 
0.89 
0.1† 
0.84 
0.1 
0.59 
0.1* 
0.87 
0.1 
Mean RR = mean RR interval    TP = total power 
SDNN = standard deviation of normal RR intervals  LF = low-frequency power 
HF = high-frequency power    NU = normalized units 
ln = natural logarithm     ms = milliseconds 
* = p<0.05 vs. other 3 conditions for specified group 
† = p<0.05 vs. SB1 for specified group 
‡ = p<0.05 vs. SB2 for specified group 
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Table E.14 
HRV During Test 4 (Mean, sd) 
 
 Group 
 
 
EX CT 
 
 
PB SB1 Tilt SB2 
 
PB SB1 Tilt SB2 
 
Mean RR 
(ms)  
 
958.33 
123.4‡ 
982.9 
155‡ 
775.4 
126* 
1039.5 
166 
965.22 
161.1‡ 
1004.7 
156‡ 
773.6 
131* 
1091.5 
145 
SDNN 
(ms)  
 
91.8 
52 
85.9 
30 
71.6 
30* 
89.8 
25 
79.4 
32 
87.5 
33 
61.3 
26* 
90.6 
25 
lnTP 
(lnms2)  
 
7.74 
0.9 
7.66 
0.7 
7.40 
1.1* 
7.82 
0.8 
7.68 
0.9 
7.77 
0.8 
7.15 
0.9* 
7.88 
0.6 
lnLF 
(lnms2)  
 
6.05 
0.7†‡ 
6.54 
0.9 
6.42 
1.2 
6.69 
0.7 
5.89 
1.2†‡ 
6.58 
1.1 
6.2 
1.0 
6.73 
0.6 
lnHF 
(lnms2)  
 
6.84 
1.4† 
6.03 
1.2 
4.63 
1.6* 
6.54 
1.0 
6.95 
1.2† 
6.49 
0.8 
4.52 
1.1* 
6.72 
0.8 
lnLFNU 
(ln%)  
 
3.31 
0.8†‡ 
4.07 
0.3 
4.41 
0.2* 
3.89 
0.4 
3.19 
0.6†‡ 
3.88 
0.5 
4.40 
0.1* 
3.82 
0.4 
lnHFNU 
(ln%)  
 
4.09 
0.4†‡ 
3.56 
0.5 
2.62 
0.7* 
3.75 
0.5 
4.24 
0.2†‡ 
3.79 
0.4 
2.72 
0.6* 
3.81 
0.6 
lnLF/ 
lnHF  
 
0.91 
0.2†‡ 
1.11 
0.2 
1.48 
0.4* 
1.04 
0.2 
0.85 
0.1†‡ 
1.02 
0.1 
1.42 
0.3* 
1.01 
0.2 
lnHF/ 
lnTP  
 
0.88 
0.1† 
0.78 
0.1 
0.62 
0.2* 
0.84 
0.1 
0.90 
0.1† 
0.84 
0.1 
0.63 
0.1* 
0.85 
0.1 
Mean RR = mean RR interval    TP = total power 
SDNN = standard deviation of normal RR intervals  LF = low-frequency power 
HF = high-frequency power    NU = normalized units 
ln = natural logarithm     ms = milliseconds 
* = p<0.05 vs. other 3 conditions for specified group 
† = p<0.05 vs. SB1 for specified group 
‡ = p<0.05 vs. SB2 for specified group 
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Table E.15 
 
HRV During Test 5 (Mean, sd) 
 
 Group 
 
 
EX CT 
 
 
PB SB1 Tilt SB2 
 
PB SB1 Tilt SB2 
 
Mean RR 
(ms)  
 
985.34 
148.6‡ 
983.2 
167‡ 
773.2 
142* 
1025.0 
185 
987.06 
99.8‡ 
1042.2 
140‡ 
801.7 
108* 
1116.0 
159 
 
SDNN 
(ms)  
 
99.3 
56 
79.8 
32‡ 
79.7 
50‡φ 
101.2 
30 
91.1 
29 
87.8 
23‡ 
68.0 
29‡φ 
93.5 
27 
lnTP 
(lnms2)  
 
7.66 
0.9 
7.58 
0.6 
7.42 
1.0* 
7.96 
0.6 
7.92 
0.5 
8.02 
0.9 
7.36 
0.9* 
7.96 
0.8 
lnLF 
(lnms2)  
 
5.87 
0.8†‡ 
6.31 
0.7 
6.18 
0.9 
6.58 
0.5 
6.2 
0.7†‡ 
6.72 
1.1 
6.38 
1.1 
6.57 
0.6 
lnHF 
(lnms2)  
 
7.3 
1.2 
5.84 
1.2‡φ 
5.58 
1.1‡φ 
6.96 
0.8 
7.04 
0.9† 
6.66 
0.8 
4.62 
1.0* 
6.93 
0.7 
lnLFNU 
(ln%)  
 
2.89 
0.8* 
4.06 
0.3 
4.12 
0.2 
3.63 
0.4 
3.36 
0.5† 
3.84 
0.5 
4.41 
0.1* 
3.67 
0.3 
lnHFNU 
(ln%)  
 
4.32 
0.2 
3.59 
0.44φ 
3.52 
0.5φ 
4.01 
0.4 
4.19 
0.2 
3.78 
0.5 
2.65 
0.6* 
4.03 
0.3 
lnLF/ 
lnHF  
 
0.82 
0.1 
1.10 
0.1φ 
1.12 
0.1φ 
0.96 
0.1φ 
0.89 
0.1 
1.01 
0.1 
1.41 
0.2* 
0.95 
0.1 
lnHF/ 
lnTP  
 
0.95 
0.1 
0.77 
0.1‡φ 
0.75 
0.1‡φ 
0.88 
0.1 
0.88 
0.1 
0.83 
0.1 
0.62 
0.1* 
0.87 
0.1 
Mean RR = mean RR interval    TP = total power 
SDNN = standard deviation of normal RR intervals  LF = low-frequency power 
HF = high-frequency power    NU = normalized units 
ln = natural logarithm 
* = p<0.05 vs. other 3 conditions for specified group 
† = p<0.05 vs. SB1 for specified group 
‡ = p<0.05 vs. SB2 for specified group 
φ = p<0.05 vs. PB for specified group 
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Figure E.1 Relationship Between Delta VO2peak and Delta lnLF/lnHF during PB in EX 
r = 0.42 
p = 0.17 
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Figure E.2 Relationship Between Delta VO2peak and Delta lnLF/lnHF during TILT in EX 
 
 
r = 0.07 
p = 0.82 
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